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CHAPTER1
Abstract
New insights in the field of biotechnology allow the understanding of processes in the
body down to the smallest detail and to intervene in the event of deviation. One type of
intervention is the treatment of diseases with recombinant proteins, such as antibodies
or enzymes. The efficacy of these biopharmaceutical active substances makes it possible
to treat diseases which have hitherto been difficult to deal with, such as malign neoplasm
or multiple sclerosis. The more complex the mode of action of the drug applied, the more
complex is the biomolecule of choice. This complexity has an impact on the processabil-
ity, formulation and application of biopharmaceuticals. In particular, the colloidal and
conformational solution stability is a challenge during their shelf life. Protein solution
instabilities can cause process delays or in a worst case scenario life-threatening immune
reactions in the patient‘s body and are thus important to control.
The solution stability is dependent on the molecular properties and the environmen-
tal conditions. A high-impact parameter is the protein concentration. To save process
costs and to simplify drug administration, the concentration of the target molecule is
maximally increased during processing and formulation. The increase in protein concen-
tration to highly concentrated conditions does not only affect protein stability itself but
also increases the possible number of stability-influencing parameters. Due to the reduced
distance between the molecules at high concentrations long- as well as short-range forces
do have an impact on the protein solution behavior. The complex interplay of the result-
ing interactions are difficult to depict. Additionally, as a result of the increased number
of molecules in solution, the two-dimensional protein interactions occurring in an ideal
dilute solution become multidimensional, so that a characterization by conventional pre-
dicting methods reaches its limits. Due to the lack of an established predicting analytical
tool it is therefore common practice to store the molecules of interest under varying
solution conditions over a period of 12-24 months and analyze the samples for protein
unfolding or aggregation, afterwards. This method is precise and ensures the safety of
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the patient but is time and cost intensive. Furthermore, with the help of this method,
only knowledge about the stability range is gained, but no information is available on
the mechanisms of protein-protein or protein-solvent interactions. Thus the transfer of
the results to other molecules or solution conditions is limited. Novel analytical methods
are demanded, which enable a better characterization of protein solution behavior and
parameters which allow a direct prediction of protein solution stability even in the highly
concentrated regime. A promising method for analyzing complex fluids such as highly
concentrated protein solutions is rheology.
Rheology is the science of fluent materials and describes the flow behavior and the defor-
mation of matter. According to rheology, experimental objects can be divided according
to their elasticity and their viscosity. In the case of an ideally elastic body, the extent of
the deformation is directly proportional to the applied stress, and the body moves back
into its initial position after applied force. An ideally viscous body reacts to an effective
force with a time-delayed deformation and the deformation is irreversible. Protein solu-
tions behave viscoelastic. This means that after application of a force, they only partially
relax and accordingly demonstrate partially elastic, partially viscous behavior. The vis-
coelastic properties of protein solutions depend on the size and number of molecules in
solution, their flexibility, the degree of cross-linking, and the degree of molecule-molecule
and molecule-solvent interactions. The changes in the viscoelastic behavior of fluids can
be described very precisely by the measurable storage and loss moduli (G′ and G′′). In
contrast to industrial branches such as the food or cosmetics industry, the characteriza-
tion of the viscoelastic behavior of protein solutions has not yet been established in the
biopharmaceutical industry.
The aim of this thesis is therefore to investigate the potential of rheology for the bio-
pharmaceutical process and formulation development. Focusing on the characterization of
the viscoelastic behavior of highly concentrated protein solutions. In addition, the deter-
mined rheological parameters were evaluated for their suitability to predict the long-term
stability of these complex fluids. To refine the predictive approach, in a next step, the
rheological measurements were combined with results of orthogonal analyzing tools. Fur-
thermore, the microrheological technique was optimized by a tracer particle screening.
Prior to the rheological characterization, handling and standard analytics for studying
highly concentrated protein solutions were optimized. In the first part of the thesis an
analytical microfluidic device is presented, which enables the automated determination of
protein concentration by means of UV absorption. Commercially available devices for the
determination of protein concentration are limited either by high-throughput compati-
bility or the measuring range. For the exact determination of the protein concentration,
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highly concentrated protein solutions must therefore be diluted several times. The time
consuming dilution procedure can lead to unacceptable standard deviations especially
when handling small sample volumes. It is for this reason that a disposable silicone chip
was developed for automated high-throughput measurements at microliter scale. The de-
vice allows the direct measurement of UV absorption in a wide protein concentration
range by the use of microfluidic channels, which enable a layer thickness of less than
1 mm. The device was validated according to ICH guidelines and the application was
demonstrated by a case study on an automated liquid handling station. The use of the
device allows high-throughput absorption measurements in a protein concentration range
of around 0.1-100 mg/ml with an accuracy of 99.2 %.
As a second preparatory step a robot-based method for generating protein phase diagrams
was adapted to the handling of highly concentrated protein solutions. The protein phase
diagrams generated in this way were used to compare the long-term stability behavior of
studied proteins with the rheological measurements. With this automated platform more
than 20 phase diagrams with different protein types, protein concentrations, additives
types and concentrations, and changing pH values could be screened.
The main focus of this work was the rheological characterization and the interpretation
of obtained viscoelastic properties of protein solutions under varying process and formu-
lation conditions. For the comparatively weak viscoelastic protein solutions, oscillating
experiments were performed in the high-frequency range for the determination of the
rheological parameters. In this respect, G′ and G′′ were determined over a frequency
ramp with oscillatory squeeze flow.
Within the framework of this work, a rheological screening of the model protein lysozyme
from chicken egg white in a concentration range of 100-225 mg/ml and varying solution
conditions was carried out. This screening initially served to evaluate suitable viscoelastic
key parameters. The viscoelastic moduli G′ and G′′ were determined over a frequency
range of 100-40000 rad/sec and the crossover point of the two resulting curves calculated.
The frequency value of the detected crossover point, ωCO, was selected to be correlated
with the protein phase behavior. It was shown that highly concentrated protein solutions
show a characteristic viscoelastic behavior which is sensitive towards changing solution
conditions. Furthermore, the ωCO values of all samples, determined directly after sample
preparation (t0), could successfully be correlated with the phase behavior of lysozyme
after 40 days of incubation (t40). The large-scale screening allowed to draw a solubility
limit for lysozyme based on ωCO values at 20000 rad/sec. The calculated ωCO limit pro-
vides the prerequisite for the prediction of the long-term solution stability of lysozyme,
with only one rheological measurement, conducted directly after sample preparation.
3
Chapter 1 Abstract
In a next step, the predictive rheological approach was combined with molecular dy-
namics (MD) simulations. The MD simulations used in this work provide information
on the surface characteristics of the proteins being studied and can therefore explain the
long-term behavior of protein samples predicted by the rheological approach. For this
purpose, a case study with Glutathione-S-Transferase was performed in its pure form
and fused with a potentially stabilizing tag (Cherry-Tag™) under varying solution con-
ditions. The rheological characterization allowed a precise prediction of the colloidal and
conformational solution stability of both studied proteins. The rheological screening re-
vealed the strong solubility-enhancing nature of the Cherry-Tag™. In combination with
the results of the MD simulations, the solubility increase could be attributed to a pro-
nounced change in the protein surface charge and protein surface hydrophobicity caused
by the Cherry-Tag™.
Monoclonal antibodies and antibody related species belong to a quickly expanding field
of application in the pharmaceutical industry. Due to the complexity and size, the long-
term stability of this molecule class is classified as particularly critical. This challenging
situation is aggravated by the fact that new application forms require antibody titers of
more than 100 mg/ml. In order to confront these challenges, the study of viscoelastic-
ity was transferred to antibodies under process-relevant conditions. It was shown that
viscoelastic measurements are very sensitive to changes in the solution conditions of an-
tibody formulations and that the parameter ωCO enables the prediction of the colloidal
stability of the antibody under investigation. The rheological analysis was also linked
with established, orthogonal methods for the characterization of the protein surface, the
protein mobility and thermal stability studies. The application of the resulting analytical
toolbox ensures a precise prediction of the protein solution stability and is therefore an
important contribution to the rapid development of stable and safe antibody formula-
tions.
The mechanical high-frequency rheology used for the above listed screenings is not com-
mon in the pharmaceutical industry and a corresponding device is currently not commer-
cially available. Therefore, parallel to the mechanical measurements the optimization of
the microrheological technique was expedited. In the case of microrheological measure-
ments, the parameters G′ and G′′ are determined by means of dynamic light scattering.
To gain reproducible, correct results it is required that the tracer particles do not interact
with the proteins in solution. Therefore, the surface characteristic and the interaction ten-
dency of four different potential tracer particles were investigated under changing buffer
conditions. It was found that the choice of the tracer particle has a significant influence
on the rheological results. An internally developed polystyrene particle with a modified
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surface turned out to be the only suitable tracer particle for the microrheological measure-
ments of protein solutions tested. With this particle type, a high measurement accuracy
and a good correlation with the results of mechanical rheometers could be achieved.
In summary, the emphases of this work have been extensively studied to obtain a com-
prehensive picture of the viscoelastic properties of highly concentrated protein solutions.
In particular, the sensitivity of viscoelastic parameters against changing protein solution
conditions has been demonstrated and a rheological parameter, ωCO, has been introduced
that allows predictive statements about the solubility of proteins in highly complex solu-
tions. The introduced and validated parameter, particularly in combination with further
analytical methods used here, enables a fast and reliable characterization of viscoelastic
fluids and can thus also be applied in other research disciplines.
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CHAPTER2
German Abstract: Zusammenfassung
Neue Erkenntnisse im Bereich der Biotechnologie ermöglichen es Vorgänge im Körper
bis ins kleinste Detail zu verstehen und bei Abweichungen regulierend einzugreifen. Eine
Art des Eingreifens ist die Behandlung von Krankheiten mit rekombinanten Proteinen,
wie Antikörpern oder Enzymen. Die Wirkspezifität dieser biopharmazeutischen Wirk-
stoffe ermöglicht die Behandlung von bisher schwer zu therapierenden Erkrankungen
wie maligne Neoplasie oder multiple Sklerose. Je komplexer der Wirkmechanismus des
eingesetzten Medikaments ist, desto komplexer ist das Biomolekül welches zum Einsatz
kommt. Diese Komplexität hat Auswirkungen auf die Prozessierbarkeit des Biophar-
mazeutikums. Insbesondere die kolloidale und konformelle Stabilität des Zielmoleküls
ist eine Herausforderung während des Herstellungsprozesses, des Aufreinigungsprozesses
und der Formulierung. Proteinlösungsinstabilitäten können Prozessverzögerungen oder
im schlimmsten Fall lebensbedrohliche Immunreaktionen im Körper des Patienten verur-
sachen und sind daher wichtig zu kontrollieren.
Die Stabilität des Biomoleküls ist abhängig von der Beschaffenheit des Moleküls an
sich sowie den Umgebungsbedingungen. Ein Lösungsparameter mit hohem Einfluss ist
die Proteinkonzentration. Um die Prozesskosten zu senken und die Verabreichung des
Medikaments zu erleichtern, wird die Konzentration des Zielmoleküls während der Verar-
beitung und der Formulierung maximal erhöht. Die Erhöhung der Proteinkonzentration
hin zu hochkonzentrierten Bedingungen hat nicht nur Auswirkungen auf die Protein-
stabilität sondern erhöht auch die mögliche Anzahl von Mechanismen, die diese beein-
flussen. Der Parameterraum vergrößert sich mit dem zunehmenden Einfluss von haupt-
sächlich attraktiven kurzreichweitigen Wechselwirkungen. Zusätzlich werden, durch die
Erhöhung der Molekülzahl, die in idealer Lösung vorliegenden zweidimensionalen Protein-
Wechselwirkungen mehrdimensional, sodass eine Charakterisierung mittels herkömm-
licher prädiktiver Analysemethoden an ihre Grenzen stößt. Um die Lösungsstabilität
von hochkonzentrierten Proteinlösungen und Formulierungen sicherzustellen ist es wegen
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fehlender prädiktiver Methoden gängige Praxis, das Molekül von Interesse unter variieren-
den Lösungsbedingungen über eine Zeit von 12-24 Monaten zu lagern und daraufhin auf
Entfaltung oder Aggregation zu analysieren. Diese Methode ist zeit- und kostenintensiv.
Mit Hilfe dieser Methode wird außerdem ausschließlich Wissen über den Stabilitätsbere-
ich gewonnen, allerdings keine Informationen über den Mechanismus dahinter, welcher
für die Übertragbarkeit der Ergebnisse auf andere Moleküle oder Lösungsbedingungen
von Bedeutung wäre. Es werden innovative, neuartige Methoden gefordert, welche das
Verhalten von Proteinen in hochkonzentrierten Bereich besser charakterisieren können.
Außerdem gilt es Parameter zu evaluieren, die eine Vorhersage der Lösungsstabilität auch
im hochkonzentrierten Bereich ermöglichen. Eine vielversprechende Methode zur Analyse
komplexer Flüssigkeiten, wie hochkonzentrierte Proteinlösungen, ist die Rheologie.
Rheologie ist die Lehre der fließenden Stoffe und beschreibt damit das Fließverhalten
und die Verformung von Materie. Nach der Lehre der Rheologie werden Versuchsob-
jekte nach ihrer Elastizität beziehungsweise ihrer Viskosität unterteilt. Bei einem ideal
elastischen Körper ist das Ausmaß der Deformation direkt proportional zur eingesetzten
Spannung und der Körper bewegt sich nach der Krafteinwirkung in seine Ausgangslage
zurück. Ein ideal viskoser Körper reagiert auf eine Krafteinwirkung mit einer zeitlich
verzögerten Deformation und die Verformung ist irreversibel. Proteinlösungen verhalten
sich viskoelastisch. Das bedeutet, dass sie nach Aufbringung einer Kraft nur unvollständig
relaxieren, also teilweise elastisches, teilweise viskoses Verhalten aufweisen. Die viskoe-
lastischen Eigenschaften von Fluiden sind von der Größe und Anzahl der Moleküle in Lö-
sung, deren Flexibilität, Vernetzungs- und Interaktionsgrad abhängig. Die Änderungen
des viskoelastischen Verhaltens von Fluiden können sehr genau durch das Speicher- und
das Verlustmodul (G′ und G′′) beschrieben werden. Im Gegensatz zu Industriezweigen
wie der Lebensmittel- oder Kosmetikindustrie ist die Charakterisierung des viskoelastis-
chen Verhaltens von Proteinlösungen in der biopharmazeutischen Industrie noch nicht
etabliert.
Ziel dieser Arbeit war es deshalb, das Potenzial der Rheologie für die biopharmazeutis-
che Prozess- und Formulierungsentwicklung zu untersuchen. Hierbei lag der Fokus auf
der Charakterisierung des viskoelastischen Verhaltens hochkonzentrierter Proteinlösun-
gen. Darüber hinaus wurden die ermittelten rheologischen Parameter auf ihre Eignung
zur Vorhersage der Langzeitstabilität von Proteinlösungen geprüft. Um den prädiktiven
Ansatz zu verfeinern, wurden in einem nächsten Schritt die rheologischen Messungen
mit Ergebnissen orthogonaler Analytikmethoden kombiniert. Darüber hinaus wurde die
Mikrorheologische Technik durch ein Tracer-Partikel-Screening optimiert.
Vorbereitend zur rheologischen Charakterisierung, wurde die Handhabung und Standar-
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danalytik von hochkonzentrierte Proteinlösungen optimiert. Der erste Teil dieser Arbeit
beschreibt die Entwicklung eines analytischen Mikrofluidik-Chips der die automatisierte
Messung der Proteinkonzentration mittels UV Absorption ermöglicht. Bei kommerziell
erhältlichen Geräten, für die Bestimmung der Proteinkonzentration, ist entweder die
Hochdurchsatzkompatibilität oder der Messbereich limitierender Faktor. Für die exakte
Bestimmung der Proteinkonzentration, müssen daher hochkonzentrierte Proteinlösungen
um ein vielfaches verdünnt werden, was bei geringem Probenvolumen zu hohen Abwe-
ichungen und Zeitverlust führen kann. Daher wurde in der vorliegenden Arbeit für die
automatisierte Hochdurchsatzmessung im Mikrolitermaßstab ein Silikon-Chip entwick-
elt, der die direkte Bestimmung der Absorption von hochkonzentrierten Proteinlösungen
zulässt. Der Chip wurde nach ICH Guidelines validiert und die Anwendung mit Hilfe einer
Fallstudie demonstriert. Die Verwendung des Chips ermöglicht Absorptionsmessungen im
96-well kompatiblen Maßstab in einem Protein-Konzentrationsbereich von 0.1-100 mg/ml
mit einer Genauigkeit von 99.2 %.
Als zweiter vorbereitender Schritt wurde ein Roboter-basiertes Verfahren zur Generierung
von Proteinphasendiagrammen auf hochkonzentrierte Proteinlösungen angepasst. Die so
erzeugten Proteinphasendiagramme wurden verwendet, um das Langzeitstabilitätsver-
halten der Proteine mit den rheologischen Messungen zu vergleichen. Diese Methodik
wurde zur Herstellung von mehr als 20 Phasendiagrammen mit variierender Proteinart,
Proteinkonzentration, Additivart und Konzentration sowie variierendem pH-Wert ver-
wendet.
Der Schwerpunkt dieser Dissertation liegt in der rheologischen Charakterisierung und der
Interpretation der erhaltenen viskoelastischen Eigenschaften von Proteinlösungen unter
wechselnden Prozess- und Formulierungsbedingungen. Für die schwach viskoelastischen
Proteinlösungen wurden für die Ermittlung der rheologischen Parameter Oszillationsver-
suche im Hochfrequenzbereich durchgeführt. Hierbei wurden G′ und G′′ über einen Fre-
quenzrampe bei oszillierender Quetschströmung ermittelt.
Im Rahmen dieser Arbeit wurde für die Definition geeigneter viskoelastischer Parameter
zunächst ein rheologisches Screening mit dem Modellprotein Lysozym aus Hühnerei in
einem Konzentrationsbereich von 100-225 mg/ml unter variierenden Lösungsbedingungen
durchgeführt. Mit Hilfe dieses Screenings konnte gezeigt werden, dass hochkonzentrierte
Proteinlösungen ein für Polymere charakteristisches viskoelastisches Verhalten aufweisen.
Des Weiteren wurde der ωCO Wert aller vermessenen Proben zum Zeitpunkt t0 berechnet
und erfolgreich mit dem Phasenverhalten von Lysozym nach 40 Tagen Inkubationszeit
(t40) korreliert. Das groß angelegte Screening ermöglichte es eine Löslichkeitsgrenze für
Lysozym basierend auf den ωCO Werten zu ziehen. Der ermittelte ωCO Grenzwert schafft
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die Voraussetzung die Langzeit-Lösungsstabilität von Lysozym, mit nur einer rheologis-
chen Messung, direkt nach Probenpräparation bestimmen zu können.
In einem nächsten Schritt wurde der prädiktive rheologische Ansatz mit Molekulardy-
namik (MD)-Simulationen kombiniert. Die in dieser Arbeit eingesetzten MD-Simulationen
geben Aufschluss über die Oberflächencharakteristik der untersuchten Proteine und kön-
nen somit die Langzeit-Lösungsstabilität, welche durch den rheologischen Ansatz vorherge-
sagt wurde, begründen. Hierzu wurde eine Fallstudie mit Glutathione-S-Transferase in
ihrer Reinform und fusioniert mit einem potentiell löslichkeitserhöhenden Tag (Cherry-
Tag™) unter variierenden Lösungsbedingungen durchgeführt. Die rheologische Charak-
terisierung der beiden Proteine ermöglichte eine präzise Vorhersage der kolloidalen und
konformellen Lösungsstabilität. Das rheologische Screening gab Aufschluss über den stark
löslichkeitserhöhenden Charakter des verwendeten Cherry-Tags™. In Kombination mit
den Ergebnissen der MD-Simulation, konnte die Löslichkeitserhöhung auf eine starke Än-
derung der Oberflächenladung und der Oberflächenhydrophobizität, hervorgerufen durch
den Cherry-Tag, zurückgeführt werden.
Monoklonale Antikörper und ihre Untergruppen besitzen das am schnellsten wachsende
Anwendungsfeld in der pharmazeutischen Industrie. Durch die Komplexität und die
Größe dieser Moleküle wird deren Langzeitstabilität als besonders kritisch eingestuft.
Erschwerend kommt hinzu, dass neue Applikationsformen Antikörpertiter von mehr als
100 mg/ml in der Endformulierung voraussetzen. Um diesen Herausforderungen entge-
genzutreten, wurde die Untersuchung der Viskoelastizität auf Antikörper unter prozess-
relevanten Bedingungen übertragen. Es konnte gezeigt werden, dass viskoelastische Mes-
sungen sehr sensitiv gegenüber Änderungen der Lösungsbedingungen von Antikörper-
formulierungen sind, und dass der vorgestellte Parameter ωCO die kolloidale Stabilität
des untersuchten Antikörpers exakt vorhersagen kann. Die rheologische Analytik wurde
zudem mit etablierten, orthogonalen Methoden zur Charakterisierung der Proteinober-
fläche, der Proteinmobilität und thermischen Stabilitätsuntersuchungen verknüpft. Die
Anwendung der so entstandene analytische Toolbox gewährleistet eine präzise Vorhersage
der Proteinlösungsstabilität und ist somit ein wichtiger Beitrag für die schnelle Entwick-
lung stabiler und sicherer Formulierungen von Biopharmazeutika.
Die Anwendung mechanische Hochfrequenz-Rheologie, die für die oben aufgeführten
Screenings verwendet wurde, ist in der pharmazeutischen Industrie nicht etabliert, und
eine entsprechendes Gerät ist derzeit nicht im Handel erhältlich. Daher wurde parallel zur
Verwendung der mechanischen Rheologie die Optimierung der mikrorheologischen Tech-
nik vorangetrieben. Bei mikrorheologischen Messungen werden die Parameter G′ und G′′
mittels dynamischer Lichtstreuung bestimmt. Um reproduzierbare, korrekte Ergebnisse
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zu erzielen, ist es erforderlich, dass die Tracerpartikel nicht mit den Proteinen in Lösung
wechselwirken. In einer Studie wurden daher die Oberflächencharakteristik und die Inter-
aktionsneigung vier unterschiedlicher Tracerpartikel untersucht. Festgestellt wurde, dass
die Wahl des Tracerpartikels einen großen Einfluss auf die rheologischen Ergebnisse hat.
Ein intern hergestelltes Polystyrolpartikel mit modifizierter Oberfläche stellte sich als
einzig geeigneter Tracerpartikel für die rheologische Untersuchung von in dieser Studie
untersuchten Proteinlösungen heraus. Mit diesem konnte eine hohe Messgenauigkeit und
eine gute Korrelation mit den Ergebnissen mechanischer Rheometer erreicht werden.
Zusammenfassend wurde in der vorliegenden Arbeit ein umfassendes Bild der viskoelastis-
chen Eigenschaften von hochkonzentrierten Proteinlösungen gewonnen. Im Speziellen
konnte eine ausführliche Charakterisierung hochkonzentrierter Proteinlösungen erreicht
und ein rheologischer Parameter, ωCO eingeführt werden, der prädiktive Aussagen über
die Lösungsstabilität der hochkomplexen Lösungen zulässt. Der eingeführte und validierte
Parameter ermöglicht, gerade in Kombination mit weiteren hier verwendeten analytischen
Verfahren, eine schnelle und sichere Charakterisierung von viskoelastischen Fluiden und
kann so auch in anderen Forschungsdisziplinen Anwendung finden.
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CHAPTER3
Introduction
Biotechnology as a name was first used by Károly Ereky, an Hungarian Engineer from
1919. He used the term to describe the process by which raw materials could be bio-
logically upgraded into socially useful products [1, 2]. Ereky did research in the field
of agricultural biotechnology. However, its definition has been valid for an ever-growing
field of application [3, 4]. The revolution of the medical use of biotechnology started when
Watson and Crick deciphered the DNA in 1953 [5]. Only 20 years later the research group
around Paul Berg from Stanford University succeeded to produce the first recombinant
DNA [6]. New techniques for manipulating the expression gene and manufacturing gene
products paved the way for the commercial production of recombinant biopharmaceuti-
cal products [7, 8]. In 1978 Genentech, the first biotech company, succeeded in isolating
a gene which decodes human insulin [9]. They managed to insert the gene in a cloning
vector which can be placed and transcripted by the easy to handle bacterium Escherichia
coli. This technical achievement and the pioneering role of this company led to an incred-
ible increase in the share price from $35 to $89 within 20 minutes during Genentech’s
stock market entry two years later [10]. Tax relief as well as the support of stock market
speculators and private investors allowed the creation of about 700 biotechnology com-
panies in the following years [11]. The economical success and the better understanding
of molecular biology laid the foundation for a still increasing biopharmaceutical market.
Nowadays, the biopharmaceutical products range from small, fairly simple proteins, such
as insulin or growth hormones, antibodies and their subclasses, to complex structured
viruses or virus like particles[12, 13].
Essentially, four steps are required for the manufacture of these drug products. First,
the feedstock must be prepared so that it can serve as a source of food for the target
microorganisms (upstream processing). Then the host cell is multiplied and the desired
compound, i.e. the target molecule is expressed during the fermentation (biotransfor-
mation). As a third step, the drug substance must be purified over a large number of
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orthogonal process steps so that it can be administered as drug product to humans after
the final formulation (fourth step) [14]. In order to reduce process costs and to enable
new forms of application, ever higher protein titers are processed and formulated [15, 16].
In order to ensure the quality of the product, the manufacture and purification are sub-
ject to strict rules [13]. Special attention is given here to the stability and the associated
activity of the molecule [17, 18]. The stability of a molecule in highly concentrated solu-
tions is considered to be a critical factor as the influencing parameters change constantly
during the course of the biopharmaceutical process [19, 20] and poses new challenges
for process engineers [21, 22]. Not only the mechanical stress, triggered by pumping or
shearing, but also the environmental conditions that change over the different process
steps can lead to a decreased solution stability in form of protein aggregation or unfold-
ing [23, 24]. Furthermore, the increase in protein concentration also increases the number
of possible interaction mechanisms, which further increases the complexity of the pro-
tein behavior. The impact of molecular characteristics and the forces and interaction
mechanisms involved are discussed in more detail in section 3.1 and 3.2, respectively. In
the last decades analytical strategies were developed to identify, control and manipulate
the protein solution behavior. An overview of established analytical techniques for the
characterization and identification of protein solution behavior is given in section 3.3.
Unfortunately, there is so far no methodology that can describe and predict the stabil-
ity of the protein solution in the highly concentrated regime. To counter this problem,
novel analytical methods have to be found and evaluated. This work focuses on the eval-
uation of rheological methods and their potential for describing the solution behavior of
highly concentrated protein formulations. Section 3.4 discusses the science of soft matter,
focusing on rheological methods that can be applied to biopharmaceutical substances.
3.1 Molecular Characteristics of Proteins
Proteins are macromolecules, which can be assigned to a variety of tasks in the human
body. The processes range from signal processing over immunological responses to cat-
alytic reactions [25]. The specificity of each molecule is enabled by a unique sequence of
21 proteinogenic amino acids adapted to the particular function [26]. The sequence of the
amino acids as a polypeptide is encoded in the DNA or RNA. This allows the produc-
tion of proteins by recombinant genetic engineering. The amino acids differ in their side
chains. These have basic, acidic, nonpolar hydrophobic or polar hydrophobic properties
[27, 28]. These properties allow the assembly of the amino acids into ordered structures
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(2D structure) and their further structural formation towards the 3D structure specific
for each protein [29]. Electrostatic interactions, hydrophobic forces, van der Waals forces
and hydrogen bonds between the side chains of the polypeptide are responsible for the
correct folding of the protein [30]. In order to avoid contact with water, amino acids with
hydrophobic side chains are mostly found in the center of the protein [31]. The resulting
hydrophobic interactions in the protein core stabilize its 3D structure. Amino acids with
hydrophilic side chains interact positive with the surrounding aqueous solution and thus
stabilize the molecule with respect to intermolecular interactions [32]. The hydrophilic
character of side chains is an intrinsic property of pH dependent charge. The charge of the
amino acids is determined by the terminal carboxyl (COOH) and amine (NH2) groups
as well as by titratable amino acid residues [33]. The number of these amino acids as
well as their distribution on the protein surface are crucial for the protein polarity and
thus for their solution colloidal stability. In Figure 3.1 the charge distribution of three
proteins, namely IgG1, Glutathion-S-Transferase and lysoyzme from chicken egg-white
at pH 7 are illustrated. Positive charges are colored in blue, whereas negative charges
are colored in red. The figure also shows geometric differences of the proteins. Lysozyme
and Glutathion-S-Transferase, composed of two identical subunits, are globular proteins
with a molecular mass of 14 kDa and 52 kDa, respectively [34]. Whereas the monoclonal
antibody with a molecular mass of 145 kDa exhibits the characteristic y-shape. The ge-
ometry of the protein has an impact on the charge distribution and hydrophobicity of
the proteins. It is also decisive for the accessibility of certain surface patches.
Figure 3.1: Illustration of the 3D structure of IgG1, Glutathion-S-Transferase and
lysoyzme from chicken egg white at pH 7. The protein surface is colored
according to its surface charge distribution. Positive charges are colored in
blue, negative charges are colored in red. Molecular graphics were created
with YAZARA and POVRay.
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The native state of the protein is energetically the most stable conformation. But is only
exiguously more stable as the undesired unfolded or partly unfolded conformational state
[35]. Because of this narrow range of stability, small changes in the chemical surrounding
can lead to structural changes. The sensitivity of the proteins towards their colloidal and
conformational stability poses a major challenge for the biopharmaceutical process and
formulation development.
3.2 Conformational and Colloidal Stability of Proteins in
Solution
The conservation of the native structure as well as the solubility of proteins are dictated by
basic chemical and physical principles. After the differentiation between protein unfolding
and protein aggregation this section will address these principles and describe the forces
of impact (section 3.2.1 and 3.2.2). How these forces are triggered and which solution
parameters influence them will be explained afterwards (section 3.2.3).
3.2.1 Definition of Protein Unfolding
Protein unfolding describes the elongation of the superordinate 3D structure of a protein
into a structural disordered polypeptide chain [36, 37]. As a result of the unfolding,
the protein loses its activity and thus also its pharmacological effect [37]. Depending on
the protein, the unfolding process can proceed via one or more intermediate stages. In
recent years kinetic and equilibrium data have provided extensive information on protein
unfolding pathways [38, 39]. In addition, the molten globule state was investigated more
closely [40]. The molten globule state is a non-native compact stage with a formed 2D
but a non-developed 3D structure. Lysozyme from chicken egg white which was used in
this study as a model protein develops such a molten globule state in strongly acidic
conditions [41, 42].
3.2.2 Definition of Protein Aggregation
In this work protein aggregation include all forms of protein assembly, whether they are
amorphous or fibrillar [43], soluble or insoluble, native or non-native, in the form of crys-
tals or precipitates [44].
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Protein aggregation has a decisive influence on over 40 diseases, in terms of their out-
break, course and mortality. The negative impact of protein aggregates could be shown
for common diseases such as Alzheimer’s disease, Huntington disease and Parkinson’s
disease [43, 45]. In addition to the serious health consequences and when administered
as a drug product, the uncontrolled assembly of proteins during processing, formulation
and storage are considered as a bottleneck in the biopharmaceutical industry [46–48].
Negative consequences come in the form of yield losses or process delays due to clogged
filters or the abrupt increase of protein viscosity. Especially in the highly concentrated
regime, the mechanisms of protein aggregation are not sufficiently investigated, so that
targeted process manipulation is not possible nowadays.
Depending on the protein structure and the solution conditions, macromolecules can ac-
cumulate over different reaction pathways [43]. The aggregation nucleus can arise from an
assembly of native, elongated or partially unfolded, as well as completely unfolded pro-
teins. Additionally one can distinguish between homogeneous (protein-protein) and het-
erogeneous (protein-non-proteinogenic species) nucleation polymerization [49, 50]. The
resulting protein aggregates may be covalently (e.g., disulfide bonds, thiol binding), or
non-covalently (e.g. hydrophobic and electrostatic interactions) linked. The initial states
and binding forms of the protein aggregate are crucial for its reversibility and degree
of order. To illustrate the different aggregation pathways, these are shown in simplified
form in Figure 3.2.
Figure 3.2: Theoretical pathways of protein aggregation. Double arrows symbolize equi-
librium reactions. Whereas single arrows symbolize irreversible aggregation
steps. 1=native structure, 2=intermediate state, 3=unfolded state, 4=aggre-
gate, 5=intermediate aggregate, 6=crystal, 7=precipitate.
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Thermodynamic studies have shown that most aggregation processes proceed through the
intermediate state. The aggregation of the intermediates is promoted by the exposure of
hydrophobic side chains and the higher flexibility of the molecules [51, 52].
3.2.3 Physical and Chemical Principles of Protein Interactions
The forces that influence the protein itself as well as the protein solution behavior can
be divided into attractive and repulsive forces. Attractive interactions lead to a stabiliza-
tion within the molecule and induce the assembly of the proteins in solution. Repulsive
interactions lead to a higher flexibility of the molecule, i.e. a conformational destabi-
lization, but enhance the colloidal stability. Van der Waals forces, hydrogen bonds and
hydrophobic interactions are counted among the attractive interactions. Electrostatic
forces induced by the repulsion of uniformly charged electron double layers, on the other
hand, are repulsive [53, 54].
Van der Waals forces combine Keeson interactions, Debey interactions and London forces.
They can be described as a universal weak attractive interaction of electromagnetic origin
[55]. Keeson interactions describe the interaction of two dipoles. The Debey interactions
also known as dipole-induced dipole forces occur between a dipole and a polar molecule,
whereas London forces, which are the dominant dispersion interactions, describe the at-
tractive forces between two polarized molecules.
Another important factor of protein stability are hydrogen bonds, which can be formed
in between peptide groups and amino acid side chains. Their contribution to protein
stability was found to be significant with a strength of about 1 kcalmol−1 per bond [56].
The studies on hydrogen bonds are focused on investigations at the molecular level. How
hydrogen bonds may link proteins in the native state and if they contribute to the col-
loidal stability of proteins by strengthening the hydration layer is not totally understood
[57].
Hydrophobic interactions are used to describe the gain in free energy which occurs when
non-polar residues of proteins associate in an aqueous environment in order to reduce
the surface area in contact with water [58]. Hydrophobic interactions are governed by en-
tropy and not enthalpy features, since the attraction of hydrophobic groups counteracts
the undesirable entropy loss of water in the presence of non-polar groups [59]. Hydropho-
bic interactions are the strongest, non-covalent, non-electrostatic binding forces [60]. A
number of hydrophobic scales have been developed in the last decades to be able to assign
molecular residues dependent on their hydrophobic character [58, 61, 62]. The deviations
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of the results of different research groups demonstrate that hydrophobic forces and in-
duced interactions are not yet fully understood.
Most of the amino acids on the protein surface are able to be protonated or depro-
tonated. Dependent on the solution pH, their number and distribution on the protein
surface electrolytic double layers develop. The interaction of two electrolytic double lay-
ers is associated with an increase of the free energy. The resulting repulsive electrostatic
interactions play a major role in protein-protein association and desolvation on the molec-
ular level [63, 64].
The DLVO (Derjaguin-Landau-Verwey-Overbeek) theory presented more than 50 years
ago combines the forces which have an impact on the protein in solution by introducing
the potential of mean force [65]. In the last decades the DLVO theory was optimized
by extending the potential of mean force by specific ion effects [66], the impact of the
hydration layer on the protein surface and anisotropic interactions [53]. Notwithstanding
the improvements of the DLVO theory, the division of forces dependent on their reach
is still valid [65]. Van der Waals, hydrogen bonds and hydrophobic interactions can be
classified as short-range interactions. Electrostatic repulsion is mainly referred to as a
long-range interaction. It has to be taken into account that the range of electrostatic
interactions depends on the degree of ionization and the background electrolyte concen-
tration. The distance over which the forces show an effect is of crucial importance when
protein-protein interactions are compared by ideally dilute and highly concentrated so-
lution, as the distance of the molecules to each other changes. At highly concentrated
conditions the reduced distance between the molecules allow, that additionally to long-
range interactions, short-range interactions influence the protein monodispersity [15, 21].
That implies that analytical results of ideally dilute protein solutions can not be easily
transferred to highly concentrated conditions and that the interplay of short and long-
range interactions have to be taken into account when characterizing these solutions.
Additionally to the listed forces the molecular crowding effect can affect the protein so-
lution stability [67, 68]. Molecular crowding describes the influence of excluded volume
in extremely high concentrated protein solutions and the concominant impact on protein
conformational and colloidal stability. Molecular crowding is expected to stabilize the
native state of molecules and supports the assembly of functional protein networks. As
the impact of molecular crowding on protein solution stability has only be recently ad-
dressed, experimental results are rare and most theoretical explanations are speculative
[69].
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3.2.4 Influencing Parameters
The behavior of proteins in aqueous solutions depends strongly on intrinsic and extrinsic
properties. The description of protein-specific intrinsic properties such as shape, surface
charge and hydrophobicity can be found in section 3.1. This section discusses the forces
of impact which are caused by the physical and chemical solution properties.
Protein concentration
Proteins are soluble up to a specific molecule content. This limit is defined as the solubil-
ity line and is specific for every protein and also dependent on the surrounding solution
[70].
This work focuses on the characterization and prediction of protein solution stability in
the highly concentrated regime, where the molecule density in solution plays a decisive
role (see also 3.2.3). Under highly concentrated conditions the molecule density increases
to an extent that not only long-range but also short-range forces do have an impact on
the protein-protein interactions. Not only the distance between the molecules decreases
but also the rate of molecule collisions increases. The increased molecule density has most
often a negative impact on the solution colloidal stability but was found to stabilize the
compact native state of the protein [15, 71]. Thus, aggregation of proteins which was
triggered solely by a protein concentration increase is most often reversible [72, 73].
Short-range interactions include specific ionic bonds and hydrophobic interactions of
specific patches on protein surfaces. These directed interactions can lead not only to the
assembly of the molecules in the form of disordered aggregates, but also to an ordered
network-like structure. This network formation can have a stabilizing effect on the sol-
ubility of the protein [74]. This fascinating behavior could already be observed with a
series of monoclonal antibodies which could be concentrated up to 400 mg/ml [75]. Un-
fortunately, little is known about the exact causes and conditions under which stabilizing
networks are created, so that a targeted manipulation is not possible yet.
Temperature
The stability of a protein is a sensitive balance between enthalpic and entropic terms,
derived from the physico-chemical difference between the native and non-native state
of the polypeptide [76]. By increasing the temperature the total energy of the system
increases what directly effects the protein colloidal and conformational stability in solu-
tion. With increasing temperature the diffusion of dissolved particles, i.e. the movement
of proteins in solution, accelerates. The increased Brownian movement increases the prob-
ability of molecule collisions, which in turn leads to an increased aggregation propensity.
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The increase of the temperature above 40◦C usually leads to an irreversible conforma-
tional change of proteins. Above this temperature limit, stabilizing disulfide bridges are
weakened and endothermic oxidation processes can occur. The accompanied exposition
of hydrophobic amino acids result in non-reversible aggregation [77].
If the temperature of protein solutions is lowered, the stability of the proteins is first
increased by their slowed diffusion (up to approx. 4◦C). This effect is important for the
storage of biopharmaceutical formulations. When the temperature falls below the freez-
ing point of water, the colloidal stability decreases. On the one hand due to the ever
lower available liquid volume (crystallization of water molecules) on the other hand due
to the formation of solid-liquid interfaces. Proteins with a hydrophobic character ad-
sorb on the developed solid surfaces, what leads to aggregate formation. On a molecular
level cold denaturation can occur. Cold denaturation is caused by specific interactions
of protein non-polar groups with water. In contrast to studies at room or accelerated
temperatures it was found that hydration of these groups is thermodynamically favor-
able at cold temperatures. The exposition of non polar compounds of the protein core
leads to protein unfolding [78]. In general cold denaturation is reversible [71] unlike most
high-temperature denaturations. In this work temperature was solely used to accelerate
processes like protein aggregation or unfolding to be able to study the protein solution
behavior in a short time period. For all other experiments the temperature was kept
constant to limit the parameters of impact.
pH
The protonation or deprotonation of the proteinogenic amino acid residues is dependent
on their pKa value and the pH of the surrounding solution [79]. Thereby, the pH has a
great impact on the charge distribution and net charge of a protein. The isoelectric point
(pI) defines the pH where the protein net charge is 0 [80]. This does not imply that all
amino acids of the protein are uncharged; rather, it means that the sum of all charges
is 0. In Figure 3.3 the net charge curves of three proteins with different pIs are shown.
The charge curves were calculated on the basis of zeta potential measurements, which
are explained in more detail in chapter 3.3.
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Figure 3.3: Net charge curves of lysozyme, a monoclonal antibody and Glutathione-S-
Transferase in a pH range from 3 - 12.
Since the electrostatic potential at the pI is lowest, only weak or no repulsive electrostatic
interactions occur at this pH. Here, attractive short-range interactions, such as hydropho-
bic or van der Waals interactions, contribute to the aggregation tendency of the protein.
The further apart the solution pH and the pI are, the stronger the net charge of the pro-
tein and thus the repulsive interactions. The electrostatic repulsion which stabilizes the
protein colloidal stability also impact the protein conformation. Equally charged amino
acids in the protein core repel each other, which firstly impacts the protein flexibility
and at extreme acid or basic conditions lead to protein unfolding [28]. Thus, the selection
of buffer pH should always take both conformational and colloidal stability aspects into
account.
Co-solutes
Co-solutes correspond to molecules which are dissolved in solution with the protein of
interest. Either their presence is process related or they are added to the solution in a
targeted stabilizing manner. In order to delineate this huge subject, only co-solutes are
discussed in this section whose stabilizing or destabilizing effects on proteins have been
studied in this work (salts, polymers, amino acids).
Salt molecules dissociate in aqueous solution into positive (cations) and negative (an-
ions) ions. The impact of salt on the protein solution stability is firstly dependent on
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the salt concentration. At low salt concentrations, the salt ions stabilize the protein via
nonspecific electrostatic interactions. This phenomenon was found to be only dependent
on the ionic strength [81]. When increasing the salt concentration the differences between
salt types become more and more pronounced. The differing effect of the ions on protein
stability is generally referred to as salting-in and salting-out effect [82, 83]. Salting-in
describes the specific and unspecific binding of the ions to charged amino acid residues
of the protein [84, 85]. The related chaotropic salts have a positive effect on the colloidal
stability but a negative impact on the conformational stability of the protein in solu-
tion. Ions with salting-out character, also known as kosmotropes, are strongly hydrated
in solution and thus have a negative influence on the protecting hydration shell of the
protein [82]. They increase the aggregation propensity, however, have a stabilizing effect
on the 3D structure of the proteins in solution. Dependent on their salting-out character
salt ions can be classified according to the Hofmeister series (anions: SCN− > ClO−4 >
I− > ClO−3 > Br
− > NO−3 > Cl
− > CH3CO−2 > HPO
2−
4 > SO
2−
4 , cations: guanidinium
> Ca2+ > Mg2+ > Li+ > Na+ > K+ > NH+4 ) [86, 87]. Whereby anions are known to
have a stronger impact on the protein behavior than cations [85]. In the highly concen-
trated regime the impact of common salts on the protein solution stability can not be
generalized. Especially specific electrostatic interactions or hydration effects, triggered
by the addition of salt, can lead to a stabilization or destabilization dependent on the
protein under investigation [15, 16]. In this work three different salts (NaCl, Na2SO4,
(NH4)2SO4) were chosen to study their impact on the protein solution stability in the
highly concentrated regime.
Polymers, like polyethylene glycol, are neutral, hydrophilic additives which have a sta-
bilizing, neutral or destabilizing character on the protein dependent on their molecular
mass [88]. High molecular mass polymers induce depletion attraction leading to attrac-
tive protein-protein interactions [89]. This effect can be explained by the concentration
gradient which occurs when the relatively large polymer molecules are excluded from the
protein vicinity. The resulting polymer concentration gradient causes the attraction of
the water molecules from the gap between the proteins towards the polymer and thus to
attractive protein-protein interactions [90, 91]. The strength of this effect decreases with
decreasing polymer chain length. The presence of low molecular weight polymer molecules
can mitigate attractive protein-protein interactions due to shielding effects [88].
Amino acids, such as glycine, belong to the group of osmolytes and have a generally
stabilizing effect on proteins in solution. Several theories have been published which de-
scribe the stabilizing influence of the small organic compounds. One theory assumes that
the direct interaction of the osmolyte with the polypeptide backbone lead to structural
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stabilization of the protein [92–94]. Other studies disprove this specific interaction theory
and found higher structured water in the presence of osmolytes, which also has a stabi-
lizing impact on the protein solution stability [95–97].
The impact of the physico-chemical solution conditions on protein stability is so com-
plex, that no general valid model exists, which can describe all interaction mechanisms
[98–100]. The challenge of this work is therefore to establish analytical methods and to
validate potential parameters which are sensitive enough to depict changes in the pro-
tein behavior which are caused by the factors listed above, also for the characterization
of highly concentrated protein solutions. Only with the exact characterization of those
interaction parameters conclusions can be drawn on the conformational and colloidal
long-term solution stability of proteins.
3.3 Analytical Methods to Characterize and Predict Protein
Solution Stability
The solution stability of a biopharmaceutical molecule must be ensured throughout its
shelf life to guarantee stable process, storage and application conditions. Analytical meth-
ods allow, on the one hand, the detection of conformational changes of the protein and
its aggregation (section 3.3.1). On the other hand, several scientific groups are working
on the better understanding and analysis of the forces that cause the state change of
the proteins in solution (section 3.3.2). The characterization of the influencing forces and
the related alteration of the solution bulk properties are intended to allow the prediction
of protein solution stability. This chapter gives a brief overview of established analytical
techniques, shows their limitations and the associated need for the development of novel
methods.
3.3.1 Analysis of Protein Conformational Changes and Aggregation
The conformational change of the protein in solution can be analyzed either directly or
indirectly. Fourier transform infrared spectroscopy is a direct, very precise measurement
method [22]. The spectra analysis allows the determination of the protein 2D structure
and thus also the detection of its change in unfolding processes. Indirect methods, like
activity assays are based on color reactions which are coupled to the catalytic activity
of the proteins in solution [101, 102]. The implementation of the activity assays is only
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possible at specific solution conditions such as ideally dilute solutions. These methods
are limited to detect protein unfolding and associated non-native, non reversible protein
aggregation [103, 104].
Techniques which are capable of detecting all forms of visible protein aggregates are
mostly based on optical evaluation procedures. High-resolution cameras enable a sim-
ple method to differentiate between different types of aggregation, namely precipitation,
crystallization, gelation and skin formation [88]. Soluble aggregates with an average size
of 1-100 nm, however are not visible by eye and have to be measured via light scattering
techniques. With static light scattering measurements the molecular mass of a particle
in solution can be determined whereas dynamic light scattering (DLS) provides insights
into the hydrodynamic radii of particles and particle size distributions [105–107]. The
further development of dynamic light scattering instruments enable also the detection of
particles in highly concentrated and turbid solutions by cross-correlation or high angle
measurements [108]. The non-invasive dynamic light scattering techniques determine the
time-dependent fluctuations in the intensity of scattered light that occur due to the Brow-
nian motion of particles dispersed in solution. The time-dependent fluctuation enables
the determination of the Diffusion coefficient, which in turn can be directly correlated to
the hydrodynamic radius of the protein. The relationship between the diffusion coefficient
and the hydrodynamic radius is described by the well known Stokes-Einstein equation
[72].
In order to screen the solution stability of proteins under varying solution conditions, pro-
tein phase diagrams can be prepared. Within a phase diagram, two or more influencing
parameters, such as protein and additive concentration, are varied. When solution equi-
librium is reached, the individual samples of the phase diagram can be examined for ag-
gregation or conformational changes, using the analytical methods described above. The
resulting phase diagrams provide information about the solubility range of the protein
in the selected screening window. Baumgartner et al. published an automated method
for the preparation of protein phase diagrams in a 96-well micro scale format. In this
study, this technique was adapted to highly concentrated protein solutions [88]. The re-
sulting protein phase diagrams were used to validate predicted long-term stability results
(see Chapter 6, Chapter 7 and Chapter 8). The method is precise but also very time-
consuming since the analysis of the individual wells and the associated scoring can only
take place after the solution equilibrium is reached. According to FDA guidelines, phar-
macological active proteins must be stable at least for 12-24 months to be approved for
human administration [109].
To accelerate the conformational and colloidal changes of proteins in solution energy in
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form of increased temperature can be imported into the system. While running a temper-
ature ramp, both the melting temperature (Tm) and the aggregation temperature (Tagg)
can be depicted by fluorescence and static light scattering measurements, respectively
[110]. In several studies, it was shown that the Tm and Tagg values can be correlated
with the long-term stability of identical samples also in the highly concentrated regime
[99, 108]. Other research groups stated, that a direct correlation between the thermal
stability and the long-term stability of protein solutions is not always given [100]. These
findings indicate that the temperature has to be treated as an additional parameter, and
that the direct correlation is not readily possible.
The selection of the expedient screening area for the preparation of protein phase dia-
grams or thermal stability tests requires experience or follows the principle of trial and
error. In addition, the listed methods can accurately describe the physico-chemical state
of the proteins in solution but do not contain any information on the causes that led to
the analyzed behavior of the protein under investigated conditions. In order to facilitate
the prediction of the protein behavior in solution and thus enable a targeted manipula-
tion of the process and formulation conditions, analytical methods are necessary which
can identify the inter- and extra-molecular forces and interaction mechanisms.
3.3.2 Characterizing Analytics
To investigate the molecular surface properties in silico and experimental techniques can
be applied. Experimental methods, such as the determination of the ζ- potential [111] or
the surface tension [112], enable the description of protein net surface charge or surface
hydrophobicity, respectively. In order to be able to determine more precisely the struc-
tural features, charge distribution or the position of the hydrophobic patches [58] on the
protein surface, computational methods are necessary. In silico methods include Molecu-
lar dynamics (MD) and Monte Carlo (MC) simulations as well as Quantitative Structure
Activity Relationship (QSAR) studies. They were successfully applied for protein drug
design [113], to predict protein structures [114] and protein stability [112] in ideal dilute
solutions.
For the description of the unfolding or aggregation tendency of a protein in solution not
only the molecular characteristics but also the resulting intrinsic and extrinsic interac-
tions are of importance. To assess the various interactions, thermodynamic properties like
the diffusion coefficient [115], the osmotic pressure [116] or the solution viscosity [117] can
be determined. The deviation of these parameters from the ideal behavior describes the
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sum of all influencing interactions, also known as potential of mean force. The potential
of mean force can be semi quantitatively related to the second virial coefficient (B22),
preferably determined by self interaction chromatography [118]. The parameter is a well
documented approach to predict optimal crystallization conditions [119–121] and the ag-
gregation propensity of proteins [118, 122, 123] in ideal dilute solutions. In recent years, a
number of studies clearly demonstrated the limits of the predicting potential of the B22.
It was revealed that an insufficient correlation of the B22 and protein solution behavior
is given when the aggregation of the proteins is driven by the conformational change
of the molecule [27] or the aggregation kinetics are extremely slow [124]. Additionally,
the B22 implies only information on two dimensional protein-protein interactions as it
is measured in the ideal diluted state. In the highly concentrated regime the interaction
mechanisms are far more complex (see also 3.2.3). Multidimensional interactions, the in-
creasing impact of short-range interactions and protein network formation aggravate the
transferability of parameters, like the B22, measured in the ideal diluted state to highly
concentrated protein solutions. Saito et al. [125], Scherer et al. [126] and Saluja et al.
[127] demonstrated that there is only an insufficient correlation of the B22 and protein
solution stability when screening highly concentrated protein solutions.
So far, there is no method approved by the authorities to reliably predict the stability
of highly concentrated protein solutions. Nowadays, the selection of the ideal process
solution conditions, as well as the formulation development is very time and cost inten-
sive. Thus, the biopharmaceutical industry demands the development of a novel method
which is capable to describe the protein behavior in the highly concentrated regime. This
method should meet the following requirements:
• highly sensitive
– to depict also the weak short-range interactions
• non invasive
– to not influence the solution properties during the measurement
• low volume consumption (µL scale)
– to fulfill the requirements in the early development and enable the measure-
ment of costly formulations
• output of one single valuing parameter
– to be competitive to B22 measurements
A method not yet established in the biopharmaceutical industry, which has the potential
to meet the listed criteria, is the complex rheology. Complex rheology implies the rheo-
logical characterization of soft matter with regard to its viscoelastic properties. The next
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section deals with the investigation of viscoelastic parameters and the role of rheological
measurements in the biopharmaceutical industry.
3.4 Rheology of Viscoelastic Fluids
3.4.1 Principles of Rheology
Rheology is the science of deformation and flow. This definition includes fluid dynam-
ics, hydraulics and solid state mechanics. Rheology is used to measure fluid properties,
understand structure-property relations and to predict flow behavior of complex liquids
under processing conditions [128–130]. In a physical stressful environment there are four
ways how a material under investigation can react on an acting force.
1. The load is directly transferred to the forces which bond the atomic components
or molecules. This rheological behavior is typical for rigid materials like ceramics
or crystals.
2. The load lead to significant changes of the materials‘ shape. This behavior can be
observed with non crystalline polymers.
3. The material flows away from the load and deforms semi-permanently as with
viscoelastic materials.
4. The load forces the material to flow away and to deform permanently (plastics).
The first behavior describes ideal elastic materials. They will remember the deformation
indefinitely and return to its initial state. Based on Hook‘s law the stress (σ), which acts
on an ideal elastic material, and strain (γ) are directly and simply proportional to each
other [131].
E =
σ
γ
(3.1)
If this equation is applied to stress caused by shearing (τ), the relation to the shear
modulus (G) is obtained.
G =
τ
γ
(3.2)
Following Newton‘s law, a perfect liquid material will stop deforming instantaneously
when stress is removed and never recover to its previous state. Here, the shear rate (γ˙)
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is proportional to the shear stress (τ) with the constant of proportionality η (dynamic
viscosity):
τ = η · γ˙ (3.3)
Protein solutions behave like a combination of a Newtonian fluid and an Hookean solid.
They can partly store the energy which is applied whereas the other part dissipates.
Additionally, they exhibit a pronounced time (t) dependence and belong therefore to the
viscoealstic materials (Equation 3.4) [132]. For viscoelastic fluids the relation between
stress and strain can be interpreted as a linear combination of a Newtonian element and
a Hookean element (Maxwell model, Figure 3.4). This model is only valid in the linear
viscoelastic range [131]. As in this work only rheological tests in the linear viscoelastic
range are performed, the behavior of viscoelastic fluids in the non-linear region will not
be discussed.
Figure 3.4: Schematic diagram of a Maxwell model.
G(t) =
τ(t)
γ0
(3.4)
Dynamic rheological tests in the linear viscoelastic range are best suited to study the
viscoelastic properties of protein solutions. The most common test is oscillation [131].
When a viscoelastic material is subjected to a sinusoidal load, a constant state is obtained
in the linear viscoelastic range, in which the resulting load is also sinusoidal, has the same
radial frequency (ω) but is phase shifted by the angle δ. This relationship can be described
by:
γ(t) = γ0 · sin(ω · t) (3.5)
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and
τ(t) = τ0 · sin(ω · t+ δ) (3.6)
The resulting shear modulus takes the complex form of
G∗ =
τ(t)
γ(t)
=
τ0 · eiδ
γ0
=
τ0
γ0(cosδ + isinδ)
(3.7)
The complex shear modulus, G∗, is formed by an elastic component, the storage mod-
ulus (G′) that is in phase with the strain input and the viscous component, the loss
modulus (G′′).
G∗ = G′ + iG′′ (3.8)
with
G′ =
G(ωλ)2
1 + (ωλ)2
(3.9)
and
G′′ =
Gωλ
1 + (ωλ)2
(3.10)
G′ is the measure of the deformation energy stored by the sample during the shear
process. G′′ is the measure of the energy which dissipates [131]. To characterize the vis-
coelastic behavior frequency sweep measurements can be performed. Here, G′ and G′′
are detected over an applied frequency ramp at a set amplitude. At low frequencies,
representing large time scales, the viscoelastic material responds like a viscous fluid. At
high frequency values, representing short time scales, the material responds like a perfect
Hookean solid. Between these extremes, the material behave viscoelastic. At a material
specific frequency value, the two curves of G′ and G′′ cross each other. At frequencies
below this crossover point, the material is a viscoelastic fluid. The particles in solution
can follow the applied movement and relax in the given time frame. Above the crossover
point, the material behaves like a viscoelastic solid. Here, the time frame up to the forced
movement change is so short that the viscoelastic fluid can not completely relax. The
energy introduced into the system is thus stored until the next frequency step so that the
behavior appears predominantly elastic [133, 134]. In Figure 3.5 the characteristic curve
shapes of G′ and G′′ are plotted over the radial frequency. The relaxation processes of
complex fluids such as protein solutions can extend over 8-12 decades in frequency. In
order to obtain as complete a rheological characterization of a substance as possible, it
is necessary to determine the viscoelastic characteristics such as G′ and G′′ in a wide
frequency range [135]. Furthermore, protein solutions exhibit very small relaxation times
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Figure 3.5: Characteristic curve shape of G′ and G′′ over a wide frequency range, deter-
mined by frequency sweep measurements.
[136]. In order to be able to detect the weakly viscoelastic behavior of protein solutions,
it is therefore necessary to measure in the kilo- to megahertz frequency region. Conven-
tional mechanical rheometers, such as cone-and-plate rheometers, operate up to 200 Hz
and are thus not suitable for the measurement of viscoelastic properties of protein solu-
tions [20]. Additionally, highly concentrated protein solutions react sensitively to ambient
conditions, so that the impact of the measurement on the sample should be as low as
possible. To avoid shearing and to reach high enough frequencies, the dynamic squeeze
flow rheometry can be applied. Here, the sample is squeezed and not sheared during the
oscillatory measurement [137]. Since the restoring force of the sample is proportional to
the reciprocal of the third power of the sample thickness, low-viscosity samples can also
be measured exactly.
For this reason a squeeze-flow rheometer - the Piezo Axial Vibrator (PAV) was used in
this work to characterize the viscoelastic behavior of protein solutions. This device is
able to measure in a frequency range of 0.5-7 kHz, has a sample volume of 30 µL with a
measuring gap of 15 µm and is limited to the linear viscoelastic regime due to a very low
voltage and deformation amplitude. The excitation of the sample as well as the stress
response of the sample is realized by eight piezoelectric elements. These are arranged in
pairs on four sides of a copper tube, which holds the measurement head. The piezoelectric
elements are connected to a lock-in amplifier which transfers a constant voltage amplitude
to the piezoelectric actuators and records the resulting complex voltage amplitude of the
piezo sensors. In order to determine the viscoelastic moduli G′ and G′′, a measurement
without a sample (blank measurement) and a measurement with a sample is carried out.
31
Chapter 3 Introduction
The deflection of the probe length of the blank measurement, xˆ0 is equated with the
deflection with sample in the measuring gap xˆ, whereby the complex spring constant K∗
can be calculated. Assuming linear viscoelasticity and no slippage occurs, the complex
viscoelastic modulus G∗ can be calculated from K∗.
K∗ =
3pi
2
·R
(
R
d
)3
· G
∗
1 + ϕω
2d2
10G∗
(3.11)
With ϕ=density, R=radius of the measurement head, d=gap width and ω=radial fre-
quency [138]. The measurement accuracy of the device and the good suitability for low-
viscosity complex fluids, has been demonstrated in numerous publications [138–141].
Unfortunately, the device is not commercially available, so this work is also concerned
with an alternative rheological technique [127, 142].
Alternatively to mechanical rheometry also dynamic light scattering, diffusive wave spec-
trosopy or particle tracking techniques can be applied to determine the viscoelastic mod-
uli G′ and G′′. These measurement methods are referred to as optical microrheological
techniques [143]. All microrheological measurements have a sample volume in µL-scale
and the use of so-called tracer particles in common. The tracer particles are used to mea-
sure the relation between stress and deformation of the sample. Analogues to mechanical
rheometry a stress is applied by the tracer particles and the strain in form of the tracer
position is detected. The movement of the tracer particles is induced by Brownian motion
and thus very little stress is applied on the probes. Similar to high shear or squeeze flow
rheometry, microrheology allows access to short-time dynamics, so that the viscoelastic
response of weakly elastic materials like protein solutions can be measured [144]. In this
thesis the dynamic light scattering technique is examined more closely. An advantage
of the dynamic light scattering technique is that it is already established as an analyt-
ical tool in the biopharmaceutical process development. With dynamic light scattering
measurements the autocorrelation function (ACF - correlation of a signal with a delayed
copy of itself as a function of delay) of the light scattered by the particles is measured.
The ACF can be written as a function of the mean square displacement (MSD) of the
scattering particles. The MSD is a measure of the mean distance covered by a parti-
cle in a given period of time. The viscoelastic moduli can be obtained by calculating the
Fourier Transform of the MSD and combining the resulting term with the Stokes Einstein
Equation, resulting in:
G∗(ω) =
kbT
pia(∆r2(1/ω))Γ(1 + a(ω))
(3.12)
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G′(ω) = G∗(ω)cos(pia(ω)/2) (3.13)
G′′(ω) = G∗(ω)sin(pia(ω)/2) (3.14)
where Γ denotes the gamma function which is a result of the Fourier Transform of the
MSD, kbT=thermal energy, a=diameter of the particle, (∆r2(t))=MSD and ω=radial
frequency [145].
The rapid wide-scale adaption of microrheology techniques is prevented by technical chal-
lenges. One challenge is the selection of suitable tracer particles. Besides the concentration
and size of the tracer particle, one condition which has to be fulfilled to gain accurate
and reproducible results is the inertness of the tracer particles in solution. Interactions of
the tracer particles with themselves or with the proteins alter their mobility in solution
and therefore distort the rheological results [146, 147]. In the biopharmaceutical sector,
tracer particles with different surface properties are used. So far, the interaction with the
protein to be investigated has been either neglected or only presumed [146, 148]. The
study of tracer particle-protein interaction mechanisms and the corporate thorough eval-
uation of potential tracer particles is demanded to further push this promising analytical
technique for the biopharmaceutical development.
3.4.2 Rheological Characterization of Biopharmaceutical Solutions
In food, cosmetic and ink industry rheology is an established analytical technique to
physically characterize raw materials, intermediate and finished products [134, 149, 150].
Dependent on the processing steps rheological parameters are used to design flow pro-
cesses, predict storage stability, understand and design texture and generally control
quality attributes [134, 151–153]. In contrast, the application of the rheological tech-
nique is very limited in the biopharmaceutical industry. Only the measurement of the
dynamic viscosity is considered as a standard in the process and formulation develop-
ment. The determination of complex rheological parameters, i.e. the characterization of
the viscoelastic properties of protein solutions, is not widely used. In the last decades
the viscoelastic characterization of biopharmaceutical solutions focused mainly on the
rheology of blood [154] and the investigation of the shear thinning behavior of blood
related solutions [132, 155–157]. In the last decade, the implementation and further de-
velopment of high-frequency and microrheological rheometers as well as the increasing
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pressure of the biopharmaceutical industry to develop novel analytical methods for the
better characterization of protein solutions expended the knowledge about the viscoelas-
ticity of pharmaceutically relevant protein solutions.
Pioneer work in the area of complex rheology was done by the group of D. Kalonia. In the
last 15 years they profoundly studied the viscoelastic properties of protein solutions by
determining the storage modulus, G′ of various protein solutions at a defined frequency
value. Numerous publications demonstrate that G′ is influenced by protein stability-
relevant parameters such as pH, protein concentration, ionic strength or the amino acid
sequence of a protein [15, 20, 136, 158]. Furthermore, the value of G′ has been successfully
correlated with the strength of the protein-protein interaction [127]. This correlation was
confirmed by Neergard et al. who studied the aggregation tendency of highly concentrated
antibody solutions [159]. The listed studies demonstrate the great potential of complex
rheology to better understand the behavior of proteins in solution. The scientific chal-
lenge is to find a direct link between the viscoelastic behavior and the stability of proteins
in solution. For this purpose, the relaxation behavior of the protein solutions should be
investigated over a wide frequency range and, in addition to the storage modulus G′, the
loss modulus G′′ must be included in the rheological characterization.
34
CHAPTER4
Research Proposal
The processing and formulation of highly concentrated protein solutions gain increasing
importance in the biopharmaceutical industry [15, 16]. Advantages of the highly con-
centrated protein solutions are the associated decreased volume consumption of process
related liquids or the possibility of new application forms, like subcutaneous injections.
However, a major challenge is to keep the proteins stable in solution since the increased
molecular density enhances the aggregation propensity and adversely affects the confor-
mational stability of the target molecules [21, 22]. Aggravating, the effective forces which
have an influence on the colloidal and conformational stability of the highly concentrated
protein solutions are not yet fully understood. Consequently, there are no methods ap-
proved by regulatory authorities that can predict the solution stability of proteins in the
highly concentrated regime. Therefore, the targeted manipulation of the solution con-
ditions is not possible nowadays. The ideal solution conditions have to be identified in
time-consuming long-term stability tests in trial and error procedures [24].
In recent years, numerous studies have been undertaken to understand the complex rela-
tionships between protein-protein interactions, the environmental conditions that influ-
ence them, and the associated protein solution stability [15, 106, 119]. In silico methods,
such as MD simulations, provide insights into the surface characteristics of the proteins in
terms of their structure, charge distribution and hydrophobicity [53, 160]. The effects of
changing environmental and buffer conditions on the solution stability of proteins could
be demonstrated experimentally by means of phase diagrams [88, 161, 162]. In addition,
a parameter has been established that can describe the strength and direction of protein-
protein interactions. The second virial coefficient, B22 maps the potential of mean force
[118, 163]. This theoretic potential combines all the interactions which have an influence
on the protein under studied conditions. The semi-quantitative parameter B22 can solely
be experimentally determined in ideal dilute solutions. Studies have shown that the re-
sults thus obtained can not be transferred directly to highly concentrated conditions [125,
35
Chapter 4 Research Proposal
164]. Here, the interaction mechanisms change due to the increasing impact of forces, like
van der Waals or hydrophobic forces, which have no influence on the protein in an ideal
dilute solution. In addition, multi-dimensional interactions and complex network forma-
tions, which can not be displayed by the B22, can occur [15, 22, 125]. Therefore, a novel
analytical method is demanded which can describe the complex behavior of proteins in
highly concentrated solutions directly.
Molecules, which behave very similarly in solution as proteins, are synthetically produced
polymers. They also form stabilizing networks, react sensitively to changing solution
conditions, and behave viscoelastic [135, 139, 165, 166]. Viscoelasticity is a rheological
property that describes the complex relaxation behavior of matter which possesses both
elastic and viscous properties. Polymer solutions are mainly processed in the food and
cosmetics industry. Here, rheology is an established analytical method for quality con-
trol, to investigate the sedimentation properties or to predict the long-term stability of
the polymer solutions also at highly concentrated conditions [130, 167]. Compared to the
rheological characterization of polymer solutions the potential of rheology to characterize
biopharmaceutical relevant solutions has by far not been fully exploited.
Compared to conventional analytics applied in the biopharmaceutical industry, rheolog-
ical methods have the advantage of measuring the bulk properties of the solution and
not single protein-protein interactions [130]. They have thus the potential to capture all
interactions and network formation that occur in highly concentrated protein solutions.
The group of D. Kalonia has already shown that viscoelastic parameters are sensitive
to protein solution conditions, such as pH, ionic strength or protein type. In addition,
the elastic modulus, G′ was correlated successfully with the strength and type of protein-
protein interaction [15, 20, 127, 136]. But up to know little is known about the connection
between the viscoelastic behavior and protein solution stability.
Accordingly, the question at hand is whether the rheological data correlate with the pro-
tein solution behavior directly and if one single rheological parameter can be extracted
which is suitable to predict the long-term stability of highly concentrated protein solu-
tions.
To answer the overriding question the focus of this thesis is laid on the rheological char-
acterization of highly concentrated protein solutions and the correlation of determined
viscoelastic parameters with the protein solution long-term stability. For this purpose,
the viscoelastic properties of a model protein is firstly be investigated. The screening
range is chosen in such a way that the sensitivity of the viscoelastic measurements can
be validated against changing solution conditions. Rheological parameters which have
the potential to predict the long-term solution stability shall be extracted and correlated
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directly with the protein solution stability. As a reference protein phase diagrams are
prepared in an automated high-throughput format.
The rheological methodology shall then be extended to pharmaceutical relevant solutions,
including more complex molecules like monoclonal antibodies or structural manipulated
proteins. In order to underline the predictive performance of the developed rheological
method, this is to be combined and optimized in a further step with established orthog-
onal analytical techniques.
In order to ensure the applicability of the complex rheology in the biopharmaceutical
industry, it is also the aim of this work to select and optimize potential rheological mea-
surement techniques. Microrheology was found to be effective for the determination of
viscoelastic parameters of protein solutions. To gain reproducible and stable results the
essential tracer particles have to be selected thoroughly. An important criterion is that
the tracer particles do not interact with the proteins or with themselves during the mea-
surement. In this thesis, a screening of tracer particles with different surface properties
is attempted in order to generate knowledge about their suitability for microrheological
measurements of protein solutions.
In summary, this project aims at the characterization of highly concentrated protein
solutions based on complex rheological measurements and the evaluation of this novel
method, with regard to the prediction of protein solution stability. The resulting better
understanding of protein behavior in highly concentrated solutions is expected to make
a significant contribution towards the optimization of the biopharmaceutical process and
is a further step towards stable and safe formulations.
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Comprehensive Overview of Publications & Manuscripts
This chapter provides an overview of the manuscripts and publications compiled in this
thesis. The order of the manuscripts listed is topic-based and not chronologically ordered.
The present work can be divided into three main sections.
The first section focuses on the optimization of the concentration measurements of highly
concentrated protein solutions. The manuscript “Implementation of an analytical mi-
crofluidic device for the quantification of protein concentrations in a high-throughput
format“ describes the development and introduction of a silicone microfluidic chip. This
device enables the automated concentration determination of protein solutions in a large
concentration range in a high-throughput, 96-well plate compatible format.
The aim of the second part of this work was to better characterize highly concentrated
protein solutions and to find a methodology that predicts the long-term stability behavior
of these complex fluids. For this, rheological methods were applied. First, the viscoelastic
properties of the model protein lysozyme were determined. In the study “Squeeze flow
rheometry as a novel tool for the characterization of highly concentrated protein solu-
tions“ it was shown that the determined rheological parameters are sensitive to stability-
influencing parameters such as pH or ionic strength. In addition, a key parameter was
identified which could be correlated directly with the colloidal long-term stability of the
model protein. This key parameter, ωCO describes the frequency point of the intersection
of the rheological parameters G′ and G′′.
In the study “Prediction and characterization of the stability enhancing effect of the
Cherry-Tag™ in highly concentrated protein solutions by complex rheological measure-
ments and MD simulations“, aimed in the description of the stability enhancing effect
of the Cherry-Tag™. Therefore, the viscoelastic characteristics of native GST and GST
fused with the Cherry-Tag™ technology were investigated in varying solution conditions.
Based on the rheological results their long-term stability was predicted. In addition, the
rheological results were linked with MD simulations. With the MD simulation results,
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the causes for the predicted stability differences of GST and Cherry-GST were investi-
gated by studying their structure and surface characteristics in silico. The combination
of rheological measurements and MD simulations revealed a comprehensive micro- and
macroscopic characterization of both proteins studied.
The prediction of the colloidal and conformational long-term stability of highly concen-
trated protein solutions was further refined in the manuscript “Characterization of highly
concentrated antibody solution - A toolbox for the description of long-term solution sta-
bility“. In this study the rheological characterization of protein solutions was combined
with established orthogonal analytical methods. The resulting analytical toolbox was
used to predict the long-term solution stability of a monoclonal antibody in process- and
formulation-relevant conditions. The study demonstrated the strengths and weaknesses
of novel and established analytical techniques. In addition, the intelligent combination
of the results provided an accurate characterization of the mAb solutions and a good
prediction of their colloidal long-term behavior.
The aim of the third part of this thesis was the optimization of the rheological mea-
surement technique with regard to the applicability in biopharmaceutical laboratories.
In addition to the mechanical rheology used for the screenings presented above, mi-
crorheology has the potential to be used as a standard analytic as it is based on the
well known dynamic light scattering technique. In order to obtain reproducible results,
certain criteria must be met. An essential criterion is that the tracer particles used for
this measurement technique do not interact with the proteins in solution. In order to
ensure this, the measurement quality with the use of different tracers was investigated in
the manuscript “Impact of polymer surface characteristics on the microrheological mea-
surement quality of protein solutions - a tracer particle screening“. For this purpose, the
surfaces of four different particles were characterized and the quality of the microrheologi-
cal measurements under different solution conditions was tested. The results of this study
show which tracer surface characteristics are essential for the measurement quality and
can also recommend the use of a surface-modified tracer for the rheological measurement
of protein solutions.
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Implementation of an analytical microfluidic device for the quantification of
protein concentrations in a high-throughput format
Carsten Philipp Radtke*, Marie-Therese Schermeyer*, Yün Claudia Zhai, Jacqueline
Göpper and Jürgen Hubbuch
Engineering in Life Sciences 16 (2016): 515-524.
*contributed equally
(A) (C)
(D)(B)
This work presents the qualification and usage of a disposable
measurement device which can be used with conventional mi-
croplate photometers to determine protein concentration. The
application of the microfluidic device (µF-device) allows ab-
sorption measurements of protein concentrations from around
0.1 to 100 mg/mL with an accuracy of 99.2 % dependent on
given protein extinction coefficients. The integrated four mea-
surement chambers of increasing height (100 – 1500 µm) allow the direct calculation of
calibration curves and the determination of protein concentrations independent of used
optical path lengths with a sample volume of 36 µL. This study contains the validation
of the analytical µF-device according to ICH Guidelines as well as a representative case
study. A salt gradient screening with chromatography columns in microliter scale per-
formed on a liquid handling station presents the usability of the µF-device. It is shown
that an improvement of the repeatability and accuracy of the chromatograms could be
achieved by µF-device implementation in comparison to photometric measurements per-
formed in microtiter plates.
Squeeze flow rheometry as a novel tool for the characterization of highly
concentrated protein solutions
Marie-Therese Schermeyer, Heike Sigloch, Katharina C. Bauer, Claude Oelschlaeger and
Jürgen Hubbuch
Biotechnology and Bioengineering 113 (2016): 576-87.
This study aims at defining rheological parameters for the characterization of highly
concentrated protein solutions. As a basis for comparing rheological behavior with protein
solution characteristics the protein phase behavior of lysozyme from chicken egg white
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with concentrations up to 225 mg/mL, changing pH values and additive concentrations
was studied in a microbatch scale format.
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Oscillatory frequency sweep measurements of samples with ex-
actly the same conditions were conducted immediately after
preparation (t0). The protein solutions behave viscoelastic and
show a characteristic curve shape of the storage modulus (G′)
and the loss modulus (G′′). The measured rheological param-
eters were sensitive concerning solution composition, protein concentration and solution
inner structure. We succeeded to correlate protein phase behavior with the defined rhe-
ological key parameter ωCO. This point represents the frequency value of the intersec-
tion point from G′ and G′′. In our study lysozyme expressed a ωCO threshold value of
20000 rad/sec as a lower limit for stable protein solutions. The predictability of lysozyme
aggregation tendency and crystallization by means of squeeze flow rheometry is shown.
Prediction and characterization of the stability enhancing effect of the
Cherry-Tag™ in highly concentrated protein solutions by complex rheological
measurements and MD simulations
Pascal Baumann*, Marie-Therese Schermeyer*, Hannah Burghardt, Cathrin Dürr, Jonas
Gärtner and Jürgen Hubbuch
International Journal of Pharmaceutics (2017), submitted
*contributed equally
Protein solution stability needs to be engineered and mon-
itored throughout production and storage. In contrast to
the gold standard of long-term storage experiments applied
in industry, novel experimental and in silico molecular dy-
namics tools for predicting protein solution stability can be
applied within several minutes or hours. Here, a rheological
approach in combination with molecular dynamics simulations are presented, for deter-
mining and predicting long-term phase behavior of highly concentrated protein solutions.
A diversity of liquid phase conditions, including salt type, ionic strength, pH and protein
concentration are tested in a Glutathione-S-Transferase (GST) case study, in combination
with the enzyme with and without the solubility-enhancing Cherry-Tag™. The rheological
characterization of GST and Cherry-GST solutions enabled a fast and efficient prediction
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of protein instabilities without the need of long-term protein phase diagrams. Finally, the
strong solubility enhancing properties of the Cherry-Tag™ were revealed by investigating
protein surface properties in MD simulations. The tag highly altered the overall surface
charge and hydrophobicity of GST, making it less accessible to alteration by the chemical
surrounding.
Characterization of highly concentrated antibody solution - A toolbox for
the description of long-term solution stability
Marie-Therese Schermeyer, Anna K. Wöll, Bas Kokke, Michel Eppink and Jürgen Hub-
buch
mAbs (2017), accepted manuscript
For a better understanding of highly concentrated solutions,
this work combines established and novel analytical tools to
characterize the impact of solution properties on the stabil-
ity of highly concentrated mAb formulations. In this study
monoclonal antibody solutions in a concentration range of
50 - 200 mg/ml at pH 5 - 9 with and without glycine,
PEG4000 and Na2SO4 were analyzed. To determine the
monomer content analytical SEC runs were performed. ζ-potential measurements were
conducted to analyse the electrophoretic properties within different solutions. The melt-
ing and aggregation temperatures were determined with the help of fluorescence and static
light scattering measurements. Additionally, rheological measurements were conducted
to study the solution viscosity and the viscoelastic behavior of the mAb solutions. The
so determined analytical parameters were scored and merged as an analytical toolbox.
The resulting scoring was then successfully correlated with long-term storage (40 days
of incubation) experiments. The study indicates that the sensitivity of complex rheolog-
ical measurements in combination with the applied techniques allow reliable statements
about the impact of solution properties such as protein concentration, ionic strength and
pH shift on the strength of protein-protein interaction and solution colloidal stability.
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Impact of polymer surface characteristics on the microrheological
measurement quality of protein solutions - a tracer particle screening
Katharina C. Bauer*, Marie-Therese Schermeyer*, Jonathan Seidel and Jürgen Hubbuch
International Journal of Pharmaceutics 505 (2016): 246-54.
*contributed equally
In the present work a screening of melamine, PMMA,
polystyrene and surface modified polystyrene as tracer par-
ticles for conduction of microrheological measurements were
investigated at various protein solution conditions. The sur-
face characteristics of the screened tracer particles were evaluated by zeta potential mea-
surements. Furthermore each tracer particle was used to determine the dynamic viscosity
of lysozyme solutions by microrheology and compared to a standard. The results indicate
that the selection of the tracer particle had a strong impact on the quality of the microrhe-
ological measurement dependent on pH and additive type. Surface modified polystyrene
was the only tracer particle that yielded good microrheological results for all tested con-
ditions. The study indicated that the electrostatic surface charge of the tracer particle
had a minor impact than its hydrophobicity. This characteristic was the crucial surface
property that needs to be considered for the selection of a suitable tracer particle to
achieve high measurement accuracy.
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Implementation of an analytical microfluidic device for the
quantification of protein concentrations in a high-throughput
format
Carsten Philipp Radtke1, Marie-Therese Schermeyer1, Yün Claudia Zhai, Jacqueline
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Abstract
Nowadays the performance of experiments in automated microliter scale format are com-
mon practice in the biopharmaceutical process development. The increased number of
experiments, reduced sample volumes and usage of robotic platforms require the adjust-
ment of photometric measurements to determine the protein concentration. This work
presents the qualification and usage of a disposable measurement device which can be
used with conventional microplate photometers. The application of the microfluidic de-
vice (µF-device) allows absorption measurements of protein concentrations from around
0.1 to 100 mg/mL with an accuracy of 99.2 % dependent on given protein extinction
coefficients. The integrated four measurement chambers of increasing height (100 – 1500
µm) allow the direct calculation of calibration curves and the determination of protein
concentrations independent of used optical path lengths with a sample volume of 36 µL.
This study contains the validation of the analytical µF-device according to ICH Guide-
lines as well as a representative case study. A salt gradient screening with chromatography
columns in microliter scale performed on a liquid handling station presents the usability
of the µF-device. It is shown that an improvement of the repeatability and accuracy of
the chromatograms could be achieved by µF-device implementation in comparison to
photometric measurements performed in microtiter plates.
Keywords: absorption measurement; high protein concentration; high throughput exper-
imentation; microfluidic
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6.1 Introduction
The market of biopharmaceuticals is steadily growing especially the commercialization
of monoclonal antibody drug substances [168]. This trend requires the development of
new process steps as well as the optimization of established ones. The purification devel-
opment of the complex molecules is regarded as the most cost and time intensive step
due to high investment and material costs [169]. To face these disadvantages the down-
stream development focusses on statistically based design of experiments [170] as well as
automated sample handling and analysis [171] at an early phase. At this early phase of
product development only a low amount of target molecules are available. To gain the
highest amount of information out of the given low sample volume the execution of high
throughput screening procedures in microliter scale is the method of choice [172, 173].
Many process steps are already established in an automated microscale format, like mi-
croliter scale chromatography [174] or precipitation screenings [175]. Unfortunately they
are not used to their full potential due to limited integrated analytical methods. Imple-
mented analytical methods are often time consuming, do need high sample volumes and
are not specialized to the extended determination range tested in the high throughput
format. One of the most important parameters to be tested is the product yield and the
impurity concentration. The method of choice to determine these parameters are pho-
tometric measurements. Dependent on the tested process step, the concentrations to be
determined vary from around 0.01 mg/mL to more than 100 mg/mL. Thus, the analytical
method has to cover a wide concentration range. Since conventional photometric meth-
ods do not cover this range the samples have to be diluted. The dilution of the samples
increase the inaccuracy of the measurement and requires a rough knowledge of the initial
concentration of the molecule to be measured. Aggravating this situation in some cases,
not only one specific type of molecule has to be quantified but also samples with different
types of molecules, with varying extinction coefficients and concentrations. One example
is the determination of target molecule and impurity concentrations of fractions collected
from chromatography runs. The selection of the optimal dilution requires previous knowl-
edge of expected protein content to avoid measurement inaccuracy for one type of the
molecules to be determined. Every photometric detector has a specific absorption limit
depending on given device properties. Based on the Lambert Beer Law, the absorption
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A and therefore the maximum measureable protein concentration c is linearly dependent
on the extinction coefficient λ and the path length d of the measurement cell.
A = c ∗ λ ∗ d (6.1)
The extinction coefficient λ is dependent on the amino acids on the protein surface
which absorb light at the set wave length and therefore specific for every protein. The
parameter which can be manipulated by the developers is the path length d. The linear
relation of d to A led to the implementation of novel instruments with lower or flexible
path lengths. One example therefore is the Nanodrop spectrophotometer series from
Thermo Scientific (Waltham, USA) [176]. With these tools one to eight sample drops
with a volume of 2 µL are contained by surface tension between two planar surfaces.
The instruments can generate path lengths between 1 and 0.05 mm. The low sample
consumption, easy usage and the relatively high protein concentration which can be
measured directly, explain the sales volume of these instruments. The Solo VPE from
C. Technologies Inc. (Bridgewater, USA) is able to change the optical path length from
0.01 mm to 15 mm via a movable optical fiber (FibretteTM). From the variable path
length data the slope m can be calculated (m = ∆A/∆d). With m and known λ the
protein concentration can be determined. Due to many measurement points over a wide
path length range the tool is very precise and covers a huge protein concentration range
[177]. Disadvantages of described tools are the manual operation and the limited number
of samples which can be measured simultaneously (one sample (Nanodrop 2000c and
Solo VPE) to eight samples (Nanodrop 8000). Thus they are hardly automatable nor
high throughput compatible. An instrument which meets the high throughput needs
of the biopharmaceutical process development is the DropSenseTM 96 UV/VIS droplet
reader from Trinean (Gentbrugge, Belgium). This instrument also has a very small sample
consumption of 2 µL and is equipped with 96-well robotic compatible measurement units.
Here the protein absorption is measured in two chambers of differing heights. This two
point measurement does not allow the application of the slope technique implemented
with the SoloVPE. The microfluidic device (µF-device) presented in the current study
is an approach to combine the advantages of the instruments described above. The µF-
device and its channel structures are constructed according to the microplate format.
The specific design of the channel structures, each with four measurement chambers of
different height, allow the application of the slope method for an increased measurement
accuracy and a direct four-point calibration of every measured sample. Especially to be
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emphasized is the accurate measurement in a wide protein concentration range enabled
by the provided path lengths. Furthermore, microplate photometers already implemented
in the lab can be used so that no investment in a new instrument has to be done.
6.2 Materials and Methods
6.2.1 Design and manufacturing of the µF-device
6.2.1.1 Materials
The two component curing silicone Elastosil®RT 601 (Wacker Chemie, Burghausen, Ger-
many), a polydimethysiloxane (PDMS), was used for manufacturing the µF-device. The
replication master for the µF-device was designed in-house and manufactured by Proform
AG (Marly, Switzerland). This master served as inverted structure in the molding cavity
and therefore defined the channels of the molded µF-device. The master was designed
according to the microwell plate standard. A total of 96 channel structures are evenly dis-
tributed on the master. The inlets of the channel structures are vertical cylinders which
are aligned such as wells of a 96-well plate (see figure 6.1).
Connected to the inlet, a circular channel with four oval chambers and a vertical outlet
on the end was designed. The four chambers have different heights (100, 600, 1000 and
1500 µm) and are arranged in the pattern of the wells of a 384-well plate. This allows a
simple read out of the chambers in the microplate photometer. To improve the stability
and the automated handling of the µF-device on the liquid handling station (LHS), the
silicone µF-device was placed inside a specially designed, 3D printed cartridge (Sculpteo,
Villejuif, France). This cartridge allowed the handling by the robotic manipulator arm
of the LHS. The measurement in the microplate photometer was possible through 384
perforations which were arranged evenly according to the microplate standard.
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(A) (C)
(D)(B)
Figure 6.1: (A) CAD model of the replication master for the manufacturing of the µF-
device. (B) Magnified channel structure with the four measuring chambers of
varying channel height (100, 600, 1000, and 1500 µm) (C) Photograph of the
assembled device on the deck of the liquid handling station. The LHS-tips
dispense the samples directly into the channel structures eight at a time. (D)
Visualization of the absorption data gained in the four measuring chambers of
one channel structure to illustrate the absorption gradient due to the differing
channel heights.
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6.2.1.2 Methods
The molding process of the µF-device was executed as described by Waldbaur, Kittel-
mann, Radtke & Hubbuch [178]. Only the spacer part of the molding tool was replaced.
To obtain a clear and plain surface, a flat piece of polished stainless steel was employed
instead.
6.2.2 Qualification of the µF-device
6.2.2.1 Materials
Lysozyme from Chicken egg white was purchased in solid form from Hampton Research
(Aliso Viejo, USA). Acetic acid and sodium acetate for buffer preparation were purchased
from Merck KGaA (Darmstadt, Germany). Ultrapure water (ISO 3696) was used to pre-
pare all solutions. Protein solutions for µF-device qualification were prepared in 20 mM
acetate buffer at pH 5 with a nominal mass concentration of 50 mg/mL. A buffer exchange
of the protein solution with Sephadex media from GE Healthcare (Buckinghamshire,
Great Britain) was performed to remove buffer salts or other components present in the
purchased protein preparations. The size exclusion chromatography (SEC) column was
manually packed with a diameter of 2.5 cm and a bed height of 23 cm. The fractions were
concentrated to a protein concentration of 100 mg/mL with the help of 20 mL Vivaspin
ultra filtration spin columns (Sartorius, Goettingen, Germany) with a molecular weight
cut off of 3000 Da. For liquid handling a Tecan Freedom Evo 200 (Tecan, Crailsheim,
Germany) LHS equipped with 1 mL syringes was used. The LHS was equipped with an
Infinite® M200 pro plate reader (Tecan, Crailsheim, Germany) and controlled by Magel-
lan 7.1, both provided by Tecan. The LHS was controlled by Evoware 2.5 also provided by
Tecan. To compare the absorption results of the µF-device with an established method,
measurements of protein absorption at 280 nm in the Nanodrop 2000 (Thermo Scientific,
Waltham, USA) were performed.
6.2.2.2 Methods
The buffer exchange of the lysozyme solution was conducted at an ÄktaPrime plus sys-
tem from GE Healthcare. A total of 5 mL of lysozyme solution with a concentration of
50 mg/mL was purified. The protein was fractionated in 10 mL Falcon tubes and the
51
Chapter 6 Implementation of a Microfluidic Device
concentration measured with an extinction coefficient of 22 L/(g*cm) with the Nanodrop
2000. The concentration of the dilute protein concentration was performed with Vivaspins
and a rotational speed of 8000 rad/sec. A protein dilution series from 100 mg/mL to 0.1
mg/mL with acetate buffer was prepared. The µF-device was automatically handled and
filled on the robotic platform. The absorption at 280 nm of protein solutions and buffer
blanks were measured in the µF-device in quadruplicate. For the calculation of protein
concentration the Lambert-Beer Law was applied
c =
A
λ ∗ d (6.2)
With the absorption A, the concentration c [mg/mL], the extinction coefficient
λ [mL/mg*cm] and the path length d [cm]. Additionally the slope m, which results of the
absorptions plotted against the four given path lengths was determined. With this slope
the calculation of protein concentrations with increased measurement accuracy became
possible.
c =
m
λ
(6.3)
The evaluation of gained results and consequently the validation of the µF-device fol-
lowed the International Conference on Harmonisation (ICH) harmonized tripartite guide-
line Q2(R1) (Validation of analytical procedures: text and methodology) [15]. Following
these guidelines the accuracy, repeatability and measuring range of absorption results
gained with the developed analytical µF-device were studied. To prove the precision of
the analytical device lysozyme solution with a concentration of 5 mg/mL was prepared
and measured in four measurement units of the µF-device. The deviation of the absorp-
tion measurements were calculated. To determine the absorption range of the µF-device,
lysozyme solutions in a concentration range of 0.1 and 100 mg/mL were prepared and
measured in quadruplicate.
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6.2.3 Case Study
6.2.3.1 Materials
For the chromatography runs the buffer described in section 2.1 was used (Buffer A). By
adding 1.25 M sodium chloride (NaCl) (Merck, Darmstadt, Germany) to Buffer A the
high salt buffer (Buffer B) was prepared. Purified monoclonal antibody (mAb) solution
was provided by Synthon (Nijmegen, Netherlands). Cytochrome C (CytC) was purchased
as lyophilized powder from Sigma-Aldrich (St. Louis, USA). The mAb stock solution was
buffer exchanged and concentrated to 65 mg/mL by 20 mL Vivaspins with a molecular
weight cut off of 50000 Da. For fraction collection, fraction volume determination and UV
absorption measurements, half area UV-MTPs were used. For the preparation of high salt
buffers and the dilution of elution fractions two 96 deep well square plates (DWP) (VWR,
Germany) with a volumetric capacity of 2 mL were used. RoboColumns® prepacked with
200 µL SP Sepharose FF were purchased from Atoll GmbH (Weingarten, Germany).
Column chromatography in high throughput experimental mode using RoboColumns®
was performed on a Tecan Freedom Evo 200 LHS, additionally equipped with a Te-Chrom
column carrier.
6.2.3.2 Methods
To prepare the elution buffers, two different troughs with Buffer A and Buffer B were
assigned to the robotic platform. These components were mixed automatically in a DWP
to achieve four salt gradients with respectively 10 salt steps resulting in different end
concentrations. The gained end salt concentrations were 1.25 M, 1 M, 0.75 M and 0.5 M
NaCl. CytC was dissolved in acetate buffer and transferred to the mAb solution to reach a
starting protein concentration of 60 mg/mL mAb and 3 mg/mL CytC. This solution was
transferred to eight Eppendorf Tubes (Eppendorf, Hamburg, Germany) and also placed
in designated carriers on the robotic platform. A detailed description of parallelized
chromatography performed automated on an LHS has been published by Wiendahl et al.
[177]. In this case study an exemplary salt gradient screening was performed. Therefore,
four gradients of varying slopes were tested to separate mAb molecules from CytC via
cation-exchange chromatography (CEX). The salt gradients had a length of ten column
volumes respectively 2 mL with different end salt concentrations which resulted in four
different salt gradient slopes. For every tested salt gradient twenty elution fractions with a
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set volume of 100 µL were collected in half area UV-MTP. After measuring the absorption
at 900 and 990 nm to gain information of the precise fraction volumes following the
method published by McGown & Hafeman [179] and Lampinen et al. [180], 38 µL of
the samples were transferred to the presented analytical µF-device. A volume of 20 µL
of the samples for the 1:50 dilution and 33 µL for the 1:15 dilution were transferred to
DWPs. To reach the respective dilution low salt buffer was added to every sample (980
µL respectively 467 µL), mixed and transferred to a full area UV-MTP. Afterwards the
absorption at 280 nm and 410 nm was measured of undiluted samples transferred to the
µF-device and diluted samples transferred to the UV-MTPs. Every cation-exchange run
was executed and analyzed in duplicate.
6.3 Results
6.3.1 Qualification of the µF-device
According to the ICH Q2 guidelines the µF-device has been tested in regard to accuracy,
precision (repeatability), linearity and range. For the qualification a lysozyme solution
series from 0.1 – 100 mg/mL was prepared. After the preparation the theoretical lysozyme
concentration was verified by fourfold absorption measurements with the Nanodrop 2000.
The determined concentration values can be found in figure 6.2.
For qualification the absorption of every sample was determined in four channel struc-
tures. Additionally a buffer blank was measured and subtracted from the protein absorp-
tion values. The absorption values were plotted against the height of the four measuring
chambers synonymous to the optical path length. The resulting values and the zero value
were fitted with a linear regression. Values deviating from the regression line by more
than 3 % were excluded from the regression of the second fit calculation. Thereupon, the
slope m of the optimized regression was calculated for every measured sample. With m
and 280 (equation 6.3) the concentration could be calculated. In figure 6.2a the described
method is exemplarily shown for a protein sample containing 4.9 mg/mL lysozyme. For
this measurement the slope m with a value of 10.71 1/cm was calculated which resulted
in a protein concentration of 4.87 mg/ml (see equation 6.3). For measurements in the
areas of the upper and lower detection limits the concentration can directly be calculated
with the application of the Lambert-Beer law (equation 6.2). Here only the highest or
lowest channel height was suitable for the exact absorption measurement. For the used
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Figure 6.2: (a) Lysozyme absorption values measured in the µF-device plotted against
the channel height. Exemplarily determination of the slope m of the regression
line. The reference concentration of this sample measured in Nanodrop 2000
was 4.9 mg/mL. (b) Calculated lysozyme concentrations based on µF-device
absorption data plotted against set concentration values with corresponding
standard deviations. (c) Tabular listing of theoretical lysozyme concentra-
tions, concentrations based on Nanodrop measurements and concentrations
based on µF-device measurements with corresponding standard deviations.
photometer the range of detection was between 0.001 and 2.3 OD. Calculated lysozyme
concentrations can be found in the tabular listing in figure 6.2c. For the visualization
of the gained results, the lysozyme concentrations and related standard deviations de-
termined with the µF-device are plotted against set concentration values determined by
Nanodrop measurements in figure 6.2b.
6.3.2 Case Study
The presented analytical µF-device enables direct protein absorption measurements in a
wide concentration range implementable on a liquid handling station. In order to demon-
strate the applicability of the µF-device it was implemented in a HTE (high throughput
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experimentation) process development step. For this, HTE chromatography was per-
formed with a binary protein solution containing mAb with a starting concentration of
65 mg/mL and CytC with a starting concentration of 3 mg/mL. The actual aim of the
chromatography screening was to find the optimal salt gradient to separate these two
proteins. For this, four gradients of varying slope and end salt concentration were tested
in duplicate. Important for the selection of the best suited gradient was the proper deter-
mination of protein concentration in the collected elution fractions. The elution fractions
were analyzed directly in the channel structures of the µF-device respectively in four
chambers of differing heights and after dilution of the fractions in MTPs for comparison.
The absorption values of every single fraction are displayed as round symbols in figure
6.3 and figure 6.4. The absorption values of the mAb and CytC molecules were separated
with the help of the also measured absorption at 410 nm wavelength. At this wavelength
CytC has a second absorption maximum whereas mAb does not absorb light. With the
known absorption ratio of 280 nm and 410 nm of CytC (0.24, data not shown) the de-
tected 280 nm sum signal could be divided in mAb and CytC specific absorption. The
absorption values of the 20 elution fractions formed the basis of a nonlinear Gaussian fit
for the preparation of chromatograms describing the elution of the molecules. In figure
6.3 the absorption values at 280 nm from mAb and CytC are plotted against the elution
volume.
The fitted chromatogram represents the run with the steepest salt gradient with absorp-
tion values measured in the measuring chambers from 100 µm to 1500 µm path length in
the µF-device. With decreasing channel height the absorption values decreased. The mAb
represented by the blue symbols eluted first over an elution volume of 1000 µL. CytC,
represented by the red symbols, starts to elute at around 650 µL and over an elution vol-
ume of 850 µL. No baseline separation could be achieved. Independent on the chamber
height the curve progression was similar. Only the absorption signals of CytC measured
with a path length of 100 µm did not show a significant absorption peak. Depending on
the salt gradient slope the chromatograms showed varying resolutions. The plot set in
figure 6.4 a-d illustrates the influence of the varying salt gradients on the resolution of
the chromatographic runs.
The graphs contain the absorption values measured in the channels at a path length of
1000 µm and absorption values measured in a UV MTP. For the measurement in the
MTP the fractions had to be diluted. Depending on the expected protein content the
samples were diluted in a ratio of 1:50 (fraction 1-12) respectively in a ratio of 1:15
(fraction 13-20). The shown absorption values of the MTP are standardized to a dilution
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Figure 6.3: Elution profiles of mAb and CytC with a gradient from 0–1.25 mM NaCl in
10 CV. Plotted are absorption values at 280 nm measured in the µF-device in
the four respective measuring chambers with a height of 100, 600, 1000 and
1500 µm. Absorption values of mAb are plotted as blue circles, absorption
values of CytC are plotted as red circles. The absorption values were fitted
with a nonlinear Gaussian fit (blue and red lines).
of 1:50. With decreasing slope of the salt gradient the detected elution peaks of both
protein types widened. Additionally the elution points were shifted to higher volumes
and the resolution of the separation declined. In figure 6.4d the run with the lowest
gradient is depicted. Here the elution peak of the mAb overlays the CytC elution peak.
The absolute absorption values of the MTP were lower in the order of magnitude of
around 75 % in comparison to absorption values measured in the 1000 µm chamber of
the µF-device. With decreasing slope of the salt gradient the chosen nonlinear Gaussian
fit did get less precise independent on measurement device. In figure 6.4a fraction 4,
9 and 13 (F4, F9 and F13) are highlighted in yellow. For these fractions the approach
to calculate protein concentrations from µF-device absorption data is shown for both
proteins (figures 6.5a and 6.5b) and compared to the calculated protein concentrations
based on MTP absorption data (figure 6.5a).
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Figure 6.4: Chromatograms of the four screened elution gradients of mAb and CytC
absorption values. Illustrated are absorption values with related standard
deviations measured in the µF-device in a measuring chamber height of 1000
µm and absorption values measured in MTP after dilution. (a) Gradient from
0 – 1.25 mM NaCl in 10 CV, highlighted are fraction 4, 9 and 13 which have
been further investigated; (b) gradient from 0 – 1 mM NaCl in 10 CV; (c)
gradient from 0 – 0.75 mM NaCl in 10 CV; (d) gradient from 0 – 0.5 mM
NaCl in 10 CV.
In figure 6.5a and 6.5b the mAb respectively CytC absorption values of F4, F9 and
F13 are plotted against the path lengths of the measuring chambers of the µF-device.
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Figure 6.5: Absorption values with related standard deviations of fraction 4, 9 and 13
from mAb (a) and CytC (b) measured in the µF-device plotted against chan-
nel height with regression lines and related slope values m. The grey area
depicts the allowed deviation of 3 %. (c, d) Protein concentrations with re-
lated standard deviations of F4, F9 and F13 calculated based on µF-device
absorption values (dark colored) and based on MTP absorption values (light
colored). The concentrations based on absorption values measured in the µF-
device were calculated with the slope method (equation 6.3).
The regression lines were calculated based on at least 3 measured values of one channel
structure in duplicate. Measurement values which deviated from this regression by more
than 3 % were not included in the calculation of the slope m. The mAb absorption value
for F4 determined with a path length of 1500 µm was eliminated from further calculations
due to this deviation as well as the CytC absorption value of F9 which was determined
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with a chamber height of 1500 µm and F13 which was determined with a chamber height
of 100 µm. This exclusion criteria is illustrated by the grey area in figures 6.5a and
6.5b. The calculated regression coefficients (R2) for shown data all had a value above
0.996. The corresponding protein concentrations were determined following equation 6.3.
The protein concentrations of similar fractions were also determined based on absorption
measurements conducted in MTPs. The so calculated mAb and CytC concentrations are
compared to µF-device results in figure 6.5c. To display the wide protein concentration
range of chosen fractions in one plot, a logarithmic scale was selected. The highest mAb
concentration could be found in F4 with a value of 140 mg/mL based on data of the
µF-device and a standard deviation of 0.04 % and 210 mg/mL based on MTP data
with a standard deviation of 30.1 %. In F9 both molecules were present at a comparable
concentration. In F13 the lowest mAb concentration was detected with in a value of 0.02
– 0.03 mg/mL. All calculated protein concentrations with associated standard deviations
can be found in a tabular listing in figure 6.5d.
6.4 Discussion
6.4.1 Qualification of the µF-device
In this section the validation of the presented analytical tool according to accuracy, re-
peatability, linearity and range as prescribed by the ICH guideline Q2 (R1) is discussed.
The comparison between measured protein concentrations determined with the µF-device
and the reference concentration values determined with the Nanodrop 2000 (see figure
6.2) illustrates an excellent consistency. In accordance to ICH guidelines this complies
the validation criterion of accuracy. The determined accuracy was 99.02 % in a concen-
tration range of 0.5 – 10 mg/mL (equation 6.3) and 99.92 % in a range of 0.1 – 0.5
mg/mL and 10 – 100 mg/mL Lysozyme. The obtained measurement deviations can be
explained by the manual manufacturing of the µF-device and the used silicone material
with relatively low stiffness. With known protein concentration the applied slope method
and so fitted calibration curve can be used to calculate the extinction coefficient with
only one protein sample respectively one starting concentration. Nonetheless, with the
fourfold measurement of ten different lysozyme concentrations an excellent repeatability
could be determined expressed by an average standard deviation of 3.1 %. The linearity
of gained results could be shown both for plotting the absorption values over path length
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(R2 = 0.988) and plotting calculated concentration over reference concentration values
(R2 = 0.9998) (see figure 6.2).
6.4.2 Case Study
The aim of the executed case study was to separate the mAb molecules with a relatively
high starting concentration of 65 mg/mL from CytC molecules with a starting concen-
tration of 3 mg/mL. To find an optimal separation with CEX a screening of four salt
gradients differing in slope and end salt concentration were performed in microliter scale
on a LHS. As assumed the mAb molecules with an isoelectric point (pI) of 7.9 eluted
prior to CytC molecules with a pI of 10.4 for all performed runs with the exception of
the run presented in figure 6.4d (this phenomenon will be discussed within the next para-
graph). The explanation for this elution order can be found in the stronger electrostatic
interaction of CytC with negatively charged ligands in comparison with weaker adsorp-
tion of mAb molecules on the resin. Thus, a higher salt concentration is necessary to
desorb the CytC molecules from the resin what implies a later elution. With decreasing
gradient slope the peaks were shifted to later elution volumes. In figure 6.4d it seems that
CytC is eluting with the mAb molecules but taking the mass balance of CytC molecules
into account, it can be expected that the main peak of CytC elutes outside the set frac-
tion range. The elution of CytC at comparatively low salt concentrations are potentially
caused by a specific interaction with the mAb and thus a co-elution of CytC molecules.
The best chromatographic resolution could be found with the steepest gradient and an
end salt concentration of 1.25 mM NaCl. To further optimize the run with the aim of a
baseline separation, a step elution with a step height of 0.4 mM NaCl hold for 5 CV for
mAb elution and a second step with 1.25 mM NaCl hold for 4 CV to elute CytC from
the column is recommended, based on the results of the gradient screening. In the next
paragraph the absorption values of µF-device measurements will be discussed and com-
pared to MTP absorption measurements. Fractions analyzed with the analytical device
have a mean standard deviation of 3.5 % compared to MTP measurements with a mean
standard deviation of 8.2 % (see figure 6.3 and 6.4). The higher accuracy of absorption
measurements executed with the µF-device can be explained by direct analysis of all
fractioned samples without the need of dilution. In figure 6.3 the absorption measure-
ments of every measuring chamber is plotted. The decrease of absorption values with
decreasing path length respectively height of measuring chamber is in good agreement
with the Lambert Beer law (equation 6.1). The selected nonlinear Gaussian fit represents
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the absorption values very precise. This not only implies that the absorption values can
be fitted with a characteristic chromatographic elution curve but also that the absorp-
tion values actually represents the eluting protein amount. The CytC peak cannot be
depicted well by the fit of results of the 100 µm measuring chamber. Here, the measured
absorption values of CytC are close to the buffer blank absorption what may explain
the weak fit results. In figure 6.4 the influence of the salt gradient on the elution profile
measured in the µF-device and in the MTP is shown. The absolute absorption values of
the MTP and the µF-device varied due to divergent path length and the dilution of the
fractions for MTP measurements. In principal the curve progressions of chromatograms
obtained by absorption results of the µF-device and MTP are comparable as well as elu-
tion starting points, absorption maxima and elution end points. Deviations traceable to
the measurement system are obtained with CytC peaks and were especially significant at
the flattest tested gradient (see figure 6.4d). One explanation may be the chosen dilution
rate of 1:50 for the fractions F1-F12. Due to the low amount of CytC in these fractions
the error caused by dilution had a higher impact. Contributing to this assumption the
comparability of CytC peaks was better for a flatter gradient depicted in figure 6.4c.
Here, CytC molecules elute where the fractions have been diluted in a ratio of 1:15 what
gives a better precision of the results. In all displayed graphs the measured absorption
values oscillate around the fit curve for measurements executed in µF-device and MTP.
The oscillatory movement is periodical and due to the practical implementation of the
chromatographic run on the LHS. The dispensing of the buffers is not continuous as in
common chromatographic runs but subsequently. This potentially cause a longer hold-
ing time of the proteins on the column. This phenomenon had an increased impact on
fit results with decreasing salt gradient slope. To increase fit accuracy the step size as
well as the fraction size should be decreased. To depict the dependencies of specific path
length of the measuring chambers on the absorption values the linear relation is shown
in figure 6.5a and 6.5b for three exemplarily chosen fractions (F4, F9, and F13). The
regression coefficient of 0.996 proves the linearity of the adsorption values gained with
different chamber heights. The mAb absorption value of F4 measured in the chamber
with a height of 1500 µm was excluded from further calculations due to the exceedance
of the determined absorption limit of 2.3 OD. The same reasoning applies to the CytC
absorption value of F13 measured in a chamber of 100 µm height. At this point the quan-
tification limit was reached. This explanation does not hold true for the deviation of the
CytC absorption value of F9 measured in the 1500 µm chamber height. Here the devia-
tion is potentially due to a measurement error in the channel structure caused by small
air bubbles. With the help of the slope of the discussed regression lines the concentra-
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tions of mAb and CytC in the respective fractions could be calculated. These calculated
concentrations were compared to the concentrations determined with MTP absorption
values and are displayed in figure 6.5c. The calculated values represent the expected
concentrations of mAb and CytC when taking the related chromatograms of figure 6.4a
into account. In direct comparison, deviations between MTP and µF-device results of
more than 60 % were detected for both protein species. One explanation of these high
discrepancies can be found in the extent of calculated standard deviations. The stan-
dard deviations of determined mean protein concentrations measured in the microfluidic
channels had a maximum value of 0.06 mg/mL. The comparatively low standard devia-
tions of these measurements prove the reliability of the developed µF-device. In contrast,
the standard deviations of protein concentrations determined with MTP were between
1.08 and 64.71 mg/mL (20 – >100 %). These standard deviations were so high that
the standard deviation error also covered concentrations calculated with µF-device ab-
sorption results. The high standard deviations of the concentrations calculated based on
MTP results could be explained with dilution errors, additional required liquid handling
steps and the potential formation of a meniscus in the wells of the MTP. The angle of
this meniscus is highly dependent on protein concentration and buffer compositions. The
consideration of this phenomenon is complex especially when measuring varying con-
centrations at varying liquid levels during one screening, such as occurred in this case
study. The deviations potentially caused by meniscus can be excluded by application of
the µF-device due to the completely filled channel structures. Including the discussed
standard deviations the calculated concentrations based on µF-device and MTP results
are comparable and support the statement that the presented µF-device is applicable
for absorption measurements. In the discussed case study the target molecule (mAb)
and the impurity (CytC) could be quantified due to the second absorption maximum of
Cytochrome C at 410 nm. To distinguish between target molecule and impurities having
similar absorption characteristics the spectral method published by Hansen, Skibsted,
Staby & Hubbuch [181] and Hansen, Jamali & Hubbuch [182] may be transferred to the
presented µF-device. This possible application will be part of future investigations.
6.5 Concluding Remarks
The presented analytical µF-device could be validated according to ICH guidelines. In
the course of this validation the accuracy, repeatability and linearity was proven for a
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concentration range from 0.1 – 100 mg/mL, with lysozyme as model protein. This qual-
ification permits the application of the µF- device for protein absorption measurements
in the biopharmaceutical process development. The case study demonstrated a success-
ful application of the µF-device on a liquid handling station. The analytical µF-device
was simple to implement in an existing automated development step. Furthermore, the
absorption of elution fractions measured with the presented µF-device resulted in com-
prehensible characteristic elution profiles. Consequently, the µF-device presented in this
study is a promising alternative or supplement to existing devices combining a wide
measurement range with high throughput compatibility.
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Abstract
This study aims at defining rheological parameters for the characterization of highly con-
centrated protein solutions. As a basis for comparing rheological behavior with protein
solution characteristics the protein phase behavior of lysozyme from chicken egg white
with concentrations up to 225 mg/mL, changing pH values and additive concentrations
was studied in a microbatch scale format. The prepared phase diagrams, scored after 40
days (t40) give insights into the kind and kinetics of the phase transitions that occur. Os-
cillatory frequency sweep measurements of samples with exactly the same conditions were
conducted immediately after preparation (t0). The protein solutions behave viscoelastic
and show a characteristic curve shape of the storage modulus (G′) and the loss modulus
(G′′). The graphs provide information about the cross-linking degree of the respective
sample. The measured rheological parameters were sensitive concerning solution compo-
sition, protein concentration and solution inner structure. The rheological moduli G′ and
G′′ and especially the ratio of these parameters over a frequency range from 100 to 40000
rad/sec give information about the aggregation tendency of the protein under tested con-
ditions. We succeeded to correlate protein phase behavior with the defined rheological
key parameter ωCO. This point represents the frequency value of the intersection point
from G′ and G′′. In our study lysozyme expressed a ωCO threshold value of 20000 rad/sec
as a lower limit for stable protein solutions. The predictability of lysozyme aggregation
tendency and crystallization by means of squeeze flow rheometry is shown.
Keywords: Protein Phase Behavior; Solubility; Formulation; Rheology; Storage and Loss
Modulus
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7.1 Introduction
Over the lifespan of a biopharmaceutical molecule - combining development into drug
substance and drug product - the molecule has to withstand different fluid phase transi-
tions during processing, while the final formulation and storage buffer ensures a long-term
stability of the final product.
Depending on the respective process the target molecule comes into contact with chang-
ing buffer conditions. Examples are a potential pH shift due to buffer exchange steps, an
increase of the ionic strength as a result of the elution step in cation and anion exchange
chromatography or the increase of the protein concentration after polishing operations.
The buffer conditions applied influence protein solubility and hence aggregation tendency
of the protein, depending on the molecule and the strength of the deviation from ideal
conditions Dumetz, Snellinger-O’brien, Kaler & Lenhoff [54], Baumgartner et al. [88], and
Pelegrine & Gasparetto [183]. While unintentional and irreversible aggregation needs to
be avoided, controlled crystallization or precipitation might be a central step in modern
processing. Finally one of the most decisive steps in the biopharmaceutical drug devel-
opment are the formulation and storage of the final drug product. Without a proven
long-term storage stability the aim of marketability can not be reached. Aggravating
this situation, novel dosage forms like subcutaneous injections require volumes below 1.5
mL Liu, Nguyen, Andya & Shire [184]. To obtain a high enough medication dosage, one
has to strongly increase the target molecule concentration in the formulation buffer. Due
to the high concentration the agglomeration tendency increases and as a side effect of
protein-protein interaction the viscosity increases as well.
It would thus be desirable to know physico-chemical parameters which contain informa-
tion about the aggregation tendency of the target molecule for a given fluid phase or
formulation. In order to address this issue it is state of the art to test the long-term
stability of a target molecule via trial and error. The molecule is injected in the poten-
tially appropriate buffer and then placed in a storage compartment until equilibrium is
reached. Afterwards the sample is scored as stable or unstable. This method is generally
accepted but it is time consuming and requires experience in the selection of appropriate
buffers. An apriori prediction of the protein phase behavior would reduce development
costs and time. However without a suitable characterization of protein solutions a worth-
while predictability of their phase behavior will never be reached. A better understanding
of protein phase behavior in solution is necessary.
In the last decades a considerable amount of research work has been done to understand
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protein behavior in varying solution conditions [27, 85, 88, 185]. Due to the complex-
ity of the system one approach has been to study the different physical and chemical
parameters, which influence the aggregation process, separately. Step by step different
interaction theories and influencing parameters were evaluated [150, 186, 187]. Kumar,
Dixit, Zhou & Fraunhofer [21] analyzed the impact of short and long-range forces on
protein aggregation under varying conditions. They could show that electrostatic inter-
actions have a main impact on protein-protein interactions under ideal dilute conditions.
With increasing protein concentration the impact of hydrophobic forces strengthen [21,
164]. With the theoretical understanding of physical and chemical interaction regimes
the second virial coefficient (B22) was introduced. This parameter is measured by static
light scattering and reflects the total thermodynamic environment for protein molecules
diluted in a given solvent. The parameter characterizes solute-solute and solute-solvent
interactions [188]. The B22 could be successfully correlated with crystallization slots as
well as precipitation points [105, 120, 189, 190]. Unfortunately, that could only be shown
for ideal dilute solutions. A direct projection from results gathered in dilute solutions
to high concentrated protein solutions can not be easily made. The B22 does not take
into account short-range interactions between molecules which are almost negligible in
dilute solutions but influence the protein behavior with increasing protein concentration.
Also not displayed is the exponential increase of the macromolecular crowding effect.
This effect describes the reduction of solvent volume around molecules and occurs only
in highly concentrated protein solution. This crowding effect can make molecules behave
in radically different ways than in dilute solutions especially regarding their interaction
behavior [69, 191]. A missing link is thus a method describing both dilute and high con-
centrated protein solutions towards their phase behavior independently of interaction
characteristics.
In order to address this dilemma, the current study analyses the systems flow character-
istics, hence the rheology of protein solutions. Advantages of rheological measurements
are, that they provide information on solution inner structure as well as implicit flow
characteristics and that they are independent of the target molecule concentration. In
the cosmetic, food and color industry rheological measurements are performed to analyze
the stability of dispersions and emulsions. Rheological standard analytics serve to assure
quality criteria with regard to homogeneity, sedimentation characteristics, sensation ex-
perience and material haptics [153, 192–194]. Routinely rheologically analyzed materials
are polymer solutions [195–198]. Polymers and proteins have some solution characteristics
in common: They are complex in structure, form macromolecular networks in crowded
solutions and show both viscoelastic behavior. That implies that the material exhibit
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both viscous and elastic characteristics when undergoing deformation. The characteris-
tics are represented by the measurable parameters G′ (storage modulus) and G′′ (loss
modulus). G′ describes the elastic component of the measured sample, G′′ the viscous
component of the probe.
In the biotechnological field the information density of rheological measured parameters
is comparatively unused. Since the turn of the century the need of an analyzing tool
intensified and as a consequence biotech research groups are taking a closer look on the
rheological characterization of protein solutions. Rheological measurements revealed a
correlation between the viscosity and therefor the injectability of a protein formulation
and the strength of protein-protein interactions [199]. With the help of ultrasonic rhe-
ological measurements the group around Kalonia could demonstrate that the solution
composition and model protein concentration do have a strong impact on the solution
rheology [136]. Furthermore, they could show that the rheological parameterG′, measured
by frequency sweep measurements, is sensitive to the type and strength of protein-protein
interaction [15, 20, 127]. Neergaard & Kalonia [159] could prove a linear correlation of
the storage modulus G′ with the strength of protein-protein interaction under tested
conditions. The knowledge of the protein flow characteristics paves the way for a bet-
ter understanding of the protein solution characteristics. So far, the missing link is the
correlation of the measurable rheological parameters with the most important solution
property namely - protein solubility. Such an undertaking is already seen at the polymer
industry where rheological parameters are already used to predict long-term storage sta-
bility of polymer solutions [131, 139].
To understand the correlation between the rheological characteristics and the aggrega-
tion tendency of a protein solution, the molecular flow properties of a liquid containing
proteins need to be analyzed. The viscosity of a sample is related to the way and the
strength molecules are interacting in the solution and is directly linked to its relaxation
time. The relaxation time of the sample is dependent on the temperature, the type of
molecule, the solute and solvent concentration. These parameters demonstrably influence
the phase behavior of a molecule in the respective solution. The measured relaxation time
(τ) is directly linked to observable parameters G′ and G′′ and the radial frequency (ω):
G′ ∝ ω
2τ2
1 + ω2τ2
(7.1)
G′′ ∝ ωτ
1 + ω2τ2
(7.2)
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The moduli shift to lower or higher values, depending on the sample inner structure and
specific to the currently set frequency values.
The overriding question to be answered is, whether the rheological data allows a direct
correlation to the phase behavior of proteins. To find an answer to this question, we
investigated if the above mentioned sensitivity of the moduli shift can be used to rhe-
ologically characterize the protein solution with regard to its aggregation tendency. To
do so, we first established phase diagrams of the protein lysozyme as a function of pro-
tein concentration, pH, salt type and salt concentration. The systems were scored after
40 days (t40) to mark a potential phase shift. Samples with identical conditions where
prepared and rheologically characterized at t0 to see if a correlation exists between the
inner structure of a solution and its long-term stability.
7.2 Materials and Methods
Materials
The model protein used in this study was lysozyme from chicken egg white (Hampton
Research, Aliso Viejo, CA, USA). It was supplied as a lyophilized powder. The protein
has a size of 14,3 kDa, a theoretical pI of 10.7 [200, 201] and an extinction coefficient
of 2.2 l/(mol ∗ cm). Acetic acid, sodium acetate, citric acid, trisodium citrate, sodium
monobasic phosphate, sodium dibasic phosphate, BisTris propane (1,3-bis(tris(hydroxy
methyl) methylamino) propane), MOPSO (β-Hydroxy-4-morpholine-propane-sulfonic acid),
ammonium sulfate, sodium chloride and sodium hydroxide for titration were purchased
from Merck KGaA (Darmstadt, Germany) and Sigma- Aldrich (St. Louis, MO, USA). Ul-
trapure water (ISO3696) was used to prepare all solutions. For verification measurements
viscosity standards (Olbrich, Hemer, Germany) produced in accordance to the premium
quality of BS EN ISO/IEC17025 were used. To reduce the residual salt content of the
lyophilized protein, the prepared protein solution was buffer exchanged with Sephadex
media from GE Healthcare (Buckinghamshire, Great Britain). The column was manually
packed with a diameter of 2,5 cm and a bed height of 23 cm. For the concentration of the
protein 20mL Vivaspin ultra filtration spin columns (Sartorius, Göttingen, Germany)
with a molecular weight cut off of 3000Da were used. 96 -well microbatch crystallization
plates from Greiner Bio-One (Frickenhausen, Germany) were used for the preparation of
protein phase diagrams.
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Methods
Sample preparation
Buffers used in this study all had an ionic strength of 100 mM. For the experiments
buffers with pH values of 3, consisting of citric acid and trisodium citrate, pH 5, consist-
ing of acetic acid and sodium acetate, pH 7, consisting of MOPSO and pH 9, consisting of
BisTris Propane were selected. Lysozyme from chicken egg white was dissolved in the re-
spective buffer with a starting concentration of 150 mg/ml. To get rid of residual salts an
SEC method followed. The buffer exchange was conducted at an ÄctaPrime plus system
from GE Healthcare. Here 5 mL of lysozyme solution with a concentration of 150 mg/ml
was purified with a Sephadex adsorber packed in a constant flow method. The protein
was fractionated in 10 mL Falcon tubes and the concentration measured with an extinc-
tion coefficient of 2.2 l/(mol ∗ cm). The concentration of this dilute protein solution to
250 mg/mL was performed with Vivaspins (Sigma- Aldrich), and a rotational speed of
8000 rad/sec. Subsequently, a protein dilution series with the corresponding buffer was
prepared, so that after the addition of the second component, either a high salt or low
salt buffer in a ratio of 1:5 (buffer:protein solution), the required final protein concentra-
tion could be achieved. The second component was added directly on the liquid handling
station or in the case of the rheological measurements manually, immediately before the
measurement.
Preparation of protein phase diagrams
The automated method for the preparation of protein phase diagrams was realized with
the help of a Tecan robotic platform (Maennedorf, Switzerland). Four different troughs
with buffers were assigned to the robotic platform. Two low salt and two high salt buffers.
These components were mixed automatically in a buffer plate to achieve six salt con-
centrations. These solutions and the manually prepared protein samples were mixed in
a ratio of 1:5 to achieve the desired 96 different conditions. One crystallization plate
consists of two different pH values, protein concentrations from 100-225 mg/mL and salt
concentrations from 0-175 mM. The crystallization plates were placed in the Rock Imager
from Formulatrix (Bedford, MA, USA), an automated high resolution imaging system
for protein crystallization. The plates were marked with a bar code and photographed in
specified time intervals. After 40 days every single well was scored as clear, crystallized
or precipitated. To verify that the crystals consisted out of protein and not crystallized
salt, photographs with ultraviolet light were taken.
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Squeeze Flow Rheometry measurements
The elastic portion of a protein solution - comparably low to other materials - requires
frequency values in the kilo Hertz region, to reach the interesting area of linear viscoelas-
ticity. Conventional mechanical Rheometers are limited to frequencies up to 100 Hz [202].
Not only a high frequency range is indispensable for a suitable measurement technique
but also a low sample volume, acceptable measurement times, low mechanical stress and
highly accuracy and reproducability of the measurement are required. An instrument
which fulfills all the requirements is the Piezo Axial Vibrator [138]. The measurement
accuracy of this tool is proven for various solutions, even for low viscous samples [139,
141, 202]. It has already been shown, that this tool is also well suited for protein solu-
tion measurements [203]. The measurement principle of the Piezo Axial Vibrator (PAV)
is based on axial oscillating piezo elements and operates at frequencies between 1 and
6000Hz. The lower part of the device is surrounded by a double walled cylinder and can
be easily tempered by a circulating fluid. A LockIn - amplifier is directly connected to the
measurement cell and controls the dynamic squeeze flow excited by four piezo elements.
It also processes the response signal four different piezo elements take up. A complete
scheme of the instrument is described in the doctoral thesis of L. [138].
All measurements were conducted at a temperature of 20◦C and a sample volume of
25 µL. The sample is directly pipetted on the measuring head and the measurement
chamber is hermetically closed with a thick stainless steel top plate leaving a circular
gap. The gap width d is chosen depending on the viscosity of the sample. In this work we
used a relatively narrow gap of 15 µL matching the relatively low viscosity of lysozyme
solutions. The principle of the measurement system is based on the measurement of the
electronic characteristics of the piezo electrodes without the sample and with the sample
in the measurement gap. With the difference in the electronic response of the measure-
ment voltage one can calculate the rheological properties of the sample. First the dynamic
displacement xˆ0 is measured. The measurement with exact the same frequency values is
conducted with the sample in the measurement chamber. With this measurement the
dynamic displacement xˆ is measured in accordance with the rheological characteristics
of the sample. By formulating the equation of motion and the ratio of
xˆ0
xˆ
the complex
compressive rigidity K* can be calculated:
K∗ =
3pi
2
·R
(
R
d
)3
· G
∗
1 + ϕω
2d2
10G∗
(7.3)
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R is the radius of the plate, d is the gap width, ρ is the density of the squeezed material
and ω the radial frequency. With K* one can calculate G* and η*. G* can be easily
divided in its imaginary and real part.
G* =
√
(G′)2 + (G′′)2 (7.4)
A detailed derivation of these parameters is described in the doctoral thesis of L. Kirschen-
mann [138]. For the rheological characterization of protein solutions the loss (G′′) and
storage moduli (G′) were calculated over a frequency range from 100-40000 rad/sec in 22
measurement points. Everey measurement was performed in duplicate.
Characterization of viscoelastic materials by means of rheological moduli
G′ and G′′ are measured over the radial frequency ω for the characterization of the given
protein solution. The parameters show a characteristic curve shape that is shifted along
the x-axes with changing molecular weight or the formation of intermolecular scaffolds
of the tested material. In Figure 7.1 such a characteristic curve shape is illustrated. The
graph can be divided in two main parts. The frequency value of the crossover point
(ωCO), where G′ ∼ G′′, marks the dividing line. The point is metrologically reached
when the vibration period τ is as long as the relaxation time λ of the sample. In the
frequency area before the intersection occurs the molecules move almost freely in the
solution without forming any ordered structure. At lower frequencies the structure of
the temporary entanglement network is relatively flexible. Due to the relative motion
between the macromolecules deformation energy is transformed into frictional heat and
gets lost. The viscous behavior dominates. At high frequencies the structures have less
flexibility and therefor a higher rigidity. Due to the limited relative motion the molecules
are able to store more deformation energy than gets lost. The elastic behavior dominates.
This can be done through a reticular structure the molecules form in the solution. In this
work G′ and G′′ are plotted as a function of the radial frequency in a range of 10 -
100000 rad/sec. The measurement points were fitted with a fourier fit of the second class
and the crossover point, here considered as a rheological key parameter, calculated with
equating the two Fourier fits and in the following abbreviated with ωCO.
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Figure 7.1: Characteristic curve shape of G′ and G′′ for a viscoelastic material. Subdivi-
sion of the graph in soluble, aggregating and scaffold forming protein solutions
depending on the applied frequency.
7.3 Results
In order to correlate protein phase behavior (determined after 40 days of incubation, t40)
under different fluid phase conditions to the rheological behavior, measured initially after
mixing (t0), a matrix of conditions for protein solutions at different protein concentration,
pH and salt content was analyzed.
7.3.1 Protein Phase Diagrams
Protein phase behavior under different fluid phase conditions was evaluated as described
above. The phase state of the protein at a pH range from 3 - 9, a protein concentration
of 100-225 mg/mL and a sodium chloride concentration of 0-175 mM is shown in Figure
7.2 a.
At pH5 and pH7 lysozyme is soluble up to a concentration of 225 mg/mL over the whole
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(a) (b)
Figure 7.2: Protein phase behavior of lysozyme. At pH values from 3-9, protein concen-
trations from 100-225 mg/mL and (a) sodium chloride concentrations from
0-175 mM and (b) ammonium sulfate concentrations from 0-175 mM.
tested sodium chloride concentration range. A large crystallization area can be detected
at pH3 starting at a salt concentrations of 100 mM and a protein concentrations of
100 mg/ml. Also at a pH of 9 crystals nucleate starting at a salt concentration of 100 mM
and a lysozyme concentration of 125 mg/mL. For pH9 the samples stayed stable without
the addition of sodium chloride.
In order to test if influences based on kosmotropic strength and nature of salt can be
seen by the proposed method the addition of ammonium sulfate was investigated. At
pH5 and pH7 samples remained homogeneous fluids throughout the experiment (Figure
7.2 b). At pH3 crystals nucleated starting at a lysozyme concentration of 200 mg/mL
without salt. Systems at pH3, a protein concentration of 200 and 225 mg/mL and an
ammonium sulfate concentration of 25 mM respectively 125 mM stayed stable over the
whole time span of 40 days. At pH9 crystals were formed at protein concentrations above
125 mg/ml starting at an ammonium sulfate concentration of 25 mM.
7.3.2 Rheological Behavior
To study the general influence of the sample conditions on the rheological parameters G′
and G′′ frequency sweep measurements were conducted for all systems described above.
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The standard deviation of the measurements with the Piezo Axial Vibrator never ex-
ceeded 1%. In the following the influence of the protein concentration, the pH value and
the type and concentration of salt on the rheological behavior of the protein is repre-
sented.
The majority of the measured samples behave linear viscoelastic in the chosen frequency
range. The viscous part (G′′) of the probe dominates the elastic part (G′) up to the first
crossover point which is marked as a circle in the shown Figures.
Influence of protein concentration
Protein aggregation is inherently dependent on protein concentration for given fluid con-
ditions. In Figure 7.3 samples of lysozyme with constant pH and sodium chloride concen-
tration of 175 mM with varying protein concentration are shown. With increasing protein
concentration the curves of G′ and G′′ shift closer to each other. That leads to a shift of
the crossover point to lower frequency values from ca. 34000 rad/sec to 8000 rad/sec for
increasing protein concentrations. The first crossover point of the Figure 7.3 c is phys-
ically incorrect and can be neglected. This physically incorrect calculation of G′ occurs
when the detection limit of the PAV is reached at very low frequency values and samples
with a low elastic response, like protein solutions. The incorrect record of the response
signal could also be noticed for lysozyme solution with a concentration of 200 mg/ml, at
pH9 and the addition of 175 mM ammonium sulfate.
Influence of pH
Protein-protein interactions and thus protein phase behavior exhibits a high level of
sensitivity towards changing pH. The latter is mainly due to a change in electrostatic re-
pulsion, due to varying charge on the protein surface. To evaluate if the resulting change
in interaction forces in a protein solution is also depicted by rheological measurements,
a range of pH values by otherwise constant conditions are compared. Figure 7.4 com-
pares samples at pH3, pH5, pH7 and pH9 and constant protein concentration without
additional salt. The Figures show clearly that the sample at pH 3 has the lowest ωCO at
11662 rad/sec. The ωCO for samples at pH 5 and pH7 are located at higher frequency
values. These samples have a very low elastic part and behave almost like water. The
ωCO for the sample at pH 9 is at 22250 rad/sec and thus the second lowest.
Influence of Salt
Generally different salt types may alter the structure of water and thus also the impact
of hydrophobic forces in the system. To evaluate this sodium chloride and ammonium
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(a) (b)
(c)
Figure 7.3: Influence of protein concentration on the curve shape of the loss and storage
modulus. Shown are the loss and storage modulus from lysozyme at protein
concentrations of 100 (a), 150 (b), and 200 mg/mL (c), at pH 3 and a sodium
chloride concentration of 175 mM. Recorded at 22 frequency points over a
frequency range from 100-40000 rad/sec.
sulfate were added to the system to reach final concentrations of 50 mM and 175 mM.
Figure 7.5 a-c and Figure 7.5 d-f show the respective course of G′ and G′′ under varying
salt concentrations. To avoid additional influence of changing protein concentration this
was kept constant. For both salts the general trend is comparable. For sodium chloride
the ωCO ranges from 11662 rad/sec to 8030 rad/sec for low to high salt, while for ammo-
nium sulfate we see a significant decrease of ωCO from 22250 rad/sec to 5422 rad/sec. A
clear exception was found for the system containing 50 mM sodium chloride. Over a wide
frequency range G′ is above G′′. The curve of G′ is parallel to the x-axes up to the second
crossover point. G′′ describes a shape with a pronounced minimum. With increasing salt
concentration this behavior gets lost. The elastic modulus is above the viscous modulus
and there is no plateau of G′. The crossover point is at a relatively low frequency value
of ωCO = 8030 rad/sec.
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(a) (b)
(c) (d)
Figure 7.4: Influence of pH on the curve shape of the loss and storage modulus. Shown are
the loss and storage modulus from lysozyme at a constant protein concentra-
tion of 200 mg/mL, at pH 3 (a), 5 (b), 7 (c) and 9 (d) without salt. Recorded
at 22 frequency points over a frequency range from 100-40000 rad/sec.
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(a) (d)
(b) (e)
(c) (f)
Figure 7.5: Influence of sodium chloride and ammonium sulfate on the curve shape of
the loss and storage modulus. Shown are the loss and storage modulus from
lysozyme at a constant protein concentration 200 mg/mL, at pH 3 and varying
salt concentrations of 0, 50 and 175 mM. Recorded at 22 frequency points over
a frequency range from 100-40000 rad/sec. (a) Lysozyme pH 3 200 mg/mL
0 mM NaCl; (b) Lysozyme pH 3 200 mg/mL 50 mM NaCl; (c) Lysozyme
pH 3 200 mg/mL 175 mM NaCl; (d) Lysozyme pH 9 200 mg/mL 0 mM AS;
(e) Lysozyme pH 9 200 mg/mL 50 mM AS; (f) Lysozyme pH 9 200 mg/mL
175 mM AS
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7.3.3 Correlation of ωCO and Protein Phase Behavior
Analyzing the obtained curve shape of G′ and G′′ for different fluid phase conditions, it
becomes apparent, that the measured rheological parameters react sensitive to varying
solution compositions. The parameter chosen for this study is the frequency value ωCO
for which G′ equals G′′. In the next section this parameter will be correlated with the
protein phase behavior of identical sample composition.
Figure 7.6: Correlation of ωCO and protein phase behavior for selected samples at pH 3
with 175 mM sodium chloride and without salt (dark red and red circles) and
varying protein concentrations; at pH 5 (orange triangle), pH 7 (green square)
and pH 9 (blue diamond) without salt and a constant protein concentration
of 200 mg/mL.
In Figure 7.6 the ωCO of samples at t0 are juxtaposed to a photograph showing one well
of a crystallization platecontaining exactly the same sample taken after 40 days of incu-
bation (t40). The ωCO is plotted as a function of the protein concentration. The Figure
shows samples with different protein concentrations and differing pH values. For sam-
ples at pH3 containing 175 mM sodium chloride the ωCO falls rapidly from values above
30000 rad/sec to values below 15000 rad/sec as a function of increasing protein concentra-
tion. The photographs show that the solubility limit for lysozyme is exceeded somewhere
in between 100 and 150 mg/mL at a pH value of 3 and a sodium chloride concentration of
175 mM. Samples at pH 3 without additional salt do have their ωCO at higher frequency
values. The solubility line shifts to values in between 150 and 200 mg/mL.
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For the comparison of the ωCO values determined for samples with and without salt,
∆ωCO has been calculated. ∆ωCO is the difference of ωCO values between samples to be
compared. In this context the ωCO values without salt minus the ωCO values with added
sodium chloride (∆ωCO=ωCO,1-ωCO,2) at different protein concentrations. The influence
of added salt seems to be a function of protein concentration. The ωCO values for samples
with a lysozyme concentration of 100 mg/mL without salt and a salt concentration of
175 mM are almost similar (∆ωCO=616 rad/sec). Both systems are stable at t40. At a
protein concentration of 150 mg/mL the ∆ωCO increases to a value of 14480 rad/sec
(sample without salt is stable, sample containing 175 mM sodium chloride is unstable
at t40 ) while the values close up to ∆ωCO of only 3632 rad/sec at 200 mg/mL (both
systems are unstable at t40).
A change of the systems to other pH values with constant protein concentration and
ionic strength consequently leads to a change of lysozyme solubility. Lysozyme crystal-
lizes at pH3 and a concentration of 200 mg/mL without any salt. Here the ωCO are
situated below 15000 rad/sec. At pH9 close to the pI, lysozyme is soluble at identical
conditions and the ωCO is situated above 20000 rad/sec. At pH5 and pH7 the studied
model protein is soluble over the whole screened area and the ωCO are situated at very
high frequency values. Therefore, at conditions with increasing agglomeration tendency
the ωCO is situated at a lower frequency area while the more stable conditions express
higher values. Figure 7.7 compares all measured ωCO values of the rheological screening
at t0 with the obtained scoring of the crystallization plates at t40. It becomes apparent
that a distinct limit frequency value (ωlimit) develops. All examined samples, whose ωCO
is situated above ωlimit are soluble and exhibit a high long-term stability. Samples where
the ωCO is situated below ωlimit do agglomerate in form of crystal formation under tested
conditions.
The solubility limit of lysozyme is found to be ωlimit = 20000 rad/sec under tested con-
ditions.
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Figure 7.7: ωCO of every measured sample plotted against the protein concentration. The
blue circles represent measurement points of soluble samples. The orange
diamonds represent measurement points of samples scored as crystallized.
The red line symbolizes ωlimit for lysozyme under tested conditions.
7.4 Discussion
This work deals with the rheological characterization of protein solutions containing
lysozyme from chicken egg white. The primary objective is to find a correlation of the de-
termined rheological parameters and the protein phase behavior. The study of the phase
behavior showed that lysozyme is stable over a wide pH and salt range, even in high
concentrated solutions. Under the given conditions, only the metastable region where
lysozyme crystallizes could be reached. The unstable region were precipitation occurs
could not be reached. From a biochemical point of view, the observed behavior of protein
solutions and phase transitions as a function of protein concentration, pH and salt type
and concentration followed established knowledge.
The rheological data obtained, responded sensitive to the solution parameters pH, pro-
tein concentration, salt type and salt concentration. The rheological results demonstrate,
that the crossover point is shifted to lower frequency values with an increase of observed
agglomeration tendency. Studies with polymer solutions have shown that strongly in-
teracting systems tend to behave more non-Newtonian. They do have a smaller linear
viscoelastic region and the crossover point at comparably low frequency values [135,
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204]. Dilute and non interacting systems tend to behave more as Newtonian solutions.
In this context, it was shown that samples with a smaller region were G′′ dominates
G′, compared to other samples, do have longer polymer chains and stronger cross-linked
structures [204–206]. These molecules can move against each other at lower frequencies,
while with increasing frequency, the molecules start to block each other. Therefor, a shift
of the cross over point to lower frequency values implies, that the molecules are less flex-
ible and mobile. Extrapolated to protein solutions this means stronger protein-protein
interaction and the formation of more or less ordered structures, which leads to aggre-
gation of the protein. For all frequency values equal or higher than defined by ωCO the
molecules can not follow the imposed movement. As seen throughout the study, ωCO is
specific for every tested system.
Influence of Protein Concentration
The explanation why the ωCO is decreasing with increasing protein concentration seems to
be straight forward. If the molecular percentage in solution is relatively low molecules can
move freely in solution without significant attractive interaction. The positively charged
protein does have a repulsive effect on molecules of the same kind and the proteins present
do not form any kind of network structure. Applied energy is only stored to a very small
portion and dissipates to a large fraction (see Figure 7.3a). The values of G′′ are higher
than the values of G′ over a wide frequency range. If the protein concentration increases,
at constant solution properties, the molecule density in solution is high enough, that
the molecules interact due to short-range interactions. Protein samples with higher pro-
tein concentrations are able to store more of the energy applied. Only at pH3 a phase
transition occurred due to an increase of the protein concentration up to 200 mg/mL
without the addition of salt. This behavior leads to the assumption that the protein is
partially unfolded at pH3. This partial unfolding of lysozyme from chicken egg white at
low pH values is also discussed by Haezebrouck et al. [207] and Venkataramani, Truntzer
& Coleman [208]. The surface of the protein is enlarged due to the partially unfolding.
The enlargement of the protein but even more a significant increase of the proteins hy-
drophobicity induce a limitation of protein movement in the solution and thus a shift of
ωCO to lower frequency values, compared to samples at other pH values. The constrained
movement could lead to the agglomeration of the proteins as shown in Figure 7.2. Another
explanatory approach would be the formation of lattices at pH 3. The lattice formation
becomes possible when the meta-stable region (crystallization area) of proteins is reached
[209]. The assumed lattice formation increases the ability of the protein solution to store
a greater portion of fed energy. So that the determined G′ values exceed the G′′ values
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at lower frequency values and thus the ωCO value decreases. The assumption is backed
up by the fact that lysozyme crystallizes and does not precipitate at these conditions.
Influence of pH
With changing pH a decrease of the region where G′′ dominates G′ for samples at pH9
and pH3 compared to samples at pH5 and pH7 is obtained (see Figure 7.4). Proteins are
polyelectrolytes. The density of their charge, relative to the pKa values of the charged
groups on the protein surface, is strongly dependent on the pH and the ionic strength of
the solution. Building on thermodynamic theories of polyelectrolites, three main parame-
ters influencing rheological properties were determined: shape, hydration and electrostatic
charge [210]. The primary effect is induced by the resistance of a diffuse electrostatic dou-
ble layer surrounding the protein. The repulsion of the double layers between different
protein molecules is called the secondary effect. The tertiary effect takes the size of the
protein into account. The primary effect does not seem to correlate to the findings of
this study. Lysozyme does have a pI of 10.7. Samples measured at pH9 are closest to
the point of zero charge. The mentioned primary effect induces a light increase of the
hydrodynamic radius of the molecule and a related increase of the flow resistance. How-
ever, a protein close to the pI (at pH9) is in the most compact form and should have the
lowest flow resistance and a ωCO at high frequency values. In our studies samples at pH9
do have a smaller region where G′′ is above G′ compared to samples at pH5 and pH7.
Yadav et al. [158] could assess the same phenomena with the protein bovine serum albu-
min (BSA). At a protein concentration of 250 mg/mL measured viscosities of the protein
gained, against the electroviscous theory, the highest viscosity values at pH values close
to the pI. At equal measurements with ideal diluted protein solution the phenomena was
reversed. The measured intrinsic viscosity of the protein was minimal close to the pI and
increased on both sides with increasing distance form the pI. It can be concluded from
these findings that the rheological behavior of a protein solution at high concentrations
is not only influenced by the first and second electroviscous effect but also by short-range
interactions. Dynamic light scattering measurements of lysozyme solutions at varying pH
values and protein concentrations substantiate the study of S. Yadav (Data not shown).
According to these findings the short-range interactions at pH9 are relatively high. The
correlation with the protein phase behavior of lysozyme at pH9 shows that an addition
of a small quantity of salt induces a phase transition. We presume that the salt covers
the charged groups of the protein so that short-range interactions induce the decrease
of ωCO and due to hydrophobic interactions the agglomeration of the molecule. At pH5
and pH7 the positively charged groups of the protein surface induce a repulsive force.
86
7.4 Discussion
This repulsion is so strong that the protein molecules are not able to interact. They can
move against each other up to high frequency values without forming aggregates or net-
works of higher order. In comparison to pH5 and pH7 the region where G′′ dominates
G′ decreases for samples at pH3 (7.3.2). The ωCO values are situated in a low frequency
region. In this case the electroviscous theory holds true. The protein molecule tend to
expand as pH moves away from the pI. This increase of the electrostatic double layer
leads to a limited flexibility of the protein and an increased agglomeration tendency. One
should also take into account the potential lattice formation and a partially unfolding
of the protein at pH3, mentioned already in the previous section. The unfolding posses
an increased protein surface and thus an increase of the electroviscous effect, as seen for
protein gels and solutions at high protein concentrations [167].
Influence of Salt
Sodium chloride seems to have a strong influence on lysozyme solution even at lower con-
centrations. Without salt the sample exhibits a long linear elastic region. The molecules
can follow the applied motion up to high frequency values. The elastic part of the probe is
almost negligible. An amount of 50 mM of sodium chloride seems to change the rheologi-
cal behavior completely. The region where G′′ dominates G′ disappears. The elastic part
of the probe is larger than the viscous part. It can thus be concluded that the sample may
show a nonlinear viscoelastic behavior at the measured frequency range. At the observed
region G′ is at a constant value over a wide frequency range. Studies on systems contain-
ing polymers have shown, that solutions with constant or slowly shifting G′ values have
a more or less perfectly elastic behavior and comparatively less energy dissipates during
applied stress. This effect can be observed with polymers in solution, which are glass
like or crystalline but also with polymers which exhibit effects of structured entangle-
ment coupling [135]. The potentially nonlinear viscoelastic behavior of this sample could
also be found in biomaterials like blood vessels [211] or cornea [212] which are made of
complex protein scaffolds. To reach this rheological region, the protein molecules have to
form a structured, cross-linked network. To obtain such a network a unique interplay of
charged groups at the protein surface, protein concentration and salt present in solution
needs to be met. For the discussed sample this implies a unique interplay of the lysozyme
and sodium chloride molecules, which leads to a predominant elastic rheological behavior
This approach is supported by the studied phase behavior and especially the kinetic of the
crystallization process (data not shown). The homogeneous nucleation took place after
ten days. Compared to samples with the same pH and protein concentration, relatively
late. The detected crystals are big and do have an ordered 3d structure. The addition
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of 175 mM sodium chloride induces an almost direct agglomeration of the protein. Just
after two hours, crystals could be detected optically. The crystals were comparatively
small and had a 2d structure. Matching, also the rheological characteristic of the sample
changed. A crossover point at comparably low frequency values is a strong argument for
protein-protein interaction. The ordered network formation, hence a constant G′ value
over a certain frequency area, as described above, could not be observed. Based on the
theoretical considerations from above the amount of salt ions in the solution is so high,
that more charged surface groups are shielded, what enables multiple protein-protein
interactions. The proteins interact over several surface groups what facilitates a fast
crystallization process.
Ammonium sulfate also shows considerable influence, both on protein phase behavior as
well as on the rheological behavior of the protein solution. At pH9 the ωCO is shifted
to lower frequency values with increasing ammonium sulfate concentration (see Figure
7.5). The curves of G′ and G′′ are very close to each other at the highest measured salt
concentration, what implies, adapting the theory from studies with polymers, a strong in-
teraction of the molecules in solution. The mobility of the protein molecules is restricted
by the salt ions due to the well known salting-out effect, so that an agglomeration in
form of crystallization takes place (see Figure 7.2). Interestingly this phenomenon does
not occur at pH3. Here the salt seems to stabilize the protein. The repulsion between the
protein molecules is stronger in ammonium sulfate solutions at low pH than at high pH
[213]. This might be explained with the sulfate binding to the positively charged residues
of lysozyme at pH3. This binding causes a decrease of the free surface energy of lysozyme
compared to the uncomplexed protein. Curtis et al. [214] could already show that ion
binding alters the surface chemistry of the protein and reverses the lyotropic series in
terms of the salting out effect. That implies that the interactions between kosmotropic
ion-protein complexes are more repulsive than those of the uncomplexed proteins. The
different influence of ammonium sulfate on the aggregation tendency of lysozyme was
also detected with the rheological measurements. At pH9, where the aggregation ten-
dency of lysozyme is increased with increasing ammonium sulfate concentration, the
ωCO is shifted to lower frequency values. Samples which aggregate do have ωCO values
below 20000 rad/sec. At pH3 the ωCO values are shifted to higher frequency regions
with increasing ammonium sulfate concentration. The shift of the ωCO strictly follows
the aggregation tendency of the protein, whether it is influenced by chaotropic effects or
ion binding on the surface of the protein.
As mentioned above the ωCO values of the analyzed systems are very sensitive towards
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the aggregation tendency of the protein. This sensitivity is not influenced by the type of
interaction that causes the network formation and aggregation of the protein in solution.
It is for this reason, that this parameter might be used as an assessment if the protein
is stable or not over a wide protein concentration range, pH range and also for different
additives and additive concentrations. For the tested conditions it was possible to de-
limit a crystallization area with measured ωCO values. Samples with ωCO values below
20000 rad/sec did crystallize. Samples with ωCO values above 20000 rad/sec were stable
over the tested time period of 40 days.
7.5 Conclusions
The present work shows that a correlation of the protein phase behavior of lysozyme and
measurable rheological parameters is possible for the studied system. With the definition
of the rheological key parameter ωCO one can make specific statements about the agglom-
eration tendency of the protein with one single measurement, immediately after sample
preparation. Due to the low sample volume needed, analytical measurements are possible
even if only very few sample volume is available or if the material costs are very high.
That makes the measurement method interesting for early and late stage development. A
very important finding is, that rheological measurements can model both electroviscous
and short-range effects. That implies that the measurement method is valid for high and
low concentrated protein solutions in comparison to the B22 value, which is only valid
for ideal dilute solutions. Furthermore, it became possible to determine correlations be-
tween crystallization kinetics, crystal morphology and the curve shapes of G′ and G′′ by
the characterization of the molecular network structure of the protein in solution. These
findings are important for the understanding of the crystallization characteristics of a
protein and thus a step further towards targeted phase transition, which can be used as
a purification step or a stable storage form of the drug substance.
The prediction of the protein phase behavior is not only interesting for the storage of the
protein but also the whole lifespan of the drug substance and drug product, including
the development of the Upstream and Downstream process as well as the selection of the
right formulation buffer. For this purpose it is important, that the analytical method is
applicable at different protein concentrations and buffer conditions. Squeeze Flow rheo-
logical measurements and the determination of the ωCO fulfill these requirements. The
analytic tool has the potential to reduce biopharmaceutical development time and costs
many times over.
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Abstract
Solution stability attributes are one of the key parameters within the production and
launching phase of new biopharmaceuticals. Instabilities of active biological compounds
can drastically reduce the yield of biopharmaceutical productions, and may induce unde-
sired reactions in patients, such as immunogenic rejections. Protein solution stability thus
needs to be engineered and monitored throughout production and storage. In contrast to
the gold standard of long-term storage experiments applied in industry, novel experimen-
tal and in silico molecular dynamics tools for predicting protein solution stability can
be applied within several minutes or hours. Here, a rheological approach in combination
with molecular dynamics simulations are presented, for determining and predicting long-
term phase behavior of highly concentrated protein solutions. A diversity of liquid phase
conditions, including salt type, ionic strength, pH and protein concentration are tested in
a Glutathione-S-Transferase (GST) case study, in combination with the enzyme with and
without solubility-enhancing Cherry-Tag™. The rheological characterization of GST and
Cherry-GST solutions enabled a fast and efficient prediction of protein instabilities with-
out the need of long-term protein phase diagrams. Finally, the strong solubility enhancing
properties of the Cherry-Tag™ were revealed by investigating protein surface properties
in MD simulations. The tag highly altered the overall surface charge and hydrophobicity
of GST, making it less accessible to alteration by the chemical surrounding.
Keywords: Protein Phase Behavior; Solution Stability; Rheology; Viscoelasticity; Highly
Concentrated Protein Solutions; Cherry-Tag™
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Nowadays, proteins are indispensable as active components of key pharmaceuticals, due
to their specificity and potency for the treatment of diverse diseases. Such molecules
vary strongly in their size, shape, hydrophobic character and surface charge. Due to the
individuality of the biomolecules, their stability and activity in aqueous solution depends
on numerous parameters, including pH, ionic strength or protein concentration. The in-
teraction of the different influencing parameters and their effect on the protein phase
behavior is highly complex and not totally understood, though the solution stability of
proteins is of primary concern during processing, formulation, and storage. As a conse-
quence, the stability of a protein solution has to be proven for the release of the medical
product by the regulatory bodies. Therefore, the long-term stability of the protein so-
lutions needs to be tested under selected buffer conditions. Besides long-term stability
tests, approaches for the fast prediction of protein phase behavior were developed in the
last decades [188, 215]. Such methods include static light scattering for the determination
of B22 values (protein self-interaction coefficient) or molecular modeling approaches to
characterize protein-protein interactions in silico [188, 216, 217]. These approaches are
able to display solute-solute and solute-solvent interactions. The results obtained with
these methods were correlated successfully with protein phase behavior, but for ideally
diluted protein solutions only [105, 120]. Short-range interactions or cluster formation,
which occur at higher protein concentrations could neither be correctly predicted with
B22 values [15] nor be included in the in silico model.
Whereas low or moderate protein concentrations are process-relevant for many biophar-
maceutical unit operations, especially during late stage formulation studies, the focus
is shifted to highly concentrated protein solutions. Product concentrations of antibody
solutions for clinical applications can be easily above 100 mg/mL [22, 184]. In the last
years the toolbox for the determination of protein phase behavior was thus extended to
methods for highly concentrated protein solutions, including the traditional approaches
of long-term protein phase diagrams [190], as well as less time consuming alternatives
such as dynamic light scattering or rheological measurements [22, 127, 208, 218]. The rhe-
ological method to characterize protein solution viscoelasticity, as introduced by Saluja
et al. [127] and extended by our group in 2016 [218] has the advantage of detecting the
entire bulk properties of the sample. The sensitivity of the complex rheological analysis
allows the identification of short and long-range interactions as well as the study of pro-
tein network formation [20].
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With the ability to predict protein stability in ideally diluted and highly concentrated
regime, the next logical step in the biopharmaceutical work flow is to manipulate protein
phase behavior, and characterize such processes with the new tools developed.
Besides choosing stabilizing excipients and buffer conditions [161, 219, 220] also chemical
modifications of proteins can be highly beneficial in terms of protein solution stability.
Such modifications include glycosylation and PEGylation strategies [221]. Such effects on
PEGylated proteins were reported for recombinant human endostatin when conjugated
with a 5 kDa PEG chain [222], and human interferon-beta when modified with a 40 kDa
PEG chain [223].
Another approach for engineering protein phase behavior and enhancing solubility is
fusing an additional protein or peptide tag to the protein of interest. Some of these pro-
tein fusions are also commonly used as affinity tags, such as the maltose-binding protein
(MBP) [224]. Further examples of solubility enhancing fusion proteins were reviewed,
including Thioredoxin (Trx), the phage T7 protein kinase (T7PK), synthetic solubility-
enhancing tags (SETs) [225, 226] and many more. In this study the newly developed
Cherry-Tag™ by Delphi Genetics (Belgium) is used as a potential protein stabilizer. The
tag was originally developed for an easy traceability of proteins as it resembles cytochrome
c, and can thus be determined in the VIS region. As soon as the fused protein becomes
unstable the chromophore function of the protein is lost, enabling a destinction between
native and non-native protein species [227]. The thermostability and solubility enhancing
properties of the Cherry-Tag™ technology was shown in studies involving enterokinase,
staphylokinase, and G-CSF [228, 229]. In order to establish the targeted use of the tag
in the biopharmaceutical industry, it is necessary to systematically study the stabilizing
effect, also under highly concentrated conditions, and over time. To be able to transfer
the gained knowledge to other molecule classes it is also indispensable to uncover the
basic chemical-physical principles on which the stabilization is based.
To investigate the stability enhancing effect of the Cherry-Tag™ a straightforward strat-
egy is presented for predicting the long-term stability of highly concentrated GST and
Cherry-GST solutions, with different straight to determine parameters from experimental
(rheological) and in silico molecular dynamics investigations. The validity of the proposed
measurement toolbox is proven by protein phase behavior studies performed in 96-well
format in the Rock Imager (Formulatrix, USA) as was proposed by Rakel et al. and
Baumgartner et al. [88, 162].
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8.2.1 Chemicals & Buffers
The proteins used in this study were Glutathion-S-Transferase (GST - 26 kDa) and GST
fused with the Cherry-Tag™ (Cherry-GST - 39 kDa). GST has a theoretical pI of 5.2. The
pI of GST was calculated based on the amino acid sequence obtained from the UniProt
database [230] with the ExPASy ProtParam tool from the Swiss Institute of Bioinfor-
matics [231]. The Cherry-Tag™ being a polypeptide with a size of 11 kDa was developed
by Delphi Genetics (Belgium). It is expressed in Escherichia coli SE1. The nucleic acid
sequence of GST was inserted into the StabyExpress T7 kit for the protein of interest
alone and into the Cherry Express T7 protein expression kit for the solubility enhanced
fusion protein (Delphi Genetics, Belgium). All proteins were produced and purified as
described in Baumann et al. [232].
1,3-Bis[tris(hydroxymethyl)methylamino]propane (BisTris propane) was purchased from
Molekula (United Kingdom). β-Hydroxy-4-morpholinepropanesulfonic acid (MOPSO)
was purchased from AppliChem (Germany). Acetic acid, citric acid, sodium chloride
(NaCL) and ammonium sulfate ((NH4)2SO4) were obtained from Merck KGaA (Ger-
many). Trisodium citrate, sodium acetate, sodium monobasic phosphate and sodium
dibasic phosphate were purchased from Sigma-Aldrich (USA). Ultrapure water (ISO3696)
was used to prepare all solutions. For verification measurements viscosity standards (Ol-
brich, Germany) produced in accordance to the premium quality of BS EN ISO/IEC17025
were used.
8.2.2 Disposables & Reaction Vessels
For buffer exchange and ultra-filtration 20 mL Vivaspin ultra filtration spin columns
(Sartorius, Germany) with a molecular weight cut off of 10000 Da were employed. The
preparation of protein phase diagrams were carried out in 96-well microbatch crystalliza-
tion plates from Greiner Bio-One (Germany).
8.2.3 Complex Rheology
Protein solutions behave viscoelastic. That implies that the protein solutions exhibit both
viscous and elastic characteristics when undergoing deformation [204]. The characteris-
99
Chapter 8 Studies on the Stability Enhancing Effect of the Cherry-Tag™
tic viscoelastic response of the samples gives insides of the strength of protein-protein
interaction and the development of protein networks. The viscoelastic characteristics of
protein solutions can be studied by frequency sweep measurements, where the rheolog-
ical parameters G′ (storage modulus - elastic portion) and G′′ (loss modulus - viscous
portion) can be calculated over a defined frequency range.
The rheological measurements were performed with the Piezo Axial Vibrator (PAV) Pech-
hold, Kirschenmann & Groß [233]. The measurement principle of the PAV is based on
axial oscillating piezo elements, and operates at frequencies between 1 and 7000 Hz. In
this work frequency sweep measurements were conducted over a frequency range of 100
- 5000 Hz in 22 frequency steps. For the rheological characterization of protein solutions
the loss (G′′) and storage modulus (G′) were calculated over the dynamic displacement
xˆ, the complex compressive rigidity K* and the equation of motion:
K* =
3Π
2
R
(
R
d
)3
G*
1 +
ρω2d2
10G*
+ ...
(8.1)
R is the radius of the plate, d is the gap width, ρ is the density of the squeezed material,
and ω the radial frequency. With K* one can calculate the complex modulus G*. G* can
be easily divided in its imaginary and real part:
G* =
√
(G′)2 + (G′′)2 (8.2)
A detailed derivation of these parameters is described in the doctoral thesis of Kirschen-
mann Kirschenmann [138]. The crossover point frequency of G′ and G′′, ωCO was used
in this study to predict the long-term phase behavior of protein solutions. All measure-
ments were conducted at a temperature of 20◦C and a sample volume of 30µl. Every
measurement was performed in duplicate. The standard deviation of the measurements
conducted with the PAV were below 1.5 %.
8.2.4 Preparation of Protein Phase Diagrams
The automated method for the preparation of protein phase diagrams was realized on a
robotic work station (Tecan GmbH, Germany). Four different troughs with buffers were
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assigned to the robotic platform, including two low salt (without additional salt) and
two high salt buffers (2 M salt added). These components were mixed automatically in a
buffer plate to achieve six salt concentrations in range of 0 to 2 M salt. These solutions and
the manually prepared protein samples (0 to 150 mg/mL) were mixed in a ratio of 1:5 to
achieve the desired 96 different conditions. One crystallization plate consisted of two dif-
ferent pH values, protein concentrations from 5-120 mg/mL and salt concentrations from
0−400mM . The crystallization plates were placed in the Rock Imager from Formulatrix
(USA), an automated high resolution imaging system for protein crystallization. The
plates were marked with a bar code and photographed in specified time intervals. After
40 days every single well was scored as clear, crystallized or precipitated based on the
taken pictures.
8.2.5 Molecular Dynamics (MD) Simulations and Molecular Descriptors
For the investigation of 3D structure surface properties of GST and Cherry-GST MD
models were generated and characterized. These models served for explaining the solu-
bility enhancing properties of the attached Cherry-Tag™. The amino acid sequence of
GST was derived from the RCSB Protein Data Bank [234] using the primary protein
structure of the class-mu 26 kDa isozyme from Schistosoma japonicum (PDB ID 1DUG).
The Cherry-Tag™ being resemblant to Cytochrome B5 was modeled using PDB ID 1I8C.
For manipulation, visualization, modeling of molecules, and molecular dynamics simu-
lations under defined conditions the Yasara software was used [235]. Seven amino acids
were added manually to GST (PDB ID 1DUG) being the linker molecules (Asp-Asp-Asp-
Asp-Lys-His-Asn). For the Cherry-Tag™, per contrast, the Cytochrome B5 sequence was
applied in its original form. Finally, both structures were linked by peptide bonding be-
tween Asn225 of the linker sequence attached to GST and the Ala226 of the Cherry-Tag™
structure. Two of the Cherry-GST monomers were assembled to one dimer. For GST
without the additional Cherry-Tag™ the same procedure was performed except for at-
tachment of the linker and the Cytochrome B5 sequence.
For generating the 3D equilibrium structure the dimers were simulated for 50 ns in
Yasara. The energy minimization was carried out using the Amber03 force field [236].
This step serves for folding the newly added amino acids and for modeling interactions of
the assembled sub-structures of the protein. As soon as the root mean square deviation
(RMSD) of the simulation was constant within 1 A˚ the simulation was stopped.
In the next step the equilibrium structure of the dimer was prepared for the MD sim-
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ulation in varying chemical environment. In a first step the degree of protonation was
adjusted structure-based in H++ [237] according to pH and salt concentration and re-
spective pKa values of the amino acids. Following, a simulation cell was formed around
the protein-dimer in Yasara guaranteeing 10 A˚ of distance of all atoms to the periodic
simulation box boundaries. The simulation box was filled with water molecules and re-
spective ions depending on salt strength simulated. An energy minimization step followed
to result in the final conditions for the MD simulation. The simulation was performed
for 10 ps at 298 K, collecting a snapshot of the modeled structure every ps. In the MD
analysis the mean structure of 10 frames of the MD simulation were presented as the
protein structure.
In a final step the molecular descriptors of the 3D models under different conditions
were determined using mantoQSAR, being an in-house developed tool for describing
protein properties. These molecular descriptors can be calculated for the entire molecule,
patches or plane projections and include information about size, shape, electrostatics and
hydrophobicity of the respective molecule under pre-defined conditions (267 descriptors
in total). Here, only the total electrostatic potential on the protein surface (sumMap-
SurfESP), the total hydrophobicity (Kyte and Doolittle hydropathy scores [61]) on the
protein surface (sumMapSurfHyd) and a molecule geometry factor (shapeMaxGeo) were
used for identifying the influence of the Cherry-Tag™ on protein solubility. The descrip-
tor sumMapSurfESP describes the total charge of a protein with negative algebraic signs
representing molecules of anionic and positive algebraic signs proteins of cationic surface
characteristics, respectively. The descriptor of protein surface hydrophobicity (sumMap-
SurfHyd) is based on the hydrophathy scores of all surface amino acids of respective
proteins. A negative algebraic sign represents hydrophilic behavior and a positive alge-
braic sign hydrophobic behavior, respectively. The molecular descriptor shapeMaxGeo
is calculated in terms of geometric properties of the protein. Distances are determined
between the center of gravity of each molecule to the protein surface at all possible an-
gles in three dimensions. Finally, the maximal measured distance is divided by the mean
distance of all angles resulting in values close to 1 for perfectly spherical proteins and
values above 1 for proteins of other shapes.
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8.3.1 Rheological Characterization of Cherry-GST and GST solutions
The rheological method proposed by Schermeyer at al. 2016 [218] was used to predict the
time dependent stability of GST and Cherry-GST solutions. According to this theory,
the shift of the crossover point of G′ and G′′ along the radial frequency, ω [rad/sec] -
ωCO - obtained by frequency sweep measurements, correlates with the phase behavior
of the studied protein in aqueous solution. It was observed that the the lower the ωCO
values, the stronger the protein-protein interactions are in solution. The protein-protein
interactions correlate in turn with the agglomeration tendency and hence the colloidal
long-term stability of the sample.
In this work GST and Cherry-GST solutions were investigated rheologically under vary-
ing buffer conditions and protein concentrations. The ωCO values of all samples were
compared to make predictions about the strength of protein-protein interaction, and
thereby the stability of the molecules in solution.
In Fig. 8.1 the determined G′ and G′′ values of four typical samples are plotted against
the radial frequency. For CherryGST and GST solutions the G′′ values dominate the G′
values over a wide frequency range, what implies a weak elasticity for all screened condi-
tions. The curve shape of the studied samples were comparable, with a related difference
of the relative position of the ωCO value, which is the crucial parameter for the prediction
of protein solution stability in this study.
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Figure 8.1: Exemplary curve shape of G′′ and G′ of Cherry-GST and GST under vary-
ing solution conditions. Shown is the rheological response of Cherry-GST
(a) respectively GST (b) with a concentration of 100 mg/ml, at pH 6 with-
out additives and Cherry-GST (c) respectively GST (d) with a concentra-
tion of 80 mg/mL at pH 8 and 400 mM (NH4)2SO4. The rheological pa-
rameters were recorded at 22 frequency points over a frequency range from
100-40000 rad/sec.
Fig. 8.2 illustrates the influence of the protein concentration, the pH value, as well as the
type and concentration of salt on the ωCO values of GST and Cherry-GST samples. The
ωCO values are plotted as a colored scale from dark red (high ωCO values) to dark blue
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(low ωCO values).
(a) (b)
(c) (d)
(e) (f)
Figure 8.2: Surface plot of ωCO values of Cherry-GST (left hand side) and GST (right
hand side) samples in a pH range from 6-10, respectively pH 7-9 and a protein
concentration range from 60-100 mg/mL. (a) and (b) without salt, (c) and (d)
with (NH4)2SO4 and (e) and (f) with NaCl. The ωCO values are depicted
as a colorbar ranging from 6000 rad/sec (dark blue) to 20000 rad/sec (dark
red).
In Fig. 8.2 (a) and (b) the ωCO values of Cherry-GST and GST samples without salt in
solution are plotted. From pH 6 to pH 9 the ωCO values of Cherry-GST solutions are
comparatively high, and show only a negligible small dependency on the protein concen-
tration (Fig. 8.2 (a)), which indicates that the molecules are flexible and can move freely
in solution. It can therefore be concluded that protein-protein interactions of Cherry-GST
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without salt in solution are weak, and do not change in the range from pH 6-9 and protein
concentrations from 60-100 mg/mL. Using ωCO as a predicting parameter, Cherry-GST
at pH 6-9 would be classified as comparatively stable up to a concentration of 100 mg/mL.
The stability of Cherry-GST in solution can be explained by repulsive electrostatic in-
teractions of the protein, as the pI of this molecule lies below the tested pH values (pI
≤ 5.2). Additionally, the amino acid structure of the attached Cherry-Tag™ is in resem-
blance with the structure of Cytochrome B5. This molecule does have a theoretical pI
of 4.3 [238, 239], and thus a negative net charge at tested pH values. Additionally, the
linker structure, which covalently binds the Cherry-Tag™ to the GST molecule mainly
consists of aspartic acid with a theoretical pI of 2.98 [240]. The combination of both
structures result in a negative surface charge of the Cherry-Tag™ at tested pH values.
It is assumed that either the negatively charged Cherry-Tag™ shields positively charged
or neutral patches on the protein surface or does have a direct impact on the protona-
tion of neighboring groups on the GST surface, what may cause a stronger negative net
charge of the whole molecule. At pH 10 the ωCO values of Cherry-GST samples dropped
below 10000 rad/sec independent on the protein content in solution. This indicates a
limitation of the protein movement and therefore a stronger interacting behavior of the
molecules. Similar to samples at pH 6-9 the net charge of the protein surface is negative
at pH 10, and should induce repulsive interactions. Thus, the shift of ωCO values to lower
frequencies cannot be explained by electrostatic surface interactions alone. The increased
viscoelasticity of Cherry-GST at pH 10 may originate from a partly unfolding due to the
strong electrostatic repulsion within the molecule. The partly unfolding would lead to an
exposition of hydrophobic core groups. It is energetically more favorable to minimize the
hydrophobic area in an aqueous solution what would lead to increased protein-protein
short-range interactions and thereby to a protein mobility reduction.
The ωCO values of GST samples are dependent on the pH and protein concentration.
The ωCO values increased with increasing pH and decreased with increasing protein con-
centration. At pH 6 and a GST concentration of 100 mg/mL the lowest ωCO value with
6856 rad/sec was calculated. At pH 10 and a GST concentration of 60 mg/mL the high-
est ωCO value of 18065 rad/sec was determined for this data set. The mobility of GST
in solution is less pronounced as the mobility of the Cherry-fusion protein especially at
higher protein concentrations. This is bound up with an increase of the deviation from the
ideal viscous behavior of GST solutions, and hence an increased propensity of protein
network formation. That implies an increase in attractive protein-protein interactions
due to forces, which are dependent on the protein concentration, such as short-range
interactions [21]. Additionally, GST solutions do have higher ωCO values with increas-
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ing distance to the pI, indicating an increased repulsion of the molecules. This repulsive
effect was explained earlier by an increasing protein net charge of GST with increasing
pH. In contrast to ωCO values of Cherry-GST samples the ωCO values did not decrease
abruptly at pH 10, but further increased. That indicates a dominant role of intermolec-
ular repulsive electrostatic forces for GST at pH 10. The fact that solely ωCO values of
Cherry-GST drop at pH 10 lead to the conclusion, that the Cherry-Tag™ provokes the
partly unfolding of the protein due to structural changes or charge multiplication.
Using the ωCO data observed for GST samples as a classification for GST long-term solu-
tion stability, samples at high pH values and low GST concentration would be predicted
to be stable.
In Fig. 8.2 (c) and (d) the ωCO values of Cherry-GST and GST samples containing
400 mM (NH4)2SO4 are plotted in a range from pH 7-9 and a protein concentration
range from 60-100 mg/mL.
(NH4)2SO4 had an impact on the ωCO values of Cherry-GST and GST. The number of
systems where ωCO values dropped below 15000 rad/sec increased for both proteins. That
implies that the mobility of the molecules decreased with the addition of (NH4)2SO4 de-
pendent on pH, protein concentration and protein type. The impact of (NH2)4SO4 on
protein-protein interactions is most often explained by the position of the SO−4 ions in the
Hoffmeister Series Dumetz, Snellinger-O’brien, Kaler & Lenhoff [54] and Baldwin [87].
According to this theory (NH4)2SO4 is a kosmotropic salt, and hence has a salting out
effect on proteins Baumgartner et al. [88] and Collins [241]. Kosmotropic salts have the
ability to strengthen the structure of water molecules around them. Due to the exclusion
of water, which previously surrounded the protein surface, hydrophobic patches on the
protein surface are uncovered, what leads to an intensified interaction of the proteins,
and therefore a decreased colloidal protein stability. These interactions weaken the mo-
bility of the molecule what induces lower ωCO values. The salting out theory explains the
viscoelastic behavior of GST very well. Here, the impact of salt was especially high at
high protein concentrations and at pH values close to the pI, where stronger hydropho-
bic protein-protein interactions are presumed. The theory can not explain the impact
of (NH4)2SO4 on the viscoelastic behavior of Cherry-GST samples. Here, the salt had
mainly an impact on samples at high pH values. The low ωCO values at pH 10 were
explained by a partly unfolding of CherryGST due to strong repulsive electrostatic inter-
actions. A shift of the reduced flexibility to lower pH values would imply that (NH4)2SO4
has a reinforcing effect on the conformational instability of Cherry-GST. However, SO−4
ions are known to have a stabilizing impact on the 3D structure of proteins. This theoreti-
cal conformational stabilization is inconsistent with the arguments mentioned above. One
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explanation for the reduced flexibility of Cherry-GST at pH 9 with (NH4)2SO4 in solu-
tion could be that the unfolding can not be suppressed by the addition of (NH4)2SO4,
but that the attraction of the partly unfolded proteins with each other is strengthened
by the addition of this salt.
Further, a distinction must be made between GST and Cherry-GST samples containing
(NH4)2SO4 in relation to the strength and extend of the ωCO drop. For Cherry-GST
samples the addition of (NH4)2SO4 had only an impact for pH 9 and 100 mg/mL and
pH 9. The impact of the salt on the viscoelastic behavior of Cherry-GST at pH 7 and
pH 8 (60-80 mg/mL) was negligible small. For GST samples instead, the addition of
(NH4)2SO4 had a strong impact on each condition tested. Here, all ωCO values de-
creased below 12562 rad/sec (pH 9, 60 mg/mL). Transferred to the solution stability
of the protein, this implies an increased aggregation propensity for GST with the addi-
tion of (NH4)2SO4 for all tested conditions and an increased aggregation propensity for
Cherry-GST samples at pH 8 with a protein concentration of 100 mg/mL as well as for
pH 9 with a protein concentration of 60-100 mg/mL.
NaCl had a different impact on the rheological characteristics on both studied proteins
in comparison to (NH4)2SO4. For Cherry-GST samples NaCl had a decreasing impact
on ωCO values solely at pH 8. The lowest ωCO value (9827 rad/sec) was detected at pH 8
and a protein concentration of 100 mg/mL (Fig. 8.2 (e)). At pH 7, the ωCO values were
more or less unaffected by the addition of NaCl with values around 19000 rad/sec, sim-
ilar to ωCO values at pH 9 with values ranging from 13000-14000 rad/sec for the tested
protein concentration range.
In comparison, the addition of NaCl had a strong impact on the rheological response of
GST samples at all conditions tested (Fig. 8.2 (f)). At pH 8 and a GST concentration
of 100 mg/mL the highest ωCO value of 20357 rad/sec was detected. The lowest ωCO
values for this screening area were observed at pH 7 and 100 mg/mL (5373 rad/sec) and
at pH 9 and 100 mg/mL (4143 rad/sec).
NaCl is classified in the middle of the Hofmeister series. It has neither a strong chaotropic
nor kosmotropic character. Nevertheless, only the rheological behavior of Cherry-GST at
pH 7 was totally uninfluenced by the addition of NaCl. Additional to the salting in
and salting out effect preferential interactions between the Na+ ions and the negatively
charged patches of the GST and Cherry-GST surface may occur. This interaction can
cause a shielding of the charged surface groups and thus a reduction of protein-protein
repulsion. Interestingly, the strongest decreasing impact on ωCO values of Cherry-GST
samples was found at pH 8 and a protein content of 100 mg/mL. At this condition NaCl
had the least effect on the rheological behavior of GST. NaCl even seemed to stabilize
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GST, as the difference between the ωCO values with and without 400 mM NaCl is pos-
itive with a value of 9850 rad/sec. The surprisingly strong and opposing effect of NaCl
on GST and CherryGST samples, respectively is difficult to be explained by theoretical
considerations. However, it is a further indication that due to the fusioned tag, the pro-
tein behavior in solution changes significantly. After reviewing various studies about the
salt impact on different molecule species Curtis et al. concluded that there is no single
unified theoretical framework to rationalize the specificity of salt ion effects on protein
intermolecular interactions Curtis & Lue [53]. The exact mechanism of NaCl on the vis-
coelastic behavior of GST respectively Cherry-GST under tested conditions seems to be
complex and is part of future investigations.
In summary the ωCO values of GST samples are lower in comparison to ωCO values of
Cherry-GST samples at similar buffer conditions and protein concentrations, except for
samples at pH 10. Without salt in solution the pH (from pH 6-9) and protein concen-
tration had a negligible small impact on the viscoelastic characteristic of Cherry-GST.
Per contrast, the rheological behavior of GST changed significantly with changing buffer
conditions and protein concentration. Also the tested salts, (NH4)2SO4 and NaCl, had
a differing impact on the rheological response of the solutions dependent on the pro-
tein type. Using the rheological measurement and more specifically the ωCO values as
a tool to predict protein solution stability, Cherry-GST was assessed as more stable in
comparison to GST at tested conditions except for pH 10. The stabilizing effect of the
tag is especially rheologically noticeable at higher protein concentrations. Additionally,
Cherry-GST is less affected by the addition of salt particularly at pH 7.
For both proteins the measurements were performed under similar buffer and environ-
mental conditions. Therefore, the reasons for the different viscoelastic behavior of GST
and Cherry-GST, and the predicted different solution stability, have to be found in the
change of protein surface characteristics due to the Cherry-Tag™. It is assumed that a
specifically strong negative charge and a shielding character of the tag may be the basis of
the predicted stability enhancement. To understand the differing impact of tested salts,
pH and protein concentration on GST and Cherry-GST solution viscoelasticity better,
the surface characteristics of both molecules were studied in silico (see 8.3.3). Prior to
the analysis of the protein surface characteristics, the predicted solution stability was
validated by long-term colloidal stability tests.
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8.3.2 Long-term Colloidal Stability of Cherry-GST and GST Solution
To validate the prediction of the long-term protein solution stability based on rheologi-
cal results, the long-term colloidal stability of both proteins was investigated by protein
phase diagrams. The samples of Cherry-GST and GST were scored after 40 days of incu-
bation in a climate chamber as precipitated, crystallized or discolored, based on optical
evaluation. To avoid repetitive text, the listed stability results will only be discussed
when a deviation from the already discussed predicted stability of Cherry-GST and GST
based on rheological investigations was observed.
In Fig. 8.3 the scoring of GST and Cherry-GST samples are shown. Red full circles
symbolize stable samples, samples where aggregation occurred are marked as blue filled
squares, gelation is marked as an open diamond and samples where a color shift from red
to yellow was observed are symbolized as blue open circles.
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Figure 8.3: Protein phase behavior of Cherry-GST at pH values from 6-10, protein con-
centrations from 20-120 mg/mL and (a) (NH4)2SO4 concentrations from
0-400 mM and (c) NaCl concentrations from 0-400 mM and protein phase
behavior of GST at pH values from 6-10, protein concentrations from
20-120 mg/mL and (b) (NH4)2SO4 concentrations from 0-400 mM and (d)
NaCl concentrations from 0-400 mM. Clear samples are plotted as red filled
circles, light precipitated samples as small light blue squares, precipitated
samples as blue squares, gel formation as blue diamonds and discolored sam-
ples as unfilled blue circles.
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Fig. 8.3 (a) displays the scoring of Cherry-GST in a pH range from pH 6-10, a protein
concentration range from 20-120 mg/mL, and the addition of 0-400 mM (NH4)2SO4.
The samples at pH 10 starting at a Cherry-GST concentration of 100 mg/mL could
not be scored due to the immediate precipitation of the protein in the preparation pro-
cess. The protein was colloidal stable at pH 6 and pH 7 over the whole tested protein
and (NH4)2SO4 concentration range. At pH 8 light precipitation occurred at a Cherry-
GST concentration of 80 and 100 mg/mL, starting from a (NH4)2SO4 concentration of
150 mM. At pH 8 and a protein concentration of 120 mg/mL the protein precipitated
over the whole tested salt concentration range. The unstable region of Cherry-GST in-
creased at pH 9. At pH 10 a color shift from red to yellow was observed for all tested
protein and (NH4)2SO4 concentrations. The color shift of Cherry-GST was shown to be
caused by conformational protein instability [232].
Phase transition was observed for GST samples in a range from pH 6-9 with and with-
out salt in solution (Fig. 8.3 (b)). The strength of precipitation increased with increasing
(NH4)2SO4 concentration. Additional to strong precipitation, gelation occurred at higher
(NH4)2SO4 concentrations. At pH 10 GST was stable at protein concentrations of 80 and
100 mg/mL with and without (NH4)2SO4 in solution. At lower protein concentrations,
GST was destabilized and precipitation and gel formation occurred when (NH4)2SO4
was added.
In Fig. 8.3 (c) the phase behavior of Cherry-GST with NaCl as a precipitant is shown. At
pH 6 Cherry-GST was stable in a protein concentration range from 20-120 mg/mL and
up to a NaCl concentration of 200 mM. At pH 7 precipitation only occurred at Cherry-
GST concentrations from 20-60 mg/mL and the addition of 250-400 mM NaCl. Similar
behavior was observed at pH 8. At pH 9 clear samples were observed with the addition
of 150-200 mM NaCl over the whole tested Cherry-GST concentration range. At pH 10
discoloration occurred for the whole tested salt and protein concentration range, similar
to the discoloration at pH 10 with (NH4)2SO4 as a precipitant (compare Fig. 8.3 (a)).
NaCl had a comparable impact on the phase behavior of GST as (NH4)2SO4 (Fig. 8.3
(d)). Precipitation occurred at pH 6, pH 7, pH 8 and pH 9 with NaCl as an additive.
Only at pH 10 in a protein concentration range from 20-100 mg/mL and the addition
of NaCl clear samples were observed. Light precipitate was observed at 100 mg/mL at
250 and 400 mM NaCl. In summary, it was found that Cherry-GST had a wider soluble
region in comparison to GST under all tested conditions.
For the validation of the rheological measurements as a predicting tool solution condi-
tions, which were rheologically analyzed were correlated directly with the studied phase
behavior. To enable an easy comparison of the actual phase behavior and rheological
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results the phase state of Cherry-GST (left hand site) and GST (right hand site) is plot-
ted repeatedly in Fig. 8.4 at buffer conditions and protein concentrations as shown in
Fig. 8.2.
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Figure 8.4: Scoring of the phase behavior of Cherry-GST (left hand side) and GST (right
hand side) in a pH range from 6-10 respectively pH 7-9 and a protein con-
centration range from 60-100 mg/mL. (a) and (b) without salt, (c) and (d)
with 0-400 mM (NH4)2SO4 and (e) and (f) with 0-400 mM NaCl. The ωCO
values are depicted as a colorbar ranging from 6000 rad/sec (dark blue) to
20000 rad/sec (dark red).
Under stable colloidal conditions, the ωCO values were higher in comparison to condi-
tions were phase transitions occurred. This observation holds true for both proteins at
all tested conditions. Also the discoloration, hence the denaturation of Cherry-GST at
pH 10 could be reflected by a major drop of the ωCO values below 10000 rad/sec. The
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only condition at which the phase transition can not be correlated to a low ωCO value
is the sample with a GST content of 100 mg/mL, at pH 8, and 400 mM NaCl. At this
specific condition gelation occurred but an increase of the ωCO value was observed. An
explanation might be that the gelation is formed by a network of native GST molecules
induced by specific ionic effects of the NaCL. Such network formations were already
described for crowded protein solutions [242]. This assumption is hypothetical and the
interesting effect of NaCl part of future studies.
The predictability of the solution stability of GST and Cherry-GST with the help of rhe-
ological measurements was successful. Therefore, the detailed discussion of section 8.3.1
can also be used for the discussion of the actual colloidal stability of Cherry-GST and
GST.
To study the conformational stability of the proteins in more detail, additionally to the
long-term phase diagrams, thermal stability studies were performed. Here, the melting
temperatures (Tm) of discussed samples were determined. As the thermal stability mea-
surements did only show marginal differences under all investigated molecules and buffer
conditions, the results can be found in the supplementary material (Figure A2).
To underline the made assumptions concerning the differing solution stability of GST and
Cherry-GST the protein surface characteristics of both proteins were further investigated
with the help of MD simulations. The results of the analytical findings are discussed in
the next sections.
8.3.3 Molecular Dynamics (MD) Simulations and Molecular Descriptors
As ζ-potential measurements (data can be found in the supplementary material, Figure
A1) are not sufficient to describe the strong enhancement of protein solution stability
when adding the Cherry-Tag™, modeling on the molecular level (MD) was performed.
The MD approach enables a deeper understanding of molecular properties, including
not only electrostatic properties, but also other factors such as shape and surface hy-
drophobicity on a three-dimensional structure level. Fig. 8.5 (a) illustrates MD models
of GST (left) and Cherry-GST (right) under different pH conditions in a range of pH 6
and 10 in 1 pH unit steps. Each of the 3D models is shown from the front side and the
back side, respectively. Blue areas represent positively charged molecule patches, and
red areas correspond to negatively charged protein surfaces. According to Fig. 8.5 (a)
the Cherry-Tag™ alone is dominated by negative surface charges in the entire pH range,
resulting in an increased negative total surface charge of the fusion protein compared to
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GST alone. GST per contrast exhibits a homogenous charge distribution in a pH range
of pH 6 to pH 8. Cherry-GST at pH 9 and pH 10 results in a highly negative charged
molecule with almost no positively charged residues remaining. Such repulsive forces of
equally charged molecules are, however not the only driving effect for enhanced protein
solubility.
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Figure 8.5: (a) MD models of GST (left) and Cherry-GST (right) at pH 6-10. Each 3D
model illustrates the front and back side of the protein, whereas blue areas
represent positively charged molecule patches, and red areas correspond to
negatively charged protein surfaces. (b) Respective total electrostatic poten-
tial on the protein surface (sumMapSurfESP), and the total protein surface
hydrophobicity (sumMapSurfHyd) of GST and Cherry-GST.
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Another factor to be considered is the geometry difference of both molecules. This was
investigated by the molecular descriptor shapeMaxGeo, which has a value of 1 for ideally
spherical shaped proteins, and increasing values for molecules of non-spherical shape.
GST results in shapeMaxGeo values are in a range of 1.35 to 1.42 for all investigated
conditions, whereas Cherry-GST was determined to be in a range of 2.08 to 2.12. Thus,
GST is rather compact and of spherical shape and the Cherry-Tag™ acts as a steric
factor, which might be another stabilizing factor for increasing protein solubility.
Whereas in Fig. 8.5 (a) qualitative values for the electrostatic potential of proteins were
discussed only, Fig. 8.5 (b) illustrates the quantitative values of the total electrostatic
potential on the protein surface (sumMapSurfESP) and the total protein surface hy-
drophobicity (sumMapSurfHyd). Different symbols are used for pH values in a range of
pH 6 to 10 with blue colors for GST and red colors for Cherry-GST. The investigated
salt concentrations are indicated as color gradients with darker colors for low salt concen-
trations. All electrostatic and hydrophobic descriptors of GST are situated close to the
coordinate origin of the plot, representing a charge homogeneity and moderate hydropho-
bic character. Per contrast, all system points of Cherry-GST are much more hydrophilic
in nature being far left of GST in Fig. 8.5 (b). This is another strong indicator of the
distinct phase behavior of both molecules, as proteins of hydrophobic nature are highly
instable in water and tend to aggregate. The qualitative trend of total electrostatic poten-
tial on the protein surface in Fig. 8.5 (a) is verified by the quantitative values illustrated
in Fig. 8.5 (b). Even at the lowest pH of 6 Cherry-GST carries negative charges whereas
GST even shows slight cationic behavior. This trend becomes more and more pronounced
for higher pH values up to pH 10. The purple line indicates the threshold of solubility
determined in the protein phase diagrams. All unstable conditions are found in a cluster
close to the coordinate origin, and all stable conditions are of hydrophilic nature with
additional charge extremes for electrostatic repulsion. The only exception was found for
Cherry-GST at pH 10 where there was no colloidal, but a conformational instability of
the protein. This effect might be explained by negative surface charge extremes (Fig. 8.5
(a) - Cherry-GST pH 10) resulting in protein unfolding. The findings of the MD sim-
ulations support the assumptions made for interpreting the rheological results and the
predicted solution stability of section 8.3.1.
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8.4 Conclusions
Engineering and monitoring protein solution stability is an essential task for producing
and launching biopharmaceutical products. Whereas established analysis in the field of
long-term protein stability still requires time-consuming experimental setups, this screen-
ing could demonstrate that new tools can help for predicting and understanding stability
attributes within several hours.
We investigated experimental and in silicoMD tools for fast prediction of protein solution
stability under different chemical surroundings and high protein content. Also the protein
of interest (GST) was investigated with an additional solubility enhancing Cherry-Tag™
fusion.
The rheology measurements indicated a strong enhancement of GST colloidal stability
with the additional fusion tag compared to the native protein under all investigated
conditions with exception of pH 10. Here, an unfolding of Cherry-GST was identified
as a consequence of excess surface charge. The stabilization of Cherry-GST compared
to GST was also pronounced under addition of (NH4)2SO4 or NaCl, though the used
concentration range usually leads to a salting out effect. The validation of such short-
time predictions based on rheology was performed by long-term stability experiments
at identical conditions, leading to comparable results of both methods. Thus, rheology
was robust to predict protein solution stability of highly concentrated protein solutions
towards changing chemical environment and molecular modifications.
Finally, to understand the solubility enhancing properties of the Cherry-Tag™ both pro-
teins were further investigated on the molecular level. The MD simulations clearly indi-
cated that the stabilizing effect of the Cherry-Tag™ can be explained by three different
effects, namely, the hydrophobicity reduction, the strong negative charge enhancement
and additionally a steric geometric effect.
It could be shown that the determination of molecular properties in combination with
rheological measurements are strong tools to study the extent and causes of protein long-
term stability. With the applied experimental and in silico MD tools in hand, buffer
optimizations and fast decisions during pharmaceutical process development are pos-
sible for ensuring product quality and stability. Also, the stabilizing properties of the
Cherry-Tag™ might become an approved protein modification by the authorities, analo-
gously to the PEGylation procedures, which are widely employed in industry.
118
8.5 Acknowledgments
8.5 Acknowledgments
The authors acknowledge the financial support by the German Federal Ministry of Edu-
cation and Research (BMBF) - funding code 0316071B - and the general support by the
industrial partners DelphiGenetics (Belgium) and m2p-Labs (Germany). This research
work is part of the project ’ERA Net Euro Trans Bio - 6: Development of an integrated
strategy for a high-throughput process development platform on a micro-scale format –
FORECAST’. We also highly acknowledge the input by B.Sc. Claudia Weigel. The au-
thors assume the complete responsibility for the contents of this publication and declare
no conflict of interest.
Supplementary Material
ζ-potential Measurements
The ζ-potential as an indicator for protein surface charge was determined by Laser
Doppler micro-electrophoresis using the Zetasizer Nano ZSP (Malvern Instruments, United
Kingdom). The velocity of the molecules is measured when a voltage of 60 mV is ap-
plied. With the help of the velocity the ζ-potential of the molecules can be calculated.
The ζ-potential represents the electric potential in the interfacial ion double layer of a
molecule. It is directly linked to the net surface charge of the molecule and is therefore
an important parameter to study protein-protein interactions resulting from electrostatic
interactions. In this study the ζ-potential of GST and Cherry-GST with a concentration
of 30 mg/mL at pH 6-10 without salt and with 400 mM (NH4)2SO4 or NaCl was de-
termined. For the measurement 20 µL of sample was pipetted in a disposable folded
capillary cell and measured with the diffusion barrier technique Corbett, Connah & Mat-
tison [243].
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Figure 8.6: ζ-potential values of Cherry-GST and GST at 30 mg/mL, pH 6-10 with and
without 400 mM (NH4)2SO4 respectively 400 mM NaCl in solution.
Determination of the Protein Melting Temperature (Tm)
To investigate the thermo-stability of GST and Cherry-GST the fluorescence spectra of
both proteins were measured over a temperature ramp. The temperature ramp was run
to force the protein to unfold. During the temperature ramp the number of exposed
fluorescent amino acids from the core increase while the protein unfolds. Due to the in-
creasing amount of detectable amino acids the signal of fluorescent light shifts along the
wavelength. This shift can be used to calculate the Tm of the protein. The fluorescence
measurements were performed with the UNit acquired from Unchained Labs (Pleasanton,
USA). Here 7 µL of the sample was manually pipetted in a sample carrier containing 12
quartz glass sample tubes. A temperature ramp from 20-90 ◦C was run and the fluores-
cence signal was recorded in 0.5 ◦C steps per minute. Then the shift of the fluorescence
signal was plotted against the temperature and the Tm values were calculated at the
inflection point of the evolved curve. Investigated samples contained 30 mg/mL of GST
or Cherry-GST at pH values of 7, 8, 9 and 10. All conditions were measured without salt
and with 400 mM (NH4)2SO4 or NaCl, respectively.
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Figure 8.7: Tm values of Cherry-GST, left hand side, and GST, right hand side at pH 7-10
with and without 400 mM (NH4)2SO4 respectively 400 mMNaCl in solution.
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Abstract
High protein titers gain increasing significance for the biopharmaceutical industry. A ma-
jor challenge in the development of highly concentrated mAb solutions is their long-term
stability and often incalculable viscosity. The complexity of the molecule itself as well as
the various molecular interactions make it difficult to describe their solution behavior. To
study the formulation stability long and short-range interactions as well as the formation
of complex network structures have to be taken into account. For a better understand-
ing of highly concentrated solutions, this work combines established and novel analytical
tools to characterize the impact of solution properties on the stability of highly concen-
trated mAb formulations. In this study monoclonal antibody solutions in a concentration
range of 50 - 200 mg/ml at pH 5 - 9 with and without glycine, PEG4000 and Na2SO4
were analyzed. To determine the monomer content analytical SEC runs were performed.
ζ-potential measurements were conducted to analyse the electrophoretic properties within
different solutions. The melting and aggregation temperatures were determined with the
help of fluorescence and static light scattering measurements. Additionally, rheological
measurements were conducted to study the solution viscosity and the viscoelastic be-
havior of the mAb solutions. The so determined analytical parameters were scored and
merged as an analytical toolbox. The resulting scoring was then successfully correlated
with long-term storage (40 days of incubation) experiments. The study indicates that the
sensitivity of complex rheological measurements in combination with the applied tech-
niques allow reliable statements about the impact of solution properties such as protein
concentration, ionic strength and pH shift on the strength of protein-protein interaction
and solution colloidal stability.
Keywords: monoclonal antibodies; conformational and colloidal stability; zeta potential;
viscosity; viscoelasticity; thermal stability; phase diagrams
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9.1 Introduction
Antibodies are used for a wide range of pharmaceutical treatments. Particularly for can-
cer or autoimmune diseases they are indispensable as specifically effective drugs [244,
245]. New therapeutic forms and mode of administrations demand an ever increasing
molecule titer of the monoclonal antibodies in the final formulation [246]. The molecular
density in solution cause new challenges for the biopharmaceutical process development,
formulation and application. Especially the colloidal and conformational long-term sta-
bility of the molecules are considered as a bottleneck [16].
The stability of highly concentrated mAb solutions is influenced by various forces. These
forces can be divided into long-range and short-range interactions. Long-range inter-
actions do have an impact on proteins in ideal dilute solutions whereas the impact of
short-range interactions increase with increasing protein titer. So that at highly concen-
trated conditions an interplay of short- and long-range intreactions occur. Following the
DLVO theory, electrostatic forces do have the longest reach and are classified as repul-
sive long-range interactions [247]. The stronger the net charge of the molecular surface,
the more likely the molecules of the same kind will repel each other and the weaker is
the aggregation tendency of the proteins in the respective solution [15]. However, it was
found that when exceeding a certain charge value the protein starts to unfold. In this
case the intramolecular repulsive interactions are so strong that the chemical bonds sta-
bilizing the protein 3D structure are destroyed [207, 248, 249]. Due to the progress of
MD simulations and the advancements of analytical techniques, the charge distribution
on the protein surface and its influence on the solution stability is well understood [21,
250]. An established method to experimentally characterize the net surface charge of a
protein is the determination of the ζ-potential. The ζ-potential describes the electric ion
potential of the interfacial double layer and can for example be determined with the help
of laser-doppler-mikro-elekrophoresis [251]. The determination of the ζ-potential provide
insights into the kind and strength of electrostatic forces which may lead to protein ag-
glomeration and unfolding.
According to the DLVO theory, Van der Waals forces are classified as short-range interac-
tions. They can be described as universal weak attractive interactions of electromagnetic
origin which are induced by dipole moments [55]. The forces between two polarized
molecules only have a short range, so that they only have a measurable effect within the
molecule and in highly concentrated protein solutions. In the last decades the DLVO the-
ory was extended by taking hydrophobic forces, specific ion effects and the impact of the
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hydration layer into account when discussing protein-protein interactions. Comparable
to van der Waals forces they can be classified as attractive short-range interactions. They
are known to have a significant impact on the native structure of a protein and protein-
protein interactions in the highly concentrated regime [21]. The experimental detection
of the type and strength of short-range interactions is comparable difficult due to their
weak individual effects.
Both, the character and strength of short and long-range interactions are influenced by
the amino acid sequence and molecular structure of the protein as well as the pH, ionic
strength and co-solutes of the surrounding solution [67, 252]. The complex interplay of
the listed forces and their individual dependency on varying solution conditions makes it
so difficult to describe and predict protein long-term stability in the highly concentrated
regime.
Because of the complexity of the interactions involved, not the forces themselves are ana-
lyzed in industry, but rather their effects on the molecular stability and the protein phase
behavior. For this purpose, the target molecule is solved in relevant solutions and, after
the equilibrium has been established, its phase state and/or 3D structure is determined.
In order to be able to compare the actual behavior of the molecules in solution, without
having to wait for the equilibrium condition, the process can be accelerated by energy
input in form of increased temperature conditions. The increased temperature induces
the agglomeration and chemical degradation of the protein in a short time period and
can therefore accelerate long-term stability tests. Weiss, Young & Roberts [99] and He
et al. [108] could show that an increase of the so depicted melting temperature values
(Tm) correlate with an increased long-term stability of studied proteins. As this method
is high throughput compatible and has a working volume in µL scale, the temperature
induced phase transition is widely used, especially in the pre-selection of buffer compo-
nents and molecule main candidates.
Although these methods provide information on the behavior of the proteins in solution,
they merely provide a glimpse of the full picture of protein solution stability. In order to
widen the view and thus to predict the long-term stability of antibodies in solution it is
necessary to clarify the underlying causes, which is why a lot of research has been done in
this area in recent years [100, 126, 253]. What is needed is a lump parameter accounting
for all the different influencing parameters. For a long time the B22 value was thought to
be such a key parameter [105, 120, 188, 254]. However, this approach has not delivered
regarding concentrated protein solutions [20, 162]. An approach where multidemensional
interactions, occuring only at high protein concentrations, are taken into account, is the
measure of protein solution viscosity. The solution viscosity, hereafter called viscosity, is
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the resistance of a fluid to gradual deformation. The rheological parameter was shown
to correlate with the aggregation tendency of biopharmaceutical molecules, especially in
the highly concentrated regime [115, 184]. Additionally to the good comparability with
protein stability, the viscosity itself is of high importance for processing and formulation.
When the viscosity exceeds the processability or syringability of the solution to be han-
dled it can not be manufactured as a liquid application, which is the favored formulation
for the very difficult to crystallize antibodies. It is for this reason that the study of the
long-term stability of a protein solution and the resulting selection of main candidates
and buffer conditions should always take viscosity investigations into account.
A further promising application of rheology with regard to protein solution stability is
the study of the viscoelastic behavior of protein solutions.
Protein solutions behave viscoelastic. That implies that the protein solutions exhibit
both viscous and elastic characteristics when undergoing deformation [204]. The viscous
behavior can be described by the loss modulus, G′′ and the elastic behavior by the stor-
age modulus, G′. The characteristic viscoelastic response of the samples provides insides
into the strength of protein-protein interaction and the development of protein networks.
The behavior of proteins considering their interactions with other proteins or co-solutes
as well as their molecular flexibility can be depicted without the manipulation of the
sample, also in the highly concentrated regime [204].
Saluja et al. [20] introduced a viscoelastic parameter which has the potential to be corre-
lated directly with the protein long-term stability. In the published work highly concen-
trated antibody solutions were characterized with ultrasonic shear rheology. Saluja et al.
determined G′ of given solutions at a set frequency value. The determined G′ values were
used to correlate the viscoelastic characteristics of protein solutions with the aggregation
tendency of different antibodies. The work of Schermeyer et al. [218] is based on these
findings. Here, frequency sweep measurements were applied to be able to calculate G′ as
well as G′′ over a wide frequency range. When measuring viscoelastic substance the values
of G′ and G′′ plotted over the radial frequency show a characteristic curve shape with a
crossover point. It was shown that dependent on the molecule interactions and molecular
flexibility the crossover point shifts along the frequency axis [131, 218]. The frequency
value of this crossover point, ωCO could be successfully correlated to the long-term phase
behavior of the model protein lysozyme at concentrations ranging from 100 - 225 mg/ml.
The study of the viscoelastic characteristic was also applied to describe the stability en-
hancing effect of the Cherry-Tag® which was fusioned to Glutathion-S-Transferase. Here,
the rheological study in combination with molecular dynamics simulation could not only
be used for the description of the colloidal solution stability but also the conformational
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stability of the fusioned protein [252].
Unfortunately none of the presented novel or established methods is FDA approved to
predict the long-term stability of antibody solutions, yet [100, 109]. The parameters which
have an impact on the molecular conformational and colloidal stability are so complex
that decision-makers hesitate to recommend one single predicting analytical method. So
that in industry, every formulation has to be stored at least 12 - 24 months to prove the
long-term stability of the target molecule, which is time and therefore cost-intensive.
To address this challenge, an analytical toolbox is presented in this work. The toolbox
includes the intelligent combination of established and novel analytical techniques for
the description and prediction of protein long-term solution stability. As strong orthog-
onal analytical techniques SEC measurements, ζ-potential and viscosity measurements,
thermal stability tests as well as complex rheological measurements are performed in a
wide screening range. The solution conditions were selected on the basis of pre-stability
tests, with the aim of being able to investigate a wide range of positive and negative in-
fluencing physico-chemical mechanisms. The impact of three types of co-solutes, namely
polyethylene glycol (PEG), sodium sulfate (Na2SO4) and glycine, on the mAb solu-
tion stability were investigated. The large-scale screening allows the investigation of the
antibody stability behavior under various conditions and also reveals the limits of the
individual analytical methods applied. Furthermore, the results of the measurements are
scored and merged in a last step. The scoring values are directly compared to long-term
stability tests. The combined scoring values conduce as a valid and safe toolbox for the
description and prediction of the mAb long-term solution stability.
9.2 Materials and Methods
9.2.1 Materials
The humanized monoclonal antibody (mAb) used in this study has a molecular weight
of 145.5 kDa and a theoretical pI of 8.7. It was kindly provided by Synthon Biophar-
maceuticals B.V.. The mAb was delivered with a monomer content of above 98 % at
pH 5.5 and a protein concentration of ca. 30 mg/ml (hereinafter: stock solution). For this
study multi component buffer systems containing CABS (Santa Cruz Biotechnology),
CHES (AppliChem), MES and TAPS (AppliChem), sodium acetate trihydrate (Fulka),
sodium dihydrogen phosphate monohydrate (Merck) and TAPSO (Sigma-Aldrich) were
used. The ionic strength of the buffer solutions was 10 mM. Glycine (Sigma), PEG4000
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and Na2SO4 (Merck) were used as additives. Ultrapure water (ISO3696) was used to
prepare all solutions. For buffer exchange and concentration of the samples 20 ml and
40 ml Vivaspin ultrafiltration spin columns (Sartorius) with a molecular weight cut off
of 60000 Da were employed. To prepare protein phase diagrams 96-well microbatch crys-
tallization plates from Greiner Bio-One were used.
9.2.2 Experimental Setup
9.2.2.1 Buffer and mAb Preparation
For the experiments multicomponent buffers were prepared following the description of
Kröner & Hubbuch [255]. Buffers used in this study were adjusted with sodium chloride
to an ionic strength of 6.7 mS/cm using the conductivity-electrode CDM 230 (Radiome-
ter Analytical). The mAb stock solution was buffer exchanged and concentrated up to
250 mg/ml with Vivaspin columns and a rotational speed of 12300 g (fixed angle rotor,
Eppendorf centrifuge 5810R). Subsequently, a protein dilution series with the correspond-
ing buffer was prepared, so that after the addition of the second component, either a high
salt or low salt buffer in a ratio of 1:5 (buffer:protein solution) the required final protein
concentration could be achieved. The second component was added manually. After the
components were mixed, an equilibration time of 15 min was kept before the analytical
measurements were started. All analytical runs were performed at 20◦C and at least in
duplicate.
9.2.2.2 Size Exclusion Chromatography
To study the mAb monomer content, the amount of high molecular weight species (HMW)
and low molecular weight species (LMW) size exclusion chromatography (SEC) runs were
performed directly after sample preparation. The SEC measurements were done with an
UHPLC system (Agilent) using an Acquity PLC BEH200 SEC column. The samples were
diluted with 100 mM phosphate buffer (pH 7.5) to a mAb concentration of 1 mg/ml. This
buffer was also used as running buffer for all chromatography runs. The measurements
were done with a flowrate of 0.3 ml/min and an injection volume of 2.5 µL. The UV
signal at 280 nm was detected and processed by the Chromeleon 7.1 chromatography
data system. The mass ratio of monomer, HMW and LMW was calculated based on the
areas of the detected peaks.
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9.2.2.3 ζ-potential Measurements
To study the surface potential of the target molecule the ζ-potential was determined
by Laser Doppler micro-electrophoresis using the Zetasizer Nano ZSP (Malvern Instru-
ments). According to the manufacturer the sensitivity of this measurement tool is ± 2
mV. A voltage of 60 mV was applied to calculate the ζ-potential over the velocity of the
molecules. The voltage was set to limit the current to a maximum of ±5 mA and the
number of runs were limited to 10. To determine the ζ-potential disposable folded capil-
lary cells and the diffusion barrier technique were used to reduce the sample volume to
20 µL. In this study the ζ-potential of mAb solutions with a concentration of 10 mg/ml in
a pH range from pH 5-11 without additives, with 15 mM glycine, 0.2 (m/V)% PEG4000
respectively 16 mM Na2SO4 was determined. The mAb and additive concentration was
reduced 10 fold to avoid interference of electro osmosis which may occur at samples with
an ionic strength greater then 150 mM [111].
9.2.2.4 Viscosity Measurements
The viscosity was measured with the Viscosizer (Malvern Instruments) using Poiseuille
flow. Here, the sample is automatically pumped through a microcapillary under con-
stant drive pressure. The time (∆ts) the sample needs to pass a set pathlength is
measured and referenced against the time (∆tr) taken for a fluid of known viscosity.
The relative viscosity values of mAb samples with 120 and 180 mg/ml protein con-
tent at pH 5, with and without 50-150 mM glycine, pH 7 with and without 50-150 mM
glycine, 100-160 mM Na2SO4 and pH 9 with and without 50-150 mM glycine respectively
0.4-4 (m/V)% PEG4000 in solution were determined.
9.2.2.5 Thermal Colloidal and Conformational Stability
To study the conformational and colloidal thermo stability of the mAb under varying
conditions a temperature ramp was run to force the protein to aggregate or/and to unfold.
The measurements were performed with the UNit (Unchained Labs) where Tm and Tagg
of 48 samples can be measured simultaneously. The Tm values were calculated at the
inflection point of the curve developed when plotting the shift of the fluorescence signal
over the applied temperature. For some samples two inflection points could be calculated.
For this reason the parameter was additionally indiced with 1 for the first inflection
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point (Tm1) and 2 for the second inflection point (Tm2). The Tagg values were calculated
based on the steepest slope which evolved when plotting the static light scattering signal
over the applied temperature. The temperature ramp started at 20◦C, ended at 90◦C
and had a step width of 1 ◦C/min. In this study samples with a mAb concentration
of 5-180 mg/ml at pH 7 without additives and samples with a mAb concentration of
120 mg/ml and 180 mg/ml at pH 5, 7 and 9 with 50, 100 and 150 mM glycine, mAb
concentration of 120 mg/ml and 180 mg/ml at pH 7 and 100, 140 and 160 mM Na2SO4
and mAb concentration of 120 mg/ml and 180 mg/ml at pH 9 with 0.4, 1.2 and 2 (m/V)%
PEG4000 were screened.
9.2.2.6 Determination of Protein Solution Viscoelasticity
To determine the storage modulus (G′) and the loss modulus (G′′ ) frequency sweep
measurements in a frequency range of 100-60000 rad/sec were performed with the Piezo
Axial Vibrator (PAV). The applied frequency range also defines the detection limit of
the measurement tool. Following the publication of Schermeyer et al. [218] the frequency
value of the crossover point of G′ and G′′ , ωCO was used to compare the viscoelastic
response of studied samples. The calculated ωCO values also conduced as a predictive
parameter. A description of the measurement tool and the derivation of G′ and G′′ can
be found elsewhere [138, 139, 218]. The height of the measuring chamber was 15 µm.
For the measurement 35 µL of sample was pipetted on the measurement head. The
measurement head was closed with a force of 2 Nm. In this study mAb solution with
concentrations of 50, 120, 180 and 200 mg/ml at pH 5, 7 and 9 without additives, with
concentrations of 50, 120, 180 and 200 mg/ml at pH 5, 7 and 9 with 150 mM glycine,
2 (m/V)% PEG4000 respectively 160 mM Na2SO4 were conducted.
9.2.2.7 Preparation of Protein Phase Diagrams
To study the colloidal long-term solution stability of the mAb protein phase diagrams
were prepared. Therefore, a robotic liquid handling station (Tecan) was used following
the method described by Baumgartner et al. [88]. To achieve 96 conditions on one plate,
four buffer troughs were prepared including two low salt and two buffers with one of
the selected additives in a high concentration. A buffer plate was prepared with these
solutions to achieve six additive concentrations ranging from 0-2.5 M glycine, 0-1.6 M
Na2SO4 and 0-20 (m/V)% PEG4000. These conditions were then mixed with manually
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prepared mAb samples ranging from 0-250 mg/ml in a ratio of 1:5 resulting in a sample
volume of 24 µL. One crystallization plate consisted of two pH values ranging from pH 5-9,
mAb concentrations ranging from 120-225 mg/ml and additive concentrations ranging
from 0-200 mM glycine, 0-160 mM Na2SO4 respectively 0-2 (m/V)% PEG4000. After
preparation the plates were centrifuged for 1 min at 1540 g to reduce air bubble content
and covered using optically clear and UV compatible sealing tape (Duck Brands). The
plates were then placed in an automated high resolution imaging system (Rock Imager,
Formulatrix). Every single well was photographed in specific time intervals. After 40 days
the samples were visually scored as colloidal stable, low precipitated or precipitated.
Additionally, Fourier transform infrared spectroscopy (FTIR) measurements were per-
formed to study the long-term conformational stability of the antibody under varying
conditions. The results revealed that the 2D structure of the antibody did not change
at studied conditions after 40 days of incubation, wherefore the results are not shown
here.
9.3 Results and Discussion
9.3.1 Preliminary Selection of Additives
In this study the predictive properties of different analytical methods on the solution
stability of highly concentrated mAb solutions is investigated. The protein solution sta-
bility is substantially dependent on the solution additives. Attention was payed that the
used additives have either positive or negative effects on the mAb solution stability and
that the impact is triggered by different physico-chemical mechanisms. Therefore, the
selection followed the results of pre-tests, where the impact of several additive types and
concentrations on the mAb solution stability was tested qualitatively with dynamic light
scattering (DLS) measurements. The methodology of the DLS measurement, conditions
tested and results can be found in the supplementary material (see section A1). Three
types of additives, namely salts, polymers and osmolytes were tested. In the following
section, possible physico-chemical mechanisms of these co-solutes on the antibody solu-
tion stability and thus the reasoning for their selection are shortly discussed.
The effect of salts on the protein solution stability is mainly dependent on their concen-
tration and type. At low ionic strengths salts primarily have a stabilizing impact, due to
nonspecific electrostatic interactions. This stabilizing effect was found to be independent
on salt type and is mostly pronounced close to the pI of proteins [256]. With increasing
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salt content, the impact of salt type becomes more pronounced. The stabilizing effect at
low salt concentrations can be reversed to a destabilizing effect, also known as salting-
out [85]. The Hofmeister series divides the salts according to their salting-out character.
Salts with a strong salting-out character are classified as kosmotropes and salts with a
predominantly salting-in character are classified as chaotropes. In several studies it was
shown that antibody solution behavior follows this theory [257]. Strongly hydrated ions
(kosmotropes) do have a negative impact on the hydration shell of proteins, increasing
the hydrophobic protein-protein interactions and therefore have a negative impact on
the protein colloidal stability (e.g. Na2SO4) [84, 256, 258, 259]. The strengthening of
inner molecular hydrophobic interactions on the other hand lead to an increased confor-
mational protein stability. Chaotropic salts, like potassium iodide, decrease hydrophobic
interactions by destroying the water structure around solved molecules. They have a de-
naturing effect on proteins but may increase the colloidal stability at low to moderate
concentrations. As the interactions of salt ions with the protein are mainly based on elec-
trostatic interactions, the impact of salt is pH dependent and dependent on the amino
acid sequence of the molecule tested. Specific interactions of salt ions with amino acid
residues are not totally understood, especially at higher protein concentrations. So that
modulations on protein-protein interactions by salt ions and their implications for protein
solution behavior cannot be completely rationalized [53]. The impact of the kosmotropic
salt Na2SO4 on the mAb solution stability will be studied in this context.
In contrast to salt ions polymers are uncharged, hydrophilic molecules whose effect on
proteins is mainly dependent on their chain length. Attractive protein-protein interac-
tions can be strengthened when adding long chain polymers by depletion attraction. The
depletion attraction arises from an increase in osmotic pressure of the surrounding so-
lution when the proteins in solution get close enough such that the excluded co-solutes
cannot fit in between them [260, 261]. Based on this theory, the comparatively large
hydrophilic polyethylene glycol (PEG) molecules exclude a certain amount of volume
from the solution which is then inaccessible to other molecules [262]. Thereby, the mAb
molecules are sterically excluded from the volume of PEG and concentrate in the re-
maining volume. The so increased mAb concentration may lead to stronger short-range
protein interactions which may cause agglomeration or unfolding of the molecules.
Short-chain polymers, on the other hand, can increase protein stability by preventing
protein-protein interactions due to sterical hindrance. Additionally it was found that the
OH group of polyethylene glycol can interact with positively charged amino acid residues
of proteins [263]. This specific binding changes the net charge of the protein and may
have a negative impact on the protein colloidal stability below the pI. In this study a
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comparatively large PEG with a molecular weight of 4000 Da will be investigated.
Osmolytes including polyols, certain amino acids and methylamines are mainly used as
stabilizing additives. The stabilizing effect of osmolytes is most often explained by the
preferential exclusion of these small molecules from the protein surrounding. The prefer-
ential exclusion implies that the concentration of the osmolyte in the immediate volume
element surrounding the protein is lower, than its concentration in the bulk phase. That
increases the water volume and its structured orientation around the protein, resulting
in a colloidal stabilization [83, 95]. The theory of protein surface hydration and the ac-
companying increase of surface tension is also known as the cavity theory. Several studies
on protein colloidal and conformational stability support the cavity theory and the sta-
bilizing character of osmolytes [264–267]. The impact of glycine on the mAb solution
behavior will be studied in this work.
9.3.2 Analytical Characterization of mAb Solution
To be able to describe the colloidal and conformational long-term stability of the mAb
solutions, various analytical methods were applied. The analytics focused on pH 5, pH 7
and pH 9 and mAb concentrations of 120 and 180 mg/ml. The impact of 50, 100 and
150 mM glycine was tested for all pH values. The effect of 0.4, 1.2 and 2.0 (m/V)%
PEG4000 was studied at pH 9. The impact of 100 - 160 mM Na2SO4 was tested at
pH 7. To evaluate the monomer, HMW and LMW content of the mAb in the stock
solution, as well as before and after sample preparation (buffer exchange and concen-
tration) SEC runs were conducted. The impact of electrostatic interactions were studied
by ζ-potential measurements. To get to know the conformational and colloidal thermal
stability of selected mAb samples Tm and Tagg values were determined. The focus here
was to evaluate the comparability of thermal and time induced phase transitions of the
mAb. Additionally, rheological measurements were performed to study the impact of
varying solution conditions on the viscosity and to correlate the viscoelastic behavior of
the mAb molecules with the long-term stability. The listed analytics shall give a detailed
picture of the micro and macroscopic antibody behavior and should, as a combination
of strong orthogonal tools, enable a precise description of the long-term stability. The
applied analytics are discussed separately.
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9.3.2.1 Initial Solution Characteristics: Size Exclusion Chromatography
A description of the influence of preparation procedure, pH and additives on the initial
solution characteristics at t0 was performed using SEC measurements upfront of the an-
alytical assays chosen in this study.
The evaluation of the chromatograms, namely the setting of the peak limits and the
area calculation of the respective peaks, were always carried out according to the same
methodology and by the same operator, so that a very small mean standard deviation
of 0.04 % could be achieved. The mAb stock solution had a monomer content of 98 %,
0.33 % HMW and a LMW content of 0.98 %.
In general the tested mAb is relatively stable against buffer exchange and concentra-
tion in relation to the monomer content determined by analytical SEC chromatography.
The monomer content in all tested samples was higher than 94.8 %. In Figure 1 (a)
the monomer, LMW and HMW content of samples after buffer exchange and original
concentrations of 120 mg/ml and 180 mg/ml are plotted. The antibody concentration
had a small decreasing impact on the monomer content of the antibody with or with-
out additive in solution. The monomer decrease may be caused by the strengthening of
mAb-mAb interactions due to the reduced distance of the molecules with increasing mAb
concentration.
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Figure 9.1: Monomer, HMW and LMW content of the tested antibody determined with
the help of size exclusion chromatography. Plotted are conditions after buffer
exchange with an original mAb concentration of 120 and 180 mg/ml, at pH 5,
pH 7 and pH 9 without additive (a) and with 150 mM glycine (b), as well
as samples at pH 7 and 160 mM Na2SO4 and samples at pH 9 containing
1.2 (m/V)% PEG4000 (c).
The pH had a more pronounced impact on the monomer content in solution in compari-
son to the mAb concentration. The monomer content decreased by 2 - 3.6 % comparing
results of samples at pH 5 with samples at pH 9. The decrease of the monomer content
with increasing protein concentration or increasing pH resulted in an increase of HMW
content. At pH 9, the HMW content increased by 1.69 % for samples with a mAb con-
centration of 120 mg/ml and 1.95 % for samples with a mAb concentration of 180 mg/ml
in comparison to the stock solution. The decrease in monomer content with increasing
pH could be a sign of the destabilization of the antibody solution due to the shift of
the buffer pH towards the theoretical pI of the molecule at 8.7. The resulting reduction
of repulsive electrostatic interaction may increase the aggregation tendency of the mAb
molecules and therefore the HMW content in solution. Even if this effect is weak at t0
it may be an indication of a decreased long-term colloidal stability of the mAb at pH 7
and pH 9 in comparison to pH 5.
Without additive in solution, the LMW content increased by 1.5 % for pH 5 and pH 9
and 1.2 % for pH 7 in comparison to the LMW content of the stock solution. The LMW
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content did not change with changing pH so that a conformational destabilization due
to the pH shift can be excluded.
The addition of glycine decreased the HMW content at all tested pH conditions (Figure
1 (b)). Especially at pH 9 this amino acid seemed to have a positive impact on the col-
loidal solution stability and is therefore considered as a stabilizing additive in this study.
The positive impact of glycine follows the general positive effect of osmolytes on the col-
loidal stability of protein solutions (see section 9.3.1). The osmolyte further increased the
LMW content at pH 5, pH 7 and pH 9. At pH 7 and a mAb concentration of 180 mg/ml
a slight decrease of LMW content was observed.
The polymer PEG4000 increased the HMW content at pH 9. This was especially pro-
nounced at 120 mg/ml (Figure 1 (c)). The increase in HMW content with PEG4000 in
solution can be explained with the depletion attraction theory. A detailed discussion of
this theory can be found in section 9.3.1. The LMW content increased by 0.34 % with
PEG4000 in solution and a mAb concentration of 120 mg/ml, respectively 0.21 % with
a mAb concentration of 180 mg/ml.
Na2SO4 had a small decreasing impact on the HMW content of the studied mAb at pH 7
(Figure 1 (c)). The decrease was within the calculated standard deviation and is therefor
negligible. Na2SO4 slightly increased the LMW content solely at pH 7 and 120 mg/ml.
The reduction of monomer content of around 2 - 3 % could also partly be caused by
the mechanical stress during centrifugation. To evaluate this hypothesis SEC runs were
performed with samples which were transferred into a buffer similar to the stock solution
buffer. Here a monomer loss of 1.6 % was determined. The observed monomer loss was
mainly due to the defragmentation of the antibody, which is reflected by a 0.9 % increase
in LMW species. Thus, the change in LMW content of the tested mAb solutions can be
attributed mainly to mechanical stress and a change in the HMW content correlated to
the varying environmental conditions.
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9.3.2.2 Electrostatic Interactions: ζ-potential Measurements
In Figure 2 the ζ-potential of mAb solutions with a protein concentration of 10 mg/ml,
in a pH range from 5 - 11, without additive, 15 mM glycine, 16 mM Na2SO4 and
0.2 (m/V)% PEG4000, respectively is shown.
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Figure 9.2: ζ-potential values of mAb at
10 mg/ml, pH 5-11 with and
without 150 mM glycine, 2
(m/V)% PEG4000 respectively
160 mM Na2SO4 in solution de-
termined by Laser Doppler mi-
croelectrophoresis.
The determined ζ-potential values are dis-
cussed with regard to protein-protein in-
teractions which may be induced by the
surface net charge of mAb molecules de-
pendent on the surrounding solution. As it
was assumed, based on the theoretical pI
of 8.7, the monoclonal antibody did have a
positive net surface charge at pH 5 with a
value of 5.7 mV and a negative net surface
charge at pH 10 and pH 11 with a value of
-3.56 mV. The ζ-potential values followed
the expected ζ-potential curve of proteins
[268]. In a pH range between pH 7 and
pH 9 the mAb molecules possessed a rela-
tively low effective charge. Here, repulsive
electrostatic protein-protein interactions are weak so that the inter-separation distance
of the molecules decreases [269]. This induces positive short-range protein-protein inter-
actions, including dipole mediated and hydrophobic interactions [270]. These attractive
interactions may increase the aggregation propensity of the antibody. The results under-
line the findings of the SEC analytics where an increase of HMW species at pH 7 and
pH 9 in comparison to pH 5 was determined.
With the selected additives in solution the ζ-potential values scattered around zero. This
leads to the assumption that glycine, PEG4000 and Na2SO4 reduce the electrostatic re-
pulsion of the mAb molecules at all tested pH values. The reduction of the mAb surface
charge by Na2SO4 and the zwitter ion glycine can be explained by attractive electrostatic
interactions between the charged additives and charged amino acid residues on the mAb
surface. PEG, on the other hand, is an uncharged molecule. A possible explanation for
the reduced ζ-potential due to PEG4000, is the interaction of the OH group of the PEG
molecule with charged amino acid side chains (see section 9.3.1). Another explanation
could be the steric hindrance of protein movement in the electric field by the long chain
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polymer.
In comparison to the ζ-potential results the SEC measurements revealed mAb solution
stability differences dependent on the additive type. Either the additives do have an ad-
ditional impact on the protein-protein interactions which can not be described solely by
ζ-potential measurements, or the electrophoretic measurements are not sensitive enough
to depict the differing impact of glycine, PEG4000 and Na2SO4 on the protein-protein
interactions. When discussing these results it should be considered that the ζ-potential
measurements had to be conducted at relatively low ionic strength to gain stable re-
sults. To keep the additive-protein ratio similar to other measurements, also the protein
concentration had to be reduced for these measurements to 10 mg/ml. Thus, a direct
comparison to analytic results gained at high protein concentrations and higher additive
content should be handled with care.
9.3.2.3 Protein Mobility: Viscosity Measurements
The study of viscosity is crucial for the processability as well as the formulation of mAb
solutions and can give insights into the strength and causes of protein-protein interac-
tions. The viscosity of mAb solutions at pH 5, pH 7 and pH 9 was tested for samples
with mAb concentrations of 120 mg/ml and 180 mg/ml. Additionally, the impact of
glycine, PEG4000 and Na2SO4 was tested at selected conditions (see Figure 3). The
reproducibility of the measurements were very high with an average standard deviation
of 0.6 %, except of conditions at 180 mg/ml and the addition of PEG4000 with an av-
erage standard deviation of 10.2 %. The high standard deviations may be due to the
local formation of a two-phase system or the instability of the mAb at these conditions.
A change in the viscosity by 1 mPas and a change greater than the calculated standard
deviation was classified as significant.
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Figure 9.3: Comparison of the viscosity values of samples with a mAb concentration of
120 and 180 mg/ml at pH 5, pH 7 and pH 9 with and without additive in
solution.
In this study the mAb concentration had the main impact on the viscosity. The vis-
cosity values at a protein concentration of 180 mg/ml were higher than viscosity val-
ues determined at 120 mg/ml, independent on pH or additive tested. The impact was
mostly pronounced at pH 5. Here a difference of around 7 mPas between 120 mg/ml and
180 mg/ml was detected. The concentration dependent increase of viscosity is a function
of the ability of the mAb to self-associate and must therefore arise from protein-protein
interactions induced by charge, hydrophobicity or dipole moments [184]. Based on the
viscosity investigations it is assumed that up to a concentration of 120 mg/ml, where
relatively low viscosity values were observed, repulsive long-range protein-protein inter-
actions dominate weak attractive short range interactions. At higher concentrations the
attractive short-range interactions gain increasing impact on the viscosity due to the re-
duced distance between the mAb molecules resulting in a viscosity increase [15].
With the change of mainly long-range mAb-mAb interactions to short-range interac-
tions, also the impact of pH on the viscosity increases. The pH dependency of protein
solution viscosity can not be described without invoking protein surface hydration. Water
molecules that are structured around the protein surface are less mobile than bulk water
molecules [271]. Thus, the viscosity depends on the strength of the hydration layer, which
in turn is directly related to the pH and the surface properties of the protein.
The viscosity values determined at pH 5 were higher compared to viscosity values at pH 7
and pH 9. pH 5 is farthest away from the pI of the studied mAb and based on ζ-potential
measurements it is presumed that the surface charge of the molecule is stronger at pH 5
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compared to pH 7 and pH 9. With this knowledge the viscosity increase at pH 5 might
be explained by the electroviscous effect [272]. The electroviscous effect considers three
kinds of contribution which may affect the viscosity. The primary effect describes the
resistance of the diffusive double layer surrounding the molecule. The secondary effect
takes the intermolecular repulsion between the double layer into account. When the in-
termolecular repulsion is so strong that it affects the molecular shape it is described as
the tertiary effect [210]. Based on these assumptions the viscosity increases with an in-
crease of molecular charge and is minimal at the pI. This theory can explain the results
of this study and has already been successfully applied for several other molecules [272–
274] and also for highly concentrated IgG1 solutions [275]. But this theory is contrary
to the general understanding that the viscosity is greatest near the pI. Saluja et al. [20]
also studied the viscosity of highly concentrated antibody formulations under varying pH
conditions. They stated that at higher concentrations viscosity can not only be described
by the electroviscous effect. Connolly et al. [276] supports this observation by a viscos-
ity screening of 29 different mAbs. The screening resulted in a very low comparability
of mAb effective charge and viscosity what contradicts the theory of the electroviscous
effect. The listed publications and the findings of this study demonstrate that no general
statements about parameters which influence the viscosity of monoclonal antibodies can
be made and that the effect of ionic strength can not be generalized, especially in the
highly concentration regime. Based on the assumption that protein-protein interaction do
have an impact on solution viscosity the significant differences obtained in the behavior
of viscosity caused by relatively similar antibody molecules may be explained by mAb
aggregation studies. Here, it could be demonstrated that mAb self-association is largely
due to Fab-Fab interactions [184]. The Fab region has the highest variability and is thus
unique for each antibody which may explain the differing viscosity behavior.
Following the generally accepted hypothesis that an increased viscosity also implicates
a decreased mAb solution stability, pH 5 at first sight would be considered as the least
favorable solution pH. Therefore, at high concentration solutions viscosity measurements
might pose an opposite statement on optimal buffer pH selection when compared to the
SEC analytics and ζ-potential determinations.
Glycine only had a weak impact on the viscosity. At pH 7 and 180 mg/ml a decrease of the
viscosity due to the addition of glycine occurred. The viscosity dropped from 7.55 mPas
without additive in solution to 5.94 mPas with 150 mM glycine in solution. A decreasing
impact of glycine on the viscosity could already be described by Wang et al. [277]. Glycine
is a hydrophilic amino acid and preferentially hydrate molecules in solution which may
reduce mAb-mAb interactions and thus the viscosity.
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An increase of the viscosity was caused by PEG4000 at pH 9. Especially at 180 mg/ml
the viscosity increased significantly up to a value of 11.67 mPas, which was the maxi-
mal viscosity value detected in this screening range. Simultaneously, with the increase of
PEG4000 content the reproducibility of the measurement weakened which resulted in a
standard deviation of up to 15 %. The increase in viscosity by the addition of PEG can
be attributed to two effects. On the one hand, PEG with a molecular weight of 4000 Da
is a relatively large long-chain molecule which increases the viscosity per se due to steri-
cal hindrance. On the other hand, it is known that high molecular weight PEGs induce
attractive protein-protein interactions by excluding volume from the environment of the
proteins which could also increase the mAb solution viscosity (see section 9.3.1).
Na2SO4 had a weak increasing impact on the viscosity values. This can be explained
by the kosmotropic character of Na2SO4 (see section 9.3.1). This kosmotropic effect
strengthen the mAb-mAb interactions, which reduces the protein mobility resulting in
an increased viscosity.
9.3.2.4 Thermal Colloidal and Conformational Stability
The accelerated temperature study provide information on the colloidal and conforma-
tional stability of the mAb under stressed conditions. Based on published thermal sta-
bility studies a difference of 1◦C was considered as a significant result and is assumed
to be caused by a stabilizing or destabilizing effect on the protein structure or protein
monodispersity [100, 278–280].
The thermal colloidal and conformational stability of the mAb was tested as a function
of protein concentration, pH, additive type and concentration. In the chosen screening
area one Tagg value and dependent on the condition one (Tm1) or two Tm (Tm1 and Tm2)
values could be detected for each sample. The exact Tm and Tagg values can be looked
up in Table 2a and Table 2b in the supplementary materials.
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Figure 9.4: Tm1, Tm2 and Tagg values of mAb
samples in a concentration range
from 1-180 mg/ml at pH 7 with-
out additive in solution deter-
mined over a temperature ramp
ranging from 20− 90◦C.
In the first part of this section the thermal
conformational stability (Tm) of the anti-
body is discussed. The Tm values which
have been calculated can be directly corre-
lated with the thermal conformational sta-
bility of the antibody. The higher the Tm
value, the higher the energy input required
to unfold the protein (see section 9.1). The
standard deviations of the measurements
did not exceed 1◦C. Except at pH 5 and
120 mg/ml with and without glycine in so-
lution and at pH 9 and 120 mg/ml with
PEG4000 in solution. The high standard
deviations at pH 5 and 120 mg/ml with
and without glycine in solution could be
due to the comparatively low intrinsic flu-
orescence of the antibody. With increasing mAb concentration, the standard deviations
decreased due to the stronger fluorescence signal. The pH dependency of the signal
strength may be due to a changing flexibility of the molecule, which causes the ex-
position of more or less detectable fluorescence amino acids on the mAb surface. The
high standard deviations observed for samples with PEG in solution may be due to the
UV scattering of PEG itself as it is a comparable big molecule and its UV signal may
overlay the scattering of the protein of interest.
To study the impact of mAb concentration the calculated Tm1, Tm2 and Tagg values are
plotted as a function of the protein concentration in Figure 4. The detected Tagg values
are similar for all tested mAb concentrations with a value of about 70◦C. They dominate
the Tm1 values up to a protein concentration of 60 mg/ml. At conditions with mAb con-
centrations of up to 60 mg/mL two fluorescence shifts were detected so that a second Tm
value, Tm2 could be calculated. Tm2 values do have similar values as Tm1 values detected
at higher mAb concentrations. The second shift of the fluorescence signal indicates that
the mAb concentration had an impact on the unfolding pathway of the protein. The
second shift implies a two step unfolding of the protein [278]. A monoclonal antibody
consists of four polypeptide chains which have a differing stability against heat [281].
Assuming that the studied antibody does have a comparable thermal stability behavior
as other monoclonal antibodies, the Fab fragment of the mAb is most sensitive to heat
treatment and denatures first. Underlining this assumption, the measured Tm1 values of
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66◦C are close to Tm values of single domain Fab analysis by Menzen [282]. A partly
unfolding of the variable region of the mAb did not take place at mAb concentrations
higher than 60 mg/ml. The increased mAb concentration seemed to conformational sta-
bilize this region.
In Figure 5 (a) the impact of protein concentration (120 mg/ml and 180 mg/ml), pH,
additive type and concentration on the Tm1 values is depicted. At these conditions no sec-
ond fluorescence shift occurred. The impact of mAb concentration from 120 - 180 mg/ml
on the thermal stability was found to be dependent on the pH. At pH 5 the Tm values are
lower compared to pH 7 and pH 9 and decrease with increasing antibody concentration
by 6◦C. pH 5 is the condition farthest away from the pI of the mAb. It was already found
that the increased net charge of the amino acids result in a reduced density of a protein
due to innermolecular repulsive electrostatic interactions [283]. The less compact protein
leads to a decrease of the Tm values. It is conceivable that the conformational change at
pH 5 is accelerated with increasing mAb concentration due to additional attractive short-
range interactions at 180 mg/ml. At pH 7 and pH 9 the increase of protein concentration
in between 120 and 180 mg/ml only had a small impact on the thermal conformational
stability of the mAb molecules. It is inferred that the innermolecular forces which have
an impact on the 3D structure of the molecule are not affected by a concentration of the
antibody at these pH values. That supports the assumption that electrostatic forces in-
duce the conformational change at pH 5. At pH 7 slightly higher Tm values were detected
in comparison to samples at pH 9. This underlines the findings of Razvi & Scholtz [284]
who stated that the highest protein thermodynamic stability can be found at physiologi-
cal conditions. That implies that antibodies are most conformational stable at conditions
similar to the extracellular matrix (pH 7.3) where they show the highest activity.
The impact of additives on the thermal conformational stability were dependent on ad-
ditive type (Figure 5 (a)). Glycine and Na2SO4 had a slightly positive impact, whereas
PEG4000 had a predominantly negative impact on the determined Tm values. The in-
crease of Tm of around 4% indicates that glycine and Na2SO4 stabilize the 3D structure
of the mAb under high temperature conditions. Glycine is an osmolyte, which are known
to have the ability to preferentially hydrate molecules (see also section 9.3.1). The sulfate
ions of Na2SO4 do have a kosmotropic character [269]. Kosmotropic salts are known to
suppress protein denaturation up to a protein specific salt concentration [88] (see also
section 9.3.1).
With PEG4000 the antibody solutions became opaque at concentrations higher than
120 mg/ml. Due to the high scattering signal the determination of Tm was not possi-
ble with a mAb concentration of 180 mg/ml. Therefore, only the Tm values determined
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Figure 9.5: Comparison of Tm1 (a) and Tagg (b) values of samples with a mAb concentra-
tion of 120 and 180 mg/ml at pH 5, pH 7 and pH 9 with and without selected
additives.
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at 120 mg/ml and PEG4000 in solution can be discussed. The polymer had a negative
impact on the conformational stability of the mAb molecules resulting in a Tm decrease
of up to 9◦C at pH 9. The decreased thermostability of the protein due to the PEG
molecules can be explained by the depletion attraction theory and an accompanied in-
creased osmotic pressure, already discussed in section 9.3.1.
The next section discusses the thermal colloidal stability of the mAb solution by com-
paring the Tagg values of tested conditions. The Tagg values indicate an increase in light
scattering and can thus be correlated directly with the agglomeration of the molecules
in solution at accelerated temperatures. A high Tagg value stands for a high thermal
colloidal stability.
The Tagg values were constant in a concentration range from 1-120 mg/ml (Figure 4).
Interestingly, the partly unfolded state of the antibody, which was detected by fluores-
cence measurements, did not have an impact on the Tagg values. This implies that the
amino acids exposed by the partial unfolding do not influence the colloidal stability of the
antibody. From 120-180 mg/ml the Tagg values increased for all pH values tested (Figure
5). This phenomenon may be explained by a reduced movement of the molecules due to
sterical hindrance at 180 mg/ml. The reduced number of molecule collisions implies a
deceleration of the aggregation kinetic.
At pH 5 higher Tagg values were detected in comparison to pH 7 and pH 9. The above
discussed stronger net charge of the protein at pH 5 may lead to a weaker thermal confor-
mational stability but increases the thermal colloidal stability by repulsive electrostatic
interactions.
Glycine increased the Tagg values of samples at pH 5 and pH 7 with a protein concentra-
tion of 120 mg/ml. Also at pH 9 at 120 and 180 mg/ml an increasing trend of Tagg due to
the addition of glycine could be observed. However, the changes were within experimental
error and are therefore not discussed. At pH 7 and a mAb concentration of 180 mg/ml
glycine decreased the Tagg by 2◦C.
PEG4000 had a decreasing impact on the determined Tagg values. With increasing
PEG4000 concentration the Tagg values decreased by 5◦C. A major drop of Tagg val-
ues with PEG4000 in solution indicates an increase of mAb-mAb interactions due to the
polymer. It is assumed that the reduced colloidal thermal stability is caused by similar
mechanisms, such as the reduced conformational stability.
Na2SO4 is a kosmotropic salt and therefore stabilizes the 3D structure but is also known
to destabilize the colloidal stability of proteins [88]. Thus, the temperature induced un-
folding should be reduced but the aggregation of mAb molecules intensified by the ad-
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dition of Na2SO4. Decreased Tagg values could only be observed for samples at pH 7,
a Na2SO4 concentration of 160 mM and a mAb concentration of 120 mg/ml with a
reduction of 12◦C. Here, the kosmotropic salt seemed to strengthen the hydrophobic
protein-protein interactions, resulting in an increased aggregation propensity [258]. At
higher protein concentrations or lower salt concentration the salt-protein-ratio is lower,
resulting in a lower impact of the kosmotropic salt and therefore no change of the mea-
sured Tagg values. This assumption could be validated by rising the salt concentration
at a mAb concentration of 180 mg/ml to 260 mM. Here also a certain drop of the Tagg
values could be observed, similar to the Tagg decrease observed for a mAb concentration
of 120 mg/ml (data not shown).
Important information also provides the location of Tagg and Tm in relation to each other.
If Tagg is higher than Tm, it can be assumed that even under isothermic conditions, the
molecule unfolds first and then aggregates and vise versa. Only at pH 7 and low mAb
concentrations (1-60 mg/ml) (Figure 4) and at pH 5 and mAb concentrations up to
180 mg/ml (Figure 5) the Tagg values dominate the Tm values. But, the discussed partly
unfolding of the antibody at low concentration conditions did not have an impact on the
thermal colloidal stability.
At pH 7 and pH 9 and mAb concentrations of 120 and 180 mg/ml the Tm values dominate
the Tagg values. At these conditions the aggregation kinetic is therefore faster than the
unfolding kinetic. Summarizing these observations, the colloidal stability is lower at pH 7
and pH 9 in comparison to pH 5 but a conformational destabilization at pH 5 due to
repulsive innermolecular interactions should be included for optimal buffer selection.
9.3.2.5 A Comprehensive View: Determination of Protein Solution Viscoelasticity
To study the complex rheological behavior of the mAb solutions the rheological parame-
tersG′ andG′′ were determined over a set frequency range. The value of these parameters,
more specifically their ratio at the different frequency points provide insights into the re-
laxation behavior of the proteins in solution [158]. The relaxation behavior in turn is
influenced by spatial limitations and the strength of molecule-molecule interaction. The
measurable relaxation behavior of the protein solution is thus directly linked to the so-
lution stability of the protein samples tested [218]. Stronger protein-protein interactions
increase the relaxation time and therefore result in a higher solution viscoelasticity. This
relation can be precisely described by the frequency value of the crossover point of G′
and G′′ , ωCO. The higher the rigidity of the system due to attractive interactions is the
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lower the ωCO values. Additional to the strength of protein-protein interactions, the ωCO
value is dependent on the size and structure of the protein itself. Under conditions where
the protein-protein interactions of two proteins are equally pronounced, a small, globular
protein exhibits higher ωCO values than a larger, structurally more complex protein. The
threshold value ωlimit can be used as a reference point. Above ωlimit protein solutions
are expected to be stable, below this value samples are expected to be colloidal unstable.
The ωlimit for lysozyme is 20000 rad/sec [218]. Since the antibody of this study has a ten
fold higher molecular mass as lysozyme and is not spherically shaped, the ωlimit value
of the mAb is expected to be lower. Additionally, liquid formulations which exhibit ωCO
values below 1000 rad/sec are generally expected to be unstable.
The standard deviations of the viscoelastic measurements were in between 0.06 - 4 %
except for conditions with PEG4000 in solution. Here, standard deviations of up to 30 %
were observed. This decreased reproducibility may be due to the additional viscoelastic
response of the PEG molecules. The calculated ωCO values of this screening varied in
relation to the studied protein concentration, pH as well as the additive type. The shift
of the ωCO values in relation to the changing solution conditions are discussed in the
next section.
In Figure 6 the impact of mAb concentration and pH without additives (a) and the im-
pact of mAb concentration and additive in solution at pH 5 (b), pH 7 (c) and pH 9 (d)
on the rheological response is shown.
The highest ωCO values were detected for low mAb concentrations at pH 5 with a value of
24043 rad/sec. The lowest ωCO values for samples without additive in solution were cal-
culated for pH 7 ranging from 21770 rad/sec at 50 mg/ml and 607 rad/sec at 200 mg/ml.
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Figure 9.6: Viscoelastic response of mAb samples without additive in solution dependent
on protein concentration and pH (a). Impact of pH with additive in solution,
namely 160 mM glycine (b), 150 mM Na2SO4 (c) and 2 (m/V)% PEG4000
(d) on the viscoelastic response. The grey area symbolizes the critical ωCO
region. Above this region the viscoelastic response indicates stable mAb so-
lutions. ωCO values below this region indicate samples which might undergo
phase transition.
With increasing protein concentration the ωCO values decreased (see Figure 6 (a)). The
increased viscoelasticity, indicated by an ωCO decrease, of the samples can be explained by
the concomitant shortened distance between the individual molecules. At low concentra-
tions, electrostatic forces dominate, which are repulsive with similarly charged molecules.
In the case of a concentration increase, the influence of the short-range interactions, which
have attractive properties, and thus limit the mobility of the molecules in solution, is in-
creased. This mobility constraint is associated with an increase in solution elasticity and
thus with a reduction of the ωCO values. The decrease of the ωCO values with increasing
protein concentration depended on the pH value of samples tested. The drop of the ωCO
was more pronounced at pH 7 and pH 9 in comparison to samples at pH 5. For samples
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at pH 5 the ωCO decreased by 33 % comparing samples with a protein concentration of
50 mg/ml and 200 mg/ml. At pH 5 the molecules in solution could follow the applied
movement up to high frequency values also at higher mAb concentrations. That implies
that even at high mAb concentrations the molecules could move along each other with-
out strong resistance due to the strong repulsive interactions, triggered by similar net
surface charge of the molecules. At pH 7 and pH 9 a decrease of 97 % and 98 %, respec-
tively occurred, resulting in a ωCO values below 1000 rad/sec for samples with a mAb
concentration of 200 mg/ml. The strong decrease of ωCO values with increasing protein
concentration implies that the type and strength of protein-protein or protein-solvent
interactions changed when increasing the protein concentration at pH values close to the
pI. It is assumed that short-range interactions which occur in the highly concentration
regime have a bigger impact on samples at pH 7 and pH 9 in comparison to pH 5. As
the impact of pH on the viscoelastic behavior is comparable to the impact on orthogo-
nal analytical parameters a detailed argumentation can be found in section 9.3.2.1 and
section 9.3.2.4.
To emphasize the impact of the pH on the viscoelastic response in Figure 6 (b)-(d) the
differences of the ωCO values at pH 5, pH 7 and pH 9 with 150 mM glycine, 2 (m/V)%
PEG4000 as well as 160 mM Na2SO4 and the ωCO values without additive in solution
are plotted against the protein concentration. At a mAb concentration of 50 mg/ml the
impact of the additives on the rheological response was comparatively low. At pH 5 and
pH 9 the ωCO values with and without additive and a mAb concentration of 50 mg/ml
are within experimental error (Figure 6 (b) and (d)). At pH 7 the used additives had a
comparatively small impact at all mAb concentrations tested (Figure 6 (c)).
The following discussion is structured based on the additive studied.
The impact of glycine on the viscoelastic behavior of mAb samples depended on the
pH. At pH 5 (Figure 6 (b)) glycine decreased the ωCO values at all mAb concentrations
tested and therefore strengthened the viscoelasticity of the protein solution. Glycine is
a zwitter ion and has the ability to interact with the protein surface with both its neg-
ative and positive charged groups [285]. The mAb molecule has a positive net charge
at pH 5. The electrostatic repulsive interactions of the molecules could thus be reduced
due to the specific interaction of glycine ions with positively charged surface groups of
the mAb molecules. Additionally it was shown that glycine can also interact with the
peptide backbone of proteins which plays an important role in protein stabilization.[92,
286, 287]. The impact of glycine on the ωCO values changed with increasing pH value
and increasing mAb concentration. The negative impact of glycine on the ωCO values
decreased comparing samples at pH 5 and pH 7 with each other (Figure 6 (c)). At pH 9
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(Figure 6 (d)) glycine even increased the ωCO values of the mAb solution significantly
in a concentration range from 100 - 200 mg/ml by 20 to > 100%. It is assumed that
close to the pI of the molecule, the specific electrostatic interaction of negatively charged
glycine ions and positively charged patches on the mAb surface are dominated by the
competition for water between the protein and the co-solute. This leads to the preferen-
tial exclusion of glycine from the protein surrounding and thus to an increased protein
solubility (see also section 9.3.1). This observation matches the findings of the thermal
stability enhancement discussed in the previous section (section 9.3.2.4). It has to be em-
phasized that glycine decreased the ωCO values at pH 5 but only down to 10000 rad/sec.
This value is still above ωCO values calculated for samples at pH 7 and pH 9. Addition-
ally, the decrease of ωCO values due to the addition of glycine at pH 5 was low compared
to the impact of PEG4000 and Na2SO4.
At pH 5 the impact of PEG4000 (Figure 6 (b)) on the ωCO values strengthened with
increasing protein concentration. The polymer seemed to decrease the repulsive effect of
the positively charged groups on the mAb surface. As already described in section 9.3.2.3
the polymer may hinder the molecular movement due to sterical hindrance or due to the
destruction of the protecting hydration shell of the mAb molecules [288]. The same effect
can be seen for samples at pH 9 (Figure 6 (d)). The impact was most pronounced at
180 mg/ml with a ωCO difference of -5600 rad/sec compared to samples without PEG in
solution. It is assumed that a further decrease of the ωCO values at pH 9 and 200 mg/ml
with PEG4000 could not be seen because the ωCO values without PEG4000 and similar
conditions were already below 200 rad/sec, which is close to the lower detection limit
of the instrument used (100 rad/sec) [138]. At pH 7 (Figure 6 (b)) in comparison, the
PEG4000 molecules seemed to have a positive impact on the flow behavior in a concen-
tration range from 150 - 200 mg/ml. The strong viscoelasticity (low ωCO values) which
was detected for samples at pH 7 could be reduced with the addition of PEG4000. The
decreasing elastic behavior of mAb solutions at these conditions may be explained by a
decrease of short-range interactions caused by a specific binding of the non polar PEG
molecules on the molecular surface [260, 289]. The impact of PEG4000 on mAb solu-
tion viscoelasticity is complex and can be interpreted in terms of several opposing factors
which depend on the solution pH and the ratio of PEG and protein molecules in solution.
This balance of opposing factors has already been described by Arakawa & Timasheff
[256] who studied the impact of PEG concentration and molecular mass on the confor-
mational and colloidal stability of β-Lactoglobulin.
Na2SO4 as an additive had a decreasing impact on the ωCO values of mAb samples in a
concentration range from 50-150 mg/ml at pH 9 (Figure 6 (d)). Here, the addition of the
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kosmotropic salt leveled the ωCO values down to 8000 rad/sec with an ωCO difference of
-8500 rad/sec in comparison to samples without Na2SO4 in solution. The sulfate ions
strengthen the hydrophobic interactions of the anyhow low charged proteins. In this way
the movement of the individual molecules was hindered which leads to a significant de-
crease of ωCO. It is assumed that the salt at pH 7 had a similar effect on the interactions
of the mAb molecules as at pH 9. However, the adjusted pH value had such a strong
influence on the rheological response of the samples that the effect of the salt on the
solution viscoelasticity was overlaid by the pH effect. At pH 5 where the mAb molecules
have a stronger net surface charge, the concentration of sulfate ions was too low to induce
strong hydrophobic interaction and thus a drop of the ωCO values.
At pH 9 and higher protein concentrations the salt seemed to have an opposite effect on
the viscoelasticity of mAb samples (Figure 6 (d)). At 200 mg/ml the ωCO values with
salt in solution were higher compared to samples without salt in solution. Here an ωCO
increase of +8100 rad/sec was observed. That implies that the strength of protein-protein
interaction decreased due to the addition of Na2SO4 starting at a mAb concentration of
200 mg/ml. Du & Klibanov [290] assumed that in highly concentrated protein solutions
kosmotropic salts do not induce hydrophobic protein-protein interactions but may com-
pete with hydrophobic protein-protein interactions which are assumed to be the dominant
stability decreasing factor at pH 9. Additionally, in this study the concentration of the
salt was kept constant while the mAb concentration increased, therefore the protein-salt
ratio varied with increasing protein concentration. A reason for the differing impact of
Na2SO4 with increasing protein concentration could thus also be found in the changing
protein-salt ratio. It is assumed that at low mAb concentrations up to 150 mg/ml, the
salting-out effect was dominant what causes an increased elasticity and therefore lower
ωCO values. At high protein-salt ratios the salting-in effect might be dominant. Here,
the salt interacts favorable with charged residues and stabilized the protein in solution
(see section 9.3.1). The mAb concentration dependent impact of Na2SO4 supports the
assumption that the type of protein-protein interaction changes with increasing protein
concentration.
In summary, the pH value had the main impact on the viscoealstic response of the mAb
samples tested. A clear differentiation between the viscoelastic behavior at pH 7, pH 9
and pH 5 could be made. The impact of the additives depended on the additive type, pH
value and also the protein concentration.
Based on the correlation of the ωCO values with the long-term stability tests (section
9.3.3) a critical range could be defined were the mAb solution is assumed to undergo phase
transition. This area is marked in grey in Figure 6. Above an ωCO value of 10000 rad/sec
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the mAb molecules are predicted to be colloidal stable below this limit, aggregation of
the mAb molecules can be expected. This knowledge enables the description of mAb
phase behavior based on one single rheological measurement.
9.3.3 Long-term Solution Stability
To be able to correlate the analytical investigations with mAb solution stability mAb
phase diagrams were studied. The prepared protein phase diagrams were visually scored
after 40 days of incubation following the method of Baumgartner et al. [88]. Consequently,
long-term stability is equated with 40 days of incubation in this study. The results of the
long-term solution stability results are only discussed when a deviation from the described
analytical results occurred (see section 9.3.2). In Figure 7 (a)-(c) the visual scoring of the
mAb phase diagrams made after 40 days of incubation (t40) are plotted. The long-term
colloidal stability of the mAb in a pH range from pH 5 - 9, with a protein concentration
of 120 - 225 mg/ml and the additives glycine, PEG4000 and Na2SO4 was tested. The
first area symbolizes conditions without additive in solution at all three subplots.
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Figure 9.7: Scoring of the phase behavior of mAb in a pH range from 5-11, a protein
concentration range from 120-225 mg/mL and (a) 0-250 mM glycine, (b)
0-2 (m/V)% PEG4000 and (c) 0-200 mM Na2SO4 visualized as 3D plots.
The scoring was done after 40 days of incubation at a constant temperature
of 20◦C based on the visual evaluation of the pictures taken by the Rock
Imager. The blue round symbols stand for samples containing soluble mAb
molecules, the small light red squares symbolize light precipitation in the
middle of the well and the dark red squares symbolize heavy precipitation.
The mAb colloidal long-term stability was mainly dependent on pH and additive type. At
pH 5 the mAb molecules were soluble at all tested conditions. It is assumed that mainly
repulsive electrostatic forces hinder the antibody to form aggregates also in the highly
concentrated regime. At pH 7 the mAb was least stable. Precipitation occurred over the
whole tested mAb concentration range. It is assumed that strong hydrophobic and dipole
induced interactions are responsible for this instability. Interestingly, the region where
the mAb is colloidal stable increases at pH 9 in comparison to pH 7. The theoretical
pI of the mAb molecules is 8.7. Theoretically, that implies that repulsive interactions
are further reduced when shifting the pH from pH 7 to pH 9. The decrease of repulsive
electrostatic forces allows the reduction of the molecular distance and thus an enhance-
ment of the attractive hydrophobic and dipole induced short-range forces. Therefore, a
reduced colloidal stability at pH 9 would have been expected. An explanation for the
higher stability of the antibody at pH 9 could be found in the charge distribution of the
mAb surface which may differ between pH 7 and pH 9. The charge distribution can have
a substantial impact on the attractive forces between the molecules [291]. In order to be
able to examine the charge distribution in more detail, molecular dynamics simulations
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have to be carried out, which are part of future studies.
In Figure 7 (a) the scoring of the phase diagrams with glycine as an additive is shown. At
pH 7 precipitates were detected at almost all samples. At pH 9 precipitation occurred with
a protein content of 135 mg/ml and glycine concentrations from 100 - 250 mM. At higher
mAb concentrations glycine seemed to stabilize the protein. In comparison PEG4000
destabilized the molecule at pH 9 (see Figure 7 (b)). Here precipitation occurred starting
at mAb concentrations of 150 mg/ml. PEG4000 seemed to have a stabilizing character
at pH 7 starting at protein concentrations of 195 mg/ml and PEG4000 concentrations
of 0.8 (m/V)%. At these conditions only low precipitation in the middle of the well or
soluble samples were detected. Na2SO4 did have a stabilizing character on the tested
mAb at pH 9 in a mAb concentration range from 180 - 225 mg/ml with 75 - 200 mM
Na2SO4, and destabilized the mAb at lower protein concentrations (see Figure 7 (c)).
At pH 7 strong precipitation occurred for all samples containing Na2SO4.
A detailed discussion of the impact of pH on the mAb colloidal stability as well as the
impact of used additives can be found in section 9.3.1 and section 9.3.2).
9.3.4 Comparison of Analytical Methods and Protein Long-term Stability
In this section the analytical methods which were applied in this study are combined
to describe the long-term solution stability of the mAb samples screened. Therefore, a
scoring had to be introduced, which is able to classify the analytical results concerning
their statement about protein stability. The correlation presented here has its focus on
the descriptiveness of the colloidal antibody stability under tested conditions.
To keep it simple all analytical results were normalized and a scoring from 0 to 10 de-
fined. Whereby 10 is a result indicating a high colloidal stability and 0 an analytical
result indicating a weak solution stability of the screened mAb. For the SEC analytics a
score of 10 was set for the maximal monomer content (96.7%) and a score of 0 was set
for the lowest monomer content (94.8%) observed, as it is assumed that a high monomer
content at t0 is an indicator for a high long-term colloidal stability. A ζ-potential of 0
(scoring value 0) indicates weak electrostatic repulsion and therefore an increased aggre-
gation propensity. The maximum ζ-potential of this study with a value of 5.7 mV was
normalized to 10. A high viscosity is unfavorable for liquid formulations and may be
correlated to strong protein-protein interactions, therefore the maximum viscosity value
of this screening (11.7 mPa/s) was normalized to 0, the minimum value (2.6 mPa/sec)
to 10. Temperature ramps are commonly used to fasten up the degradation and aggre-
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gation process of protein solutions and were successfully correlated to long-term stability
[100, 292, 293]. It was shown that the melting temperature is only predictive in cases
where degradation is linked to unfolded protein structure [282, 294, 295]. In this study
the aggregation kinetic was not dependent on the unfolding kinetic. Wherefore, the Tagg
and not the Tm values of this study were used to describe the solution stability of the
antibody. The maximal Tagg value (74 ◦C) was normalized to 10 and the minimal Tagg
value (61 ◦C) was normalized to 0. Furthermore, it could be shown that the viscoelastic
characteristic of a molecule in solution directly correlates with the long-term solution sta-
bility [218]. The characteristic ωCO value determined by frequency sweep measurements
is maximal (24043 rad/sec) at minimal aggregation propensity (score=10) and minimal
(256 rad/sec) at maximal aggregation propensity (score=0). The so determined scoring
values were weighted equally, summed and divided by the amount of scores used for the
specific sample. The scoring values can be found in the supplementary materials (Table
3).
The scoring results are visualized with the help of a surface plot to ensure an easy com-
parison with the long-term stability results (see Figure 8 (a)). To simplify the comparison
the long-term stability scoring of similar samples is plotted next to the analytical scoring
(see Figure 8 (b)). The red areas in Figure 8 (a) mark conditions were the mAb is pre-
dicted to be unstable. Blue areas symbolize conditions were the mAb is predicted to be
stable. The surface plot enables an easy detection of conditions which are predicted to
be stable and robust (in blue) as well as screening points which may be sensitive towards
slight changes of the molecular surrounding (e.g. pH 9, 180 mg/ml, 160 mM Na2SO4).
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Figure 9.8: Scoring of analytical results is shown in relation to their statement about
the long-term colloidal stability. The scoring of the phase behavior at t40 of
similar samples is depicted on the right hand side for an easier comparison.
The colloidal stability of the mAb is predicted to be dependent on protein concentra-
tion, pH and additive type. The most stable region was predicted to be at pH 5 without
additive in solution at 120 mg/ml. For mAb samples at pH 9, a mAb concentration of
180 mg/ml with the addition of PEG4000 the smallest scoring value was calculated.
In general, the colloidal solution stability could be described very well with the help of
the analytical toolbox and the defined scoring. The prediction, that samples at pH 5
are most stable, glycine does have a stabilizing character on mAb samples, Na2SO4 and
PEG4000 do have a destabilizing effect dependent on pH and mAb concentration, could
be confirmed with long-term stability tests. It is particularly to be emphasized, that the
stabilizing character of Na2SO4 at pH 9 and 180 mg/ml and the strong destabilizing
effect due to the addition of PEG4000 at similar conditions could be described correctly.
However, not sufficiently visible is the precipitation of the antibody at pH 7 with and
without additive in solution. The scoring was pushed to values around 4 due to the im-
pact on the scoring of low viscosity values measured at these conditions. At pH 7 and
120 mg/ml with and without additive in solution the viscosity was even lower than for
samples at pH 5, what resulted in viscosity scoring values above 9. The viscosity dif-
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ferences between pH 5, pH 7 and pH 9 were explained by the electroviscous effect (see
section 9.3.2.3). This effect may be helpful to explain the solution fluidity but may not
have an impact on the long-term colloidal stability, especially at mAb concentrations
equal or below 120 mg/ml. Here, the repulsive interactions at pH 5 expand the molec-
ular size and therefore increase viscosity but on the other hand increase the colloidal
stability due to strong electrostatic repulsion. SEC measurements, thermal stability test,
ζ-potential measurements and the study of mAb viscoelasticity described the instability
of mAb solutions at pH 7 correctly, whereby the wrong description based on viscosity
measurements could be partly compensated.
The protein concentration dependent impact of the additives Na2SO4 and PEG4000 was
described correctly but the effect was damped due to the insensitivity of ζ-potential and
thermal stability tests. In this study, the ζ-potential results contained important informa-
tion at conditions where electrostatic interactions dominated the repulsive or attractive
forces of solved proteins in solution, this means at ideal dilute conditions and without
additives in solution. At higher protein concentrations and with the addition of additives
the influencing factors on the protein solution stability become more complex and can-
not be depicted by protein surface charge characterization alone. The results of thermal
stability tests were more or less unaffected in relation to the changing impact of the ad-
ditives. Here, it becomes clear that different processes can occur at isothermal long-term
stability tests in comparison to accelerated temperature tests. The discrepancies between
thermal and isothermal long-term stability tests were already described [100, 252] but
so far there is no explanation why and when the discrepancy occurs. Therefore, it is
important especially in the highly concentrated regime to combine the thermal stability
tests and ζ-potential measurements with other biophysical characterization techniques
to overcome these insensitivities. The viscoelastic characterization of the mAb solutions
was found to be a reliable tool to describe the behavior of the mAb molecules in the
solution. Whereby the impact of protein concentration on the colloidal stability of the
antibody was slightly overestimated. This overestimation may be due to the formation
of structured mAb networks, which would increase the elastic portion of the probe and
result in lower ωCO values but would have a positive impact on the long-term colloidal
stability [296, 297].
The listed results illustrate the limits of used analytical techniques and the importance
of the combined use of orthogonal tools to be able to describe the long-term solution
stability at varying conditions correctly.
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9.4 Conclusions
The work presented here proposes the use of an analytical toolbox to describe the long-
term stability of highly concentrated antibody solutions. The evaluation of protein mo-
bility, rheology and the thermal stability studies of mAb solutions revealed a sensitivity
of the studied antibody towards mAb concentration, pH, additive type and concentration
with regard to the colloidal solution stability. At pH 5 the antibody solution stability was
described to be highest. Here the molecule was resistant against colloidal instability up to
protein concentrations of 200 mg/ml and also unaffected by the addition of PEG4000 and
Na2SO4. Glycine was described to further stabilize the molecule also at pH 7 and pH 9.
PEG4000 and Na2SO4 were described to have a destabilizing impact on the antibody,
except of pH 9 at high protein concentrations, where Na2SO4 was assumed to have a
stabilizing impact on the molecule.
The scoring of the novel and established techniques could be correlated successfully with
long-term stability experiments. Not only the description of the protein behavior became
possible but also a detailed characterization of the extend and type of protein-protein
interaction. Furthermore, the study demonstrates the strength and weaknesses of the
different techniques applied and that the description of the mAb phase behavior could
only be achieved by a combination of these techniques. The SEC chromatography re-
sults were a good starting point to make first rough assumptions about the long-term
stability of the antibody solutions based on soluble aggregates formed immediately af-
ter preparation. ζ-potential measurements localized correctly the pH range where only
weak electrostatic interactions induce repulsive forces. However, with the study of the
surface net charge it was not possible to differentiate between stabilizing and destabi-
lizing effects of studied additives. It was shown that an increase of viscosity does not
always correlates with antibody long-term stability. Reasons for the increased viscosity
at pH 5, where the antibody was found to be most stable, were discussed and explained
with the electroviscous effect. The colloidal and conformational thermal stability of the
antibody revealed insights into the unfolding and aggregation kinetics. Most conditions
where the additives did have an impact on the antibody solution stability were described
correctly by this high throughput compatible method. Here, only the sensitivity towards
concentration dependent interactions of co-solutes with the antibody surface could not
be depicted sufficiently. The sensitivity towards the pH and protein concentration de-
pendent impact of studied co-solutes could be achieved by characterizing the viscoelastic
behavior of the antibody solution. The ωCO values could be correlated directly with the
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observed antibody phase behavior after forty days of incubation.
The combined statement of the applied techniques resulted in a precise characterization
of the antibody behavior and a very good description of the long-term solution stability
under tested conditions. Further studies are required (e.g. study of the surface hydropho-
bicity) to refine the scoring of the applied analytical techniques for an even more precise
description. Additionally, the development of a high throughput compatible setup of the
used analytical tools is part of future work to enable an easy and fast description of
protein solution stability. Despite the potential of further development the presented and
evaluated analytical toolbox is a very important step towards an easier main candidate
selection and strategic buffer optimization so that product stability can be ensured.
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Supplementary Material
A1-Preliminary Experiments
In order to be able to select additives, which have an impact on the mAb solution stabil-
ity, DLS measurements were carried out. With the help of the DLS measurements and the
Stokes-Eisntein equation, the hydrodynamic radius (rh) of the antibody was determined
as well as higher molecular weight species detected. The increase of the rh of the mAb
and the detection of higher molecular weight species indicate a colloidal destabilization
of the mAb [115, 298]. A reduction of rh as well as the complete elimination of higher
molecular weight species indicate a stabilizing character of the tested additive. additives
with a visual pH and concentration dependent impact will be selected for the actual
study. First, the reference value of the antibody without additives was determined at pH
5, 7 and 9. The additive was then added to this solution in the lowest concentration and
measured after an hour of waiting time. This procedure was repeated with increasing
additive concentration. Glycine decreased the rh of the mAb at pH 7 and pH 9 with in-
Table 9.1: Type and concentration of additives used for pre-tests.
additive cadditive [M]
glycine 0.05 0.1 0.15 0.2 0.25 0.3
glycerol 0.01 0.02 0.03 0.04
D-sorbitol 0.02 0.04 0.06 0.08
PEG4000 0.002 0.004 0.006 0.008 0.01
Na2SO4 0.06 0.08 0.1 0.12 0.14 0.16
NaI 0.025 0.05 0.1 0.15 0.2 0.4 0.8
creasing glycine concentration. At pH 5 the rh decreased with the addition of glycine but
was not glycine concentration dependent. With glycine in solution no higher molecular
weight species could be detected. Glycerol and D-sorbitol had a comparable impact on
the antibody tested. At pH 5 and pH 7 a slight increase of the rh of the mAb was observed
whereas at pH 7 a slight decrease appeared. The impact of osmolyte concentration was
not as pronounced as for glycine. PEG4000 had a strong increasing impact on the rh of
the mAb and also on the development of higher molecular weight species for all pH values
tested. The effect was mostly pronounced at higher PEG concentrations and at pH 7.
With the addition of Na2SO4 the rh of the mAb molecules increased. This effect was
Na2SO4 concentration dependent at all pH values tested. NaI had an increasing impact
on the rh at pH 5 comparable to Na2SO4. At pH 7 instead low NaI concentrations had
a strong increasing impact on the rh of the mAb. This effect decreased with increasing
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NaI concentration to a marginal small effect at the maximal NaI concentration (800 mM)
tested. At pH 9 the impact of NaI as a n additive on the mAb rh could not been tested
due to immediate precipitation.
A2-Results Thermal Stability
Table A2a: Results of the thermal stability test. Listed are average values (duplicate
measurement) of Tm1, Tm2 and Tagg of all samples tested.
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Table A2b: Results of the thermal stability test. Listed are average values (duplicate
measurement) of Tm1, Tm2 and Tagg of all samples tested.
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A3-Scoring Values Analytical Toolbox
Table A3: Scoring values of the analytical methods applied. The raw analytical results
were normalized and a scoring from 0 to 10 defined. Whereby 10 is a result indicating a
high colloidal stability and 0 an analytical result indicating a weak solution stability of
the screened mAb.
120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml
SEC monomer 10.00 8.64 1.47 0.15 3.53 1.38
thermal stability Tagg 5.20 9.75 3.34 7.44 0.01 2.12
viscosity  9.31 1.79 9.93 4.56 9.92 4.69
charge -potential 10.00 10.00 2.98 2.98 0.11 0.11
viscoelasticity CO 10.00 7.47 3.93 0.55 5.72 2.61
AVERAGE VALUE 8.90 7.53 4.33 3.14 3.86 2.18
120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml
SEC monomer 9.84 9.14 3.88 4.36 2.83 3.21
thermal stability Tagg 8.40 10.01 4.37 6.29 1.87 3.85
viscosity  9.12 2.06 10.00 6.33 9.89 4.31
charge -potential 0.44 0.44 3.08 3.08 0.55 0.55
viscoelasticity CO 8.55 4.37 3.30 0.70 7.03 3.38
AVERAGE VALUE 7.27 5.21 4.92 4.15 4.43 3.06
120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml
SEC monomer - - - - 0.48 0.05
thermal stability Tagg - - - - 7.63 -
viscosity  - - - - 8.68 0.45
charge

-potential 1.75 1.75 0.52 0.52 0.61 0.61
viscoelasticity CO 9.31 6.43 4.10 2.10 5.03 0.00
AVERAGE VALUE 5.53 4.09 2.31 1.31 4.49 0.15
120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml 120 mg/ml 180 mg/ml
SEC monomer - - 0.99 0.53 - -
thermal stability Tagg - - 3.40 5.81 - -
viscosity  - - 9.72 5.29 - -
charge

-potential 2.19 2.19 0.69 0.69 1.36 1.36
viscoelasticity CO 8.80 7.41 4.60 0.18 1.71 4.58
AVERAGE VALUE 5.49 4.80 3.88 2.50 1.54 2.97
pH 5 pH 7 pH 9
analytical method parameter
pH 5 pH 7 pH 9
scoring - no additive
scoring - glycine
scoring - PEG4000
scoring - Na2SO4
analytical method parameter
pH 5 pH 7 pH 9
pH 5 pH 7 pH 9
analytical method parameter
analytical method parameter
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Abstract
Microrheological measurements prove to be suitable to identify rheological parameters
of biopharmaceutical solutions. These give information about the flow characteristics
but also about the interactions and network structures in protein solutions. For the
microrheological measurement tracer particles are required. Due to their specific surface
characteristic not all are suitable for reliable measurement results in biopharmaceutical
systems. In the present work a screening of melamine, PMMA, polystyrene and surface
modified polystyrene as tracer particles were investigated at various protein solution
conditions. The surface characteristics of the screened tracer particles were evaluated by
zeta potential measurements. Furthermore each tracer particle was used to determine the
dynamic viscosity of lysozyme solutions by microrheology and compared to a standard.
The results indicate that the selection of the tracer particle had a strong impact on the
quality of the microrheological measurement dependent on pH and additive type. Surface
modified polystyrene was the only tracer particle that yielded good microrheological
results for all tested conditions. The study indicated that the electrostatic surface charge
of the tracer particle had a minor impact than its hydrophobicity. This characteristic was
the crucial surface property that needs to be considered for the selection of a suitable
tracer particle to achieve high measurement accuracy.
Keywords: Microrheology; Polymer Protein Interaction; Dynamic Viscosity; Hydropho-
bicity; Tracer Particle
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With the trend towards concentrated biotherapeutics flow characteristics gain increasing
relevance for the pharmaceutical process and formulation development. One key issue is
the increasing viscosity of these concentrated protein solutions, which affects the outcome
of different processing steps like filtration and formulation [246]. For filtration the viscous
solutions are more difficult to pump and can even clog filtration membranes [299]. For
formulation the high viscosity of a solution hinders a subcutaneous delivery by syringe
[300].
With the help of rheological measurements information about the flow characteristics
of protein solutions can be obtained to prevent, predict and manipulate high viscosity.
Besides the basic information about the dynamic viscosity of the solution these measure-
ment methods enable the determination of complex rheological parameters like storage
and loss modulus, G′ and G′′, which can be used to interpret the interactions and struc-
tures formed between the proteins [127, 301]. In comparison to other complex systems,
like polymer solutions, pharmaceutically relevant protein solutions show a weak network
formation and therefore the existing elastic behavior is difficult to detect. Hence rheolog-
ical methods that are able to characterize low elastic behavior are required. Aggravating
for the downstream process and formulation development the available protein volumes
are very low and therefore expensive. So only small samples can be used for the analyti-
cal screenings of highly concentrated solutions. Conventional measurement methods like
cone-plate, plate-plate rheometers or capillary viscometers often do not meet these re-
quirements [20]. Methods with the possibility to measure in the high frequency region and
require low sample volumes are high frequency rheological [202, 302] or microrheological
measurements. High frequency rheological measurements are based on devices, which are
able to create frequencies in the kilohertz region. They have already been established for
the investigation of proteins Saluja et al. [20] and Schermeyer et al. [218]. Yet there are
only few suitable devices, which all represent prototypes and never got into production
[127, 142]. In contrast to the high frequency rheological measurements, microrheological
measurements can be performed by common dynamic light scattering (DLS) or diffusing-
wave spectroscopy (DWS) devices. This analytical technique is already established in the
biopharmaceutical process development. The principle of this method is based on the
diffusion of a particle D dependent on its hydrodynamic radius rh, the thermal energy
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kT and the network structure of the surrounding environment. For the determination of
the dynamic viscosity η the Stokes-Einstein equation can be applied
D =
kT
6pirhη
. (10.1)
For the determination of the complex moduli G′ and G′′ a more complex analysis needs to
be performed [147]. In both cases tracer particles of known size are necessary to determine
microrheological parameters. These particles are required to be considerably larger than
the size of the studied molecule and should not interact with the surrounding solution.
Tracer particles smaller in size would not accurately measure the bulk properties. Interac-
tions caused by the surface characteristics of the particle would falsify the measurement
data and therefore the rheological information [147, 303]. Currently tracer particles of dif-
ferent material are used to perform microrheological measurements of protein solutions.
They consist of materials such as melamine [146], Poly(methyl methacrylate) (PMMA)
[304], polystyrene (PS) [148] or surface modified polymers [305]. Amin, Rega & Jankevics
[146], Valentine et al. [305] and Gilroy, Hicks, Smith & Rodger [306] found that the selec-
tion of the tracer particles has an impact on the microrheological measurement quality for
protein solutions. One material, which is often reported to interact with its surrounding
or with itself, is polystyrene [303, 307]. The reason could be found in its surface charac-
teristics. By modification of the surface these particles showed less interaction [308, 309].
Looking at these findings good microrheological practice is based on a thorough selection
of tracer particles. Knowledge to evaluate the functionality are required.
In order to fill this gap we performed a screening of four different tracer particles for mi-
crorheological measurements of lysozyme solutions, used as a model system. Melamine,
PMMA, polystyrene and surface modified polystyrene, namely PEG-PS, were selected
to find out about their surface characteristics and hence their impact on measurement
quality at various system conditions. These conditions were represented by the different
lysozyme concentrations, pH-values, plus varying additives. At these conditions the sur-
face characteristics of the tracer particles were studied by zeta potential measurements.
The change in the electrostatic potential allowed conclusions about possible interactions
in solution. To identify its actual impact on the microrheological measurements the dy-
namic viscosity of the selected solutions was determined. The results gained with the
different tracer particles were compared to results of high frequency rheological mea-
surements. This measurement method was already successfully implemented by several
scientific groups [20, 202, 218, 302] and is therefor used as a standard.
180
10.2 Materials and Methods
10.2 Materials and Methods
10.2.1 Chemicals and Supplies
The tracer particles used in this study were melamine, polymethylmethacrylate (PMMA),
polystyrene and surface modified polystyrene (PEG-PS). Analogous to Amin, Rega &
Jankevics [146] and Waigh [147], their size was carefully chosen in a size range, which
should exceed the microstructural length scale of the lysozyme network, because this
protein has a comparatively small size of 1.7 nm [310]. Polystyrene with a diameter of 0.2
µm and melamine with a diameter of 0.3 µm were both purchased by Alfa Aesar GmbH
& Co. KG (Karlsruhe, Germany). PMMA with a diameter of 0.2 µm was purchased
by micro particles GmbH (Berlin, Germany). For the surface modified particles with a
diameter of 0.22 µm the blank polystyrene particles, described above, were covered with a
layer of short length polyethylene glycol (PEG) molecules. Further particle specifications
are listed in Table 10.1.
Table 10.1: Particle specifications.
Name Company Size Functional groups Lot
Polystyrene Alfa Aesar 0.2
µm
Slight anionic
charge from surface
sulfate groups
T11A024
PMMA Micro particles
GmbH
0.2
µm
- F-KM255
Melamine Micro particles
GmbH
0.3
µm
- MF-F-S1902
Pluronic F-127 Sigma Life Sci-
ences
12600
g/mol
- BCBK9787V
The modification of the polystyrene particles followed the PEGylation script of Kim
et al. [311]. Instead of Pluronic F115 Pluronic F127 (Sigma-Aldrich, St. Louis, USA)
was used. The stability of the PEG coating was verified by analytical SEC runs and
regular size measurement for each screened buffer condition (data not shown). When
using orthogonal PEGylation methods [312], the achieved PEG density, which may influ-
ence the microrheological measurements, has to be considered. The model protein used
in this study was lysozyme from chicken egg white (Hampton Research, Aliso Viejo,
CA, USA). It was supplied as a lyophilized powder. The protein has a molecular size
of 14.5 kDa, a theoretical pI of 10.7 [313] and an experimentally determined mass ex-
tinction coefficient E1%(280 nm) of 22 L/(g·cm). The buffer components acetic acid,
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citric acid, trisodium citrate were purchased form Merck KGaA (Darmstadt, Germany),
sodium acetate from Sigma-Aldrich (St. Louis, MO, USA), BisTris propane (1,3-bis-
(tris(hydroxymethyl)methylamino)propane) from MOLEKULA (München, Germany),
MOPSO (β-Hydroxy-4-morpholinepropanesulfonic acid) from AppliChem GmbH (Darm-
stadt, Germany). Sodium hydroxide and hydrochloric acid for pH-titration and the addi-
tives NaCl, (NH4)2SO4 came form Merck KGaA, the remaining additives polyethyleng-
lycol (PEG) 300 and 1000 from Sigma-Aldrich. Their specific characteristics are further
specified in Table 10.2.
Table 10.2: PEG characteristics.
characteristic PEG 400 PEG 1000
vapor density > 1 (vs air) > 1 (vs air)
vapor pressure < 0.01 mmHg (20◦C) < 0.01 mmHg (20◦C)
autoignition temp. 581 ◦F 581 ◦F
mol wt 380-420 950-1050
refractive index n20/D 1.467
viscosity ∼ 120 mPas (20◦C)
Ultrapure water (ISO3696) was used to prepare all solutions. Buffers were filtered with
0.2 µm cellulose acetate membranes (Sartorius, Göttingen, Germany). Protein solutions
were filtered with syringe filters with cellulose acetate membrane (VWR, Radnor, PA,
USA). To reduce the residual salt content of the lyophilized lysozyme solution a size exclu-
sion chromatography (SEC) was conducted with Sephadex™ resin from GE Healthcare
(Buckinghamshire, Great Britain). The column was manually packed with a diameter of
2.5 cm and a bed height of 23 cm. For the concentration of the protein 20 mL Vivaspin®
ultra filtration spin columns (Sartorius) with a molecular weight cut off of 3000 Da were
used. For the viscosity measurements ZEN2112 quartz glass cuvettes (Hellma, Müllheim,
Germany) were utilized. The zeta potential measurements were performed with folded
disposable capillary cells (Malvern Instruments, Malvern, UK) equipped with two elec-
trodes.
10.2.2 Instrumentation
The buffer exchange was conducted with an ÄKTAprime™ plus system from GE Health-
care. The protein concentration of the lysozyme solutions was determined with the
NanoDrop™ 2000c UV-Vis spectrophotometer (Thermo Fisher Scientifc, Waltham, MA,
USA). Zetapotentential and microrheological measurements were conducted with the Ze-
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tasizer Nano ZSP (Malvern Instruments, Malvern, UK) using dynamic light scattering.
With the Non-Invasive Backscatter (NIBS™) optics even turbid samples can be measured
without double scattering. The rheological results were compared to results obtained with
a squeeze flow rheometer, the Piezo Axial Vibrator (PAV). This instrument was chosen
due to its high reproducibility and therefore functions as the standard for this study. The
accuracy of this measurement tool could be proven in various publications [139, 141, 202,
203].
10.2.3 Sample Preparation
Buffers used in this study all had an ionic strength of 100 mM. For the experiments buffers
with pH values of 3, 5, 7, and 9 were prepared. The respective buffer components were cit-
ric acid and trisodium citrate for pH 3, acetic acid and sodium acetate for pH 5, MOPSO
for pH 7 and BisTris Propane for pH 9. Lysozyme of chicken egg white was dissolved in
the respective buffer with a starting concentration of 150 mg/mL. To remove residual
salts a SEC method followed. Here 5 mL of lysozyme solution with a concentration of
150 mg/mL was purified with a Sephadex™ adsorber. This was packed with a constant
flow method. The protein was fractioned in 10 mL Falcon tubes and the concentration
measured with an extinction coefficient E1%(280 nm) of 22 L/(g·cm). The concentration
of the diluted protein solution to 200 mg/mL was performed in Vivaspins® and a rota-
tional speed of 8000 rad/sec. To have neglectable impact on the studied system tracer
particle solutions of 5 w% were induced in a ratio of 1:200 (V(particle solution):V(protein
solution)) for the microrheological measurement.
10.2.4 Zeta Potential Measurements
Depending on the pH and buffer components molecules do have a characteristic surface
net charge. This charged surface results in an increased concentration of counter ions close
to the particle’s surface. The zeta potential is defined as the potential at the boundary,
inside which the ions and particles form a stable entity, when the particles move due to an
applied electric field. The method used here is based on electrophoretic light scattering.
In this case the velocity of particles moving in the electric field is determined by the
frequency change of the scattered laser light [314, 315]. The zeta potential measurements
were performed at 25◦C for tracer particles dissolved in buffer and lysozyme solution
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under conditions mentioned above. A sample volume of 20 µL was pipetted in a disposable
cuvettes and measured with the diffusion barrier technique [243]. With the correlation
to the microrheological results a change of the measurement quality due to electrostatic
interactions could be studied.
10.2.5 Determination of the Dynamic Viscosity and Complex Moduli using
Microrheology
In this study passive microrheology was applied. This method extracts rheological prop-
erties from the motion of particles undergoing thermal fluctuations. The motion of the
particles is measured by dynamic light scattering.
For the calculation of the dynamic viscosity η measured by microrheology the Stokes-
Einstein equation, listed as equation 10.1 in this study, was applied. The two unknown
parameters rh and D of the respective tracer particle were determined by two dynamic
light scattering measurements. First, rh of the respective tracer particle was determined
in buffer with an estimated viscosity of water at 25◦C. Second, D of the respective tracer
particle was determined in lysozyme solution. Considering this approach the dynamic
viscosity of protein solutions with melamine, PMMA, polystyrene and PEG-PS as tracer
particles was determined using the Zetsizer Nano ZS. The concentration of protein so-
lution was varied within the range of 30 - 200 mg/mL, the pH was shifted from 3-9.
Additionally the influence of additive type, namely NaCl, (NH4)2SO4, PEG 300 and
PEG 1000 on the accuracy of the dynamic viscosity determination was studied. A vol-
ume of 40 µL of the sample with the addition of tracer particles in the ratio of 1:200 was
directly pipetted into the quartz cuvette and measured at a stable temperature of 25◦C.
Microrheological measurements with good results for the dynamic viscosity were further
investigated by determination of the complex moduli G′ and G′′. The frequency depen-
dence of the storage (G′) and loss modulus (G′′) were obtained from a thermal energy
balance and the measured mean square displacement [316]. G′ and G′′ were determined
over a frequency range of 10 to 100000 rad/sec.
10.2.5.1 Determination of the Dynamic Viscosity Using High Frequency Rheology
The high frequency rheological measurements were performed with a squeeze flow rheome-
ter, namely the Piezo Axial Vibrator (PAV), performing a frequency sweep. With fre-
quency sweep measurements one can obtain complex rheological parameters, like the
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complex storage modulus G′ and loss modulus G′′ as well as the complex viscosity η?.
The complex viscosity can be extrapolated to the zero shear viscosity η0. The zero shear
viscosity obtained with oscillatory measurements can be equated with the dynamic vis-
cosity determined by microrheological measurements, following the Cox-Merz Rule [131,
317]. All measurements were conducted at a temperature of 25◦C and a sample volume of
30 µL. The sample was directly pipetted on the measuring head and closed with a thick
stainless steel top plate leaving a circular gap with a height of 15 µm in the measurement
chamber. A detailed operation of the appliance and a derivation of the required rheologi-
cal parameters is described in the doctoral thesis of L. Kirschenmann Kirschenmann [138].
10.3 Results
The measurement quality of microrheological measurements strongly depends on the
tracer particles and their specific surface properties in solution. To find the key charac-
teristics of a suitable tracer particle different materials, namely melamine, Poly(methyl
methacrylate) (PMMA), polystyrene (PS) and PEGylated polystyrene (PEG-PS) were
tested at various conditions. To determine the impact of pH and additives on the electro-
static surface characteristics the zeta potential was determined. Its consequences for the
quality of the microrheological measurements were evaluated by the comparison of the
determined dynamic viscosity with results of high frequency rheological measurements.
10.3.1 Impact of pH and Additives on the Zeta Potential of the Studied
Tracer Particles
Tracer particle surface characteristics are one of the main issues for the quality of a
microrheological measurement. These characteristics can induce interactions with the
proteins in solution. To better understand the impact of the electrostatic surface char-
acteristics on possible interactions the zeta potential of the respective particle was de-
termined under varying solution conditions. Therefore the influence of pH on the zeta
potential of the tracer particles in buffer solution was determined. These results were
compared to the same conditions with a constant lysozyme concentration of 150 mg/mL
in solution. The deviation of these two values of zeta potential is given by δζ. Analog
to this procedure the impact of additives on protein-particle interactions was studied at
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pH 3. Here the zeta potential determined for samples with protein in solution were com-
pared to the zeta potential determined for samples with protein and additive in solution.
Figure 10.1(a) displays the zeta potential of melamine, PMMA, polystyrene and PEG-PS
tracer particles at pH 3, 5, 7 and 9 in the respective buffer solution. For melamine the
surface potential was positive over the studied pH range. At pH 3 and 9 the zeta potential
was 11 mV. The highest zeta potential was found at pH 5 with 20 mV, the lowest value
at pH 7 with 6 mV. PMMA and polystyrene are both negatively charged and show the
same progression of zeta potential over pH. From pH 3 to 7 the zeta potential decreased
to a minimum of -25 mV for PMMA and -27 mV for polystyrene. At pH 9 the zeta po-
tential increased to a value around -18 mV for both materials. In comparison to PMMA
polystyrene showed high standard deviations for pH 3, 5 and 7. The zeta potential of
PEG-PS was determined close to zero for pH 3, 5 and 7. For pH 9 the surface potential
decreased to a slightly negative value of -4 mV.
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Figure 10.1: (a) Zetapotential and calculated standard deviations of the tracer particles
melamine, PMMA, poylstyrene and PEG-PS in buffer and (b) difference
between the zetapotential of the tracer particles in buffer and in lysozyme
solution at a constant concentration of 150 mg/mL at pH 3, 5, 7 and 9. The
depicted standard deviation are calculated for the determined zeta potential
in lysozyme solution.
With addition of lysozyme the zeta potential of the tracer particles changed depending
on tracer particle type and pH value studied. Figure 10.1(b) shows δζ for melamine,
PMMA, polystyrene and PEG-PS. The zeta potential of melamine stayed constant with
addition of lysozyme at pH 3, 7 and 9. At pH 5 the determined zeta potential of the
particle decreased. The zeta potential of PMMA and polystyrene increased with addition
of lysozyme by a δζ > 20 mV and led to a positive overall surface potential for the studied
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Figure 10.2: Differences of the zeta potential of melamine, PMMA, polystyrene (PS)
and PEG-PS in a lysozyme solution with and without addition of NaCl,
(NH4)2SO4, PEG 300 and PEG 1000 at pH 3.
pH range. In comparison to these two particles the δζ for PEG-PS was relatively small
with the highest value of 3.9 mV at pH 9. This increase led to a neutral surface potential.
In Figure 10.2 the difference of the zeta potential δζ of the tracer particles in a lysozyme
solution with and without additive at pH 3 are shown. This pH-value was chosen due to
its low impact on the microrheological measurement accuracy in comparison to pH 5, 7,
and 9 (Figure 10.4). At this condition a predominating impact of the additives is expected.
In comparison to changes in pH, the chosen additives had a minor impact on the de-
termined zeta potential of the different tracer particles. In general they decreased the
zeta potential by a maximum value of 8.5 mV. This value was found for polystyrene with
(NH4)2SO4 as additive. For PEG-PS δζ stayed constant with addition of the studied
additives. As already observed for the impact of pH in Figure 10.1 the surface potential
for this tracer particle is close to 0.
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10.3.2 Impact of the Tracer Particles on the Microrheological Measurement
Quality
The following results show the dynamic viscosity of lysozyme solution measured with
microrheology in comparison to the results gained by squeeze flow rheology used as stan-
dard. Protein concentration, pH and additive type had varying impact on the tracer
particles used in this study.
Figure 10.3(a) shows the dynamic viscosity determined by microrheological measurements
with tracer particles consisting of melamine, PMMA, polystyrene, PEG-PS and high fre-
quency measurements conducted with the PAV dependent on lysozyme concentration at
pH 3. For every measured system the dynamic viscosity increased with increasing concen-
tration. In comparison to the dynamic viscosity determined with the PAV the viscosity
derived by microrheological measurements with polystyrene as tracer particle were over-
estimated for every studied protein concentration. The results for systems with melamine
and PMMA were underestimated. The dynamic viscosity determined with PEG-PS was
closest to the values of the chosen standard and had the same progression up to 150
mg/mL.
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Figure 10.3: (a) Dynamic viscosity of a lysozyme solutions determined with the PAV
(standard) and microrheological measurements conducted with different
tracer particles dependent on concentration at pH 3. (b) Difference to the
gold standard for each tracer particle dependent on the lysozyme concentra-
tion at pH 3.
The difference between the viscosity measured by microrheological measurements and the
viscosity determined with the PAV δη and the standard deviations of the microrheolog-
ical measurements are shown in Figure 10.3(b). In general the differences increase with
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increasing protein concentration for all tested particles. The highest δη was found for
polystyrene at a lysozyme concentration of 200 mg/mL. The results for PEG-PS showed
high consistency with the PAV. For melamine at a lysozyme concentration of 200 mg/mL
δη decreased, but the standard deviation of the microrheological measurement increased
to 7.8 mPas. This was also the highest value of standard deviation determined for this
measurement series.
Figure 10.4 demonstrates the influence of pH on the difference between the dynamic
viscosity determined by microrheological measurements and the standard method at a
constant lysozyme concentration of 120 mg/mL. Additionally the standard deviations of
the microrheological measurements are displayed.
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Figure 10.4: Difference to the standard δη and the standard deviation of the microrheo-
logical measurement for each tracer particle dependent on pH at a constant
lysozyme concentration of 120 mg/mL.
The values of δη determined with melamine, PMMA and polystyrene were sensitive to
pH. In case of the measurements with melamine no clear trend could be observed. The
dynamic viscosity determined for pH 3 and pH 7 was underestimated and thus δη nega-
tive, for pH 5 and pH 9 the dynamic viscosity was overestimated and thus δη positive.
The highest difference for melamine could be found for pH 5 with a value of 1.09 mPas.
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For PMMA the smallest difference to the standard was detected at pH 7. With a de-
crease or increase of pH from this point the dynamic viscosity got underestimated and
the modulus of δη increased up to a value of 0.19 mPas. The highest values of δη as well
as the highest standard deviations were determined for polystyrene. For pH 5, pH 7 and
pH 9 the dynamic viscosity of the protein solution was overestimated by more than 5
mPas. The standard deviations increased from 0.024 mPas at pH 3 to 0.58 mPas at pH
9. The influence of the pH on PEG-PS was negligibly small and the δη did not exceeded
a modulus of 0.039 mPas.
Also the complex moduli G′ and G′′ determined with PEG-PS particles in triplicate
showed a comparable course to the results of the standard. Figure 10.5 shows the raw
data of the microrheological measurements and of the PAV as well as its fit by Fourier
transformation of second order.
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Figure 10.5: Triplicate microrheological measurement with modified polystyrene parti-
cles (PEG-PS) of the complex storage and loss modulus (G′ and G′′) in
comparison to the standard (PAV) plus its fit [218] at pH 7 and a lysozyme
concentration of 150 mg/mL.
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The impact of additives on the dynamic viscosity measured with the different tracer
particles can be found in Figure 10.6.
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Figure 10.6: Difference to the standard for each tracer particle and the standard devia-
tion of the microrheological measurement dependent on the additives NaCl,
(NH4)2SO4, PEG 300 and PEG 1000 at pH 3 and lysozyme concentration
of 120 mg/mL.
Here the differences between the microrheological measurements and the standard in-
duced by added salts and PEGmolecules are shown. Two salt types, NaCl and (NH4)2SO4,
and two PEG molecules of different molecular weight, PEG 300 and PEG 1000, were in-
vestigated in this study. Dependent on tracer particle and additive type the measurement
quality varied. The dynamic viscosity determined with melamine particles was underesti-
mated with every additive type in solution. The standard deviation calculated for samples
containing (NH4)2SO4 and melamine as tracer particle in solution was higher than the
resulting δη. The difference to the standard δη with PMMA as tracer particle was nega-
tive with sodium chloride and PEG 300 in solution. The addition of (NH4)2SO4 resulted
in a positive δη. In comparison to the standard the determined viscosity was 13 times
higher. PEG 1000 had no significant impact on the measurement accuracy with PMMA
as tracer particle. For the microrheological measurements with polystyrene and the two
studied salts δη values were higher than 3 mPas. The addition of PEG revealed a lower
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determined viscosity. In comparison with the other tracer particles the influence of the
chosen additives on the measurement quality with PEG-PS was low. The viscosity was
underestimated with addition of sodium chloride, PEG 300 and PEG 1000. (NH4)2SO4
resulted in a positive δη of 0.24 mPas, the highest difference to the standard for this
particle.
10.4 Discussion
In this work we investigated the suitability of different tracerparticles, namely melamine,
PMMA, polystyrene and PEG-PS, for microrheological measurements under various con-
ditions. The results of this investigation showed that the specific particle surface prop-
erties dependent on solution conditions like protein concentration, pH as well as the
addition of additives had an impact on the measurement quality. The changes on the
tracer particle surface and the consequences for the microrheological measurement accu-
racy are discussed in the following sections.
10.4.1 Impact of pH and Additives on the Zeta Potential of the Studied
Tracer Particles
To investigate the electrostatic surface characterisitcs and its possible influence on the
microrheological measurement quality the zeta potential of the tracer particles melamine,
PMMA, polystyrene and PEG-PS was determined under varying conditions. In the fol-
lowing section the impact of pH and additives are discussed.
For the studied pH range the sign of the measured net charge stayed the same for all
tested tracer particles. Melamine had a positive zeta potential. This observed surface
character is mainly governed by the partial positively charged amine groups, which is
in accordance with literature [318]. With addition of lysozyme the observed variance of
charge with changing pH is compensated to a constant value of 10 mV. This change
in zeta potential for pH 5 implies an interaction of the tracer particles with lysozyme.
As both particles are positive in net charge this effect has to be based on hydrophobic
interactions with the hydrocarbon segments of the melamine surface [319]. For PMMA
a negative zeta potential was determined due to the ionized carboxyl groups Baptista
et al. [320]. This finding is in good agreement to literature, which reviewed and deter-
mined zeta potential data of unmodified PMMA [321, 322]. At pH 3 comparatively high
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standard deviation was observed, which could be attributed to its pKa at 4.5. Below this
pH-value the carboxyl groups are not ionized. This could lead to a destabilization of the
particles. In lysozyme solution the zeta potential of PMMA became positive, which is
due to electrostatic protein-particle interactions between the positively charged protein
surface and the negatively charged tracer particle surface. As PMMA polystyrene had
a negative zeta potential from pH 3 to 9, which was also seen for the measurements
conducted by Ohsawa et al. Ohsawa, Murata & Ohshima [323]. In comparison to PMMA
the δζ of polystyrene in protein solution were even higher. This behavior could be ex-
plained by the strong hydrophobic character of polystyrene [324]. Another argument for
the strong hydrophobic character are the high standard deviations for the zeta poten-
tial measurements, shown in Figure 10.1. The hypothesis, that the polystyrene particles
did not reach equilibrium could not be confirmed by repeated measurements after zero,
three, and ten hours (data not shown). Here, the motion in the electric field could be
influenced by the hydrophobic forces. This may also lead to aggregation of the poorly
stabilized polystyrene particles. By addition of lysozyme the strong hydrophobic impact
on the standard deviation decreases. This decrease can be explained by the adsorption of
lysozyme to the polystyrene surface, which shields the hydrophobic surface patches. In
contrast to the other tracer particles the zeta potential of PEG-PS was close to zero for
the tested pH range. This implies a uncharged particle surface. As the PEG-PS surface
is neither charged nor hydrophobic no protein-particle interactions are anticipated. The
determination of the zeta potential with lysozyme in solution confirms this assumption,
because only a small δζ was observed.
The addition of salts or PEGs had less impact than the change in pH on the determined
zeta potential of the tracer particles in lysozyme solution. For melamine, PMMA and
polystyrene the additives decreased the zeta potential and hereby the surface charge.
Regardless if the tracer particle was positively or negatively charged the additives shield
the electrostatic groups on the surface. Comparing the two salt types (NH4)2SO4 had a
higher shielding effect than NaCl due to its higher electron valence [325]. The different
polymer length of PEG 300 and PEG 1000 did not seem to have an impact on the mod-
ulus of δζ. The zeta potential of PEG-PS is not influenced by the studied additives due
to its uncharged surface.
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10.4.2 Impact of Tracer Particle Surface on the Microrheological
Measurement Quality
The observed changes in surface characteristics discussed in the section before are evalu-
ated regarding their impact on the quality of the microrheological measurements depen-
dent on lysozyme concentration, pH and additives. The possible interactions of tracer
particles in protein solution, which cause these deviations from the ideal value, are also
taken into account.
Compared to pH and addition of additives the influence of lysozyme concentration on the
microrheological measurement quality at pH 3 was low independent on the tracer particle
type used. The maximum value of δη with changing lysozyme concentration was 1.5 mPas
for the measurement with polystyrene as tracer particle. In general δη increased with in-
creasing protein concentration. This effect is due to the decreasing molecule distances,
which promote increasing interactions [164]. Only exceptions were the measurement val-
ues of polystyrene at 30 mg/mL of lysozyme and melamine at 200 mg/mL of lysozyme.
Whereas this value for polystyrene could be assessed as an outlier the determined value
for melamine could be explained by the different ranges of electrostatic and hydrophobic
interactions. Melamine is protonated at pH 3, which causes a positive surface charge.
This can be seen in the measured zeta potential in Figure 10.1. This positive charge of
the particle and the positive charge of lysozyme at pH 3 (pI of 10.7) lead to repulsive
electrostatic interactions and result in an lower determined viscosity. This state seems to
apply for lysozyme concentrations up to 150 mg/mL. At higher concentrations shorter
distances between the particles and the proteins allow the formation of additional short-
range interactions like attractive hydrophobic interactions and hydration forces [191,
326], which could decrease δη. Like for melamine the viscosity values of the lysozyme
solutions measured with PMMA as tracer particle were underestimated, although this
particle had a contrary charge in comparison to melamine at pH 3. One possible reason
could be the adsorption of protein on the particle surface. As shown in Figure 10.1 (b)
the surface potential of PMMA with addition of lysozyme became positive. This shift
could be explained by the formation of an adsorption equilibrium of lysozyme molecules
on the PMMA surface. This change in particle surface leads to repulsive interactions
with the positively charged lysozyme molecules in solution and thus to a negative δη.
In comparison to melamine and PMMA the determined viscosity with polystyrene as
tracer particle was overestimated for all lysozyme concentrations. This particle has the
same surface potential as PMMA, but also a strongly hydrophobic character. Thus the
particle is poorly hydrated, which leads to a bad dispersability in aqueous solutions. For
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this reason one can expect strong particle-particle and particle-protein interactions [327].
Both effects might lead to higher determined viscosity values. Short-range hydrophobic
interactions between lysozyme and polystyrene intensify with increasing protein concen-
trations, which might cause the highest δη of 1.5 mPas at 200 mg/mL of lysozyme for the
studied influence of concentration at pH 3. In case of PEG-PS the hydrophobic surface
groups of polystyrene are shielded with neutral and hydrophilic PEG molecules. This
modification results in a good accordance of the determined viscosity values with the
standard, which does not change with addition of lysozyme (Figure 10.1). Due to the
neutral surface potential and hydrophilic character of PEG-PS δη is below |0.17| mPas
for the whole measurement range. To summarize the impact of lysozyme concentration
on the measured dynamic viscosity values all tracer particles showed the right trend of
increasing viscosity with protein concentration. The measurements with PEG-PS showed
the highest accuracy.
The pH-value has an impact on the microrheological measurement quality depending on
the type of tracer particle used. In comparison to the impact of lysozyme concentration
the impact of different pH values on δη was up to five times higher. The strongest impact
could be found for polystyrene at pH 5, 7 and 9. This unacceptably high difference in
viscosity and high standard deviations might be due to hydrophobic interactions of the
polystyrene particles with each other respectively interactions of the polystyrene parti-
cles with lysozyme [328]. These interactions may cause aggregation of the particles and
adsorption of lysozyme to the particle surface. Both phenomena increase the observed
hydrodynamic radius of the tracer particles and therefor lead to inadequate measure-
ment results and calculations. The adsorption of the protein was already observed in a
minor dimension with the increase of lysozyme concentration at pH 3 in section 10.4.2.
One could explain the high deviations for pH 5, 7 and 9 with an adsorption of pro-
teins to the surface, but also a denaturing effect of the strongly hydrophobic polystyrene
on the proteins. This property is already used by several research groups to investigate
protein unfolding in solution [329]. As well as for polystyrene hydrophobic interactions
could cause differences of the determined dynamic viscosity with melamine as a tracer
particle. This claim can be explained by the comparison of the zeta potential values for
melamine in buffer, shown in Figure 10.1, and lysozyme in solution at pH 5. At this
condition melamine and lysozyme both have a positive surface potential. Thus, the ob-
served change of the zeta potential of melamine in lysozyme solution in Figure 10.1 (b)
can not be explained by electrostatics. In this case hydrophobic interactions must cause
an adsorption of lysozyme to the particle, which partially shields the positively charged
groups of the melamine surface. In comparison to pH 5 δη is smaller for pH 3 and 9
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and no changes in zeta potential were observed. With this considerations one expects
hydrophobic interactions but no shielding at these pH values. For PMMA and PEG-PS
the impact of pH can be neglected. All values calculated for δη are below a value of
0.25 mPas. The best accuracy over the investigated pH range was determined for PEG-
PS with δη < 0.04 mPas according to a percentage deviation of 3 %. Therefore those two
tracer particles are suitable for microrheological measurements in the tested pH range
without additive in solution. For PEG-PS this is due to the fact that the particles’ surface
is uncharged, which is depicted in Figure 10.1. The good accordance of rheological results
obtained with PEG-PS with the standard holds true for the determination of complex
viscoelastic moduli. Figure 10.5 demonstrates that the course of G′ and G′′ obtained with
PEG-PS are in acceptable agreement with values obtained with the PAV. The scattering
of the G′ values and thus a limited reproduceability of the complex moduli are due to not
optimized meaurement settings and have to be improved for future measurements. For
this optimization the impact of particle size is of special interest. In contrast to the zero
zeta potential of PEG-PS the measurements conducted with PMMA reveal a negative
zeta potential within the tested pH range. With the assumptions made so far one would
expect a deviation in the determined dynamic viscosity for this tracer particle. Yet the
discussed deviations of the dynamic viscosity for melamine and polystyrene had their
cause in hydrophobic interactions. PMMA is more hydrophilic in character [330, 331].
This characteristic seems to dominate the quality of microrheological measurements. The
changes in electrostatic character, detected by the zeta potential measurements, have a
minor impact on the quality of the microrheological measurements. With this knowledge
the determination of hydrophobicity should be prioritized over the determination of elec-
trostatic surface characteristics.
Compared to the impact of pH the addition of the selected additives had a minor influence
on the measurement quality. The highest deviation could be found for the viscosity deter-
mined with PMMA in a 120 mg/mL lysozyme solution with 150 mM (NH4)2SO4. Poor
solubility of this tracer particle in buffer solution containing additives seem to be the only
plausible reason. Conducted size measurements of PMMA revealed aggregation caused by
the addition of the studied additives in buffer (Data not shown). For NaCl, PEG 300 and
PEG 1000 this impact could be suppressed by the addition of lysozyme. For (NH4)2SO4,
which is a common precipitating agent for protein solutions [332, 333], the aggregation
was enhanced. Further deviations were found for measurements with polystyrene and
the selected salts. As described before the zeta potential of the polystyrene particles in
these two systems shifts to a positive value with addition of lysozyme. This positive zeta
potential is reduced by the interaction with the negatively charged salt ions. This re-
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duction in electrostatics promotes the already present hydrophobic interactions between
particles and proteins. This increase in attractive interactions results in an increase in
δη. The different impact of the two salt types could be explained analog to the change
in zeta potential in Figure 10.2 with the different valence of the salt ions. Consequently,
polystyrene and PMMA are unsuitable for microrheological measurement with salt as an
additive. For melamine and PEG-PS additional salt does not have an influence on the
measurement accuracy, which makes them suitable tracer particles for these specific con-
ditions. With an alteration of conditions this observation would need to be reexamined.
In comparison to salt the microrheological measurements with PEG 300 and PEG 1000
in solution resulted in adequate viscosity values independent of PEG type and tracer
particle used.
10.5 Conclusions
Taken all influences on tracer surface characteristics and their impact on the microrheo-
logical measurement quality into account PEG-PS was the only suitable tracer particle
in this study. It resulted in good agreement for the dynamic viscosity as well as first
promising results for the complex moduli. The key factors were its hydrophilic character
and uncharged surface. Although PMMA was oppositely charged to lysozyme it showed
exclusively high deviations of measurement quality with the addition of (NH4)2SO4. The
measurement accuracy for melamine was insufficient for high protein concentrations and
changes in pH. These deviations could be explained by its charged and hydrophobic char-
acter. However, this study was conducted with respect to the pharmaceutically relevant
bioproducts. Here the accuracy of analytical measurements is very important. If costs
for PEG-PS exceed investigation budget and measurements in ideal, solute solutions are
performed, then melamine could be considered as an alternative. The highest deviations
to the standard were determined with polystyrene as tracer particle for every varied pa-
rameter in this study. The reason could be found in its charged but mainly hydrophobic
character. In principle these results reinforce the observations from other publications,
which stated that the selection of a suitable tracer particle is one of the key requirements
for the accuracy of a microrheological measurement. Our work reveals that electrostatic
interactions due to the charged surface of the tracer particles and the protein molecules
seems to have a minor impact on the measurement quality of this screening. It suggests
that the hydrophobicity of the tracer particle has the major impact on the microrheolog-
ical measurement quality. This surface property can cause strong interactions with the
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protein molecules in solution, especially at high concentrations. Consequently this char-
acteristic is the crucial surface property that needs to be considered for the selection of a
suitable tracer particle to achieve high measurement accuracy. This allows a better anal-
ysis of biopharamceutical solutions in the early process and formulation development.
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CHAPTER11
Conclusion and Outlook
This doctoral thesis was centered on developing novel methodologies to enable a bet-
ter description and prediction of the protein solution stability in the highly concentrated
regime. For this purpose, rheological methods have been successfully applied in this work.
In addition, a rheological parameter, ωCO has been established, which has the potential
to accurately predict the long-term stability of highly concentrated protein solutions.
This work required the handling of highly viscous solutions and the processing of a high
number of samples with complex flow properties. In order to ensure accurate experiments,
a device was developed which allows the automated determination of the protein concen-
tration in the highly concentrated regime in a 96-well microscale format. The accuracy,
repeatability and linearity of the introduced device as well as the applicability could be
proven in this work.
In addition, the preparation of phase diagrams, for the study of colloidal and conforma-
tional protein stability, was successfully adapted to highly concentrated protein solutions.
The automated methodology allows to screen a variety of solution conditions. The phase
diagrams produced in this way served as the basis for the correlation to the rheological
measurements.
After realization of the preparatory projects, rheological screenings of highly concentrated
protein solutions were conducted. First, the viscoelastic properties of the model protein
lysozyme were systematically investigated with a mechanical rheometer. As a rheological
standard analysis, frequency sweep measurements were performed in the high-frequency
range in order to determine the rheological parameters G′ and G′′ in the linear viscoelastic
range. The large-scale screening demonstrated that viscoelasticity is sensitive to factors
that influence protein stability, such as pH, ionic strength or protein concentration. For
the correlation of the viscoelastic behavior with the long-term stability of the investigated
protein solutions, the crossover point of G′ and G′′ was defined as a key parameter. The
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frequency value of this intersection, ωCO could be successfully correlated with the long-
term phase behavior of the model protein. Furthermore a solubility limit for lysozyme
based on the ωCO values could be defined. With that knowledge one can make specific
statements about the agglomeration tendency of the model protein, immediately after
sample preparation.
As a next step, the established rheological methodology was successfully applied to more
complex biomolecules. The rheological approach enabled the description of the solubility
enhancing effect of a fusion protein in comparison to the native form. The study demon-
strated that the rheological approach is predictive regarding the colloidal and conforma-
tional stability of GST and Cherry-GST solutions. The combination of the rheological
measurements with MD simulations allowed the exact prediction as well as the descrip-
tion of the causes for the solubility enhancing effect of the Cherry-Tag™ fusion.
Finally, an analytical toolbox was established in which the rheological methodology was
combined with established analytical methods for the description of protein-protein inter-
actions. This toolbox has been successfully applied to precisely describe and predict the
long-term stability of antibody solutions under process and formulation-relevant condi-
tions. The study demonstrated the strengths and weaknesses of the orthogonal techniques
applied and that a correct description of the complex monoclonal antibody phase behav-
ior could only be achieved by a combination of these techniques. The toolbox is considered
as a very important step towards an easier main candidate selection and strategic process
buffer and formulation optimization.
In addition to the rheological characterization of highly concentrated protein solutions a
key aspect of this thesis was to optimize alternative rheological measurement methods.
Microrheology was identified as a potential technique for the rheological characterization
of protein solutions. A high measurement quality can only be achieved if the tracer parti-
cles, required for this measuring method, are inert. To ensure this, the surface properties
of various tracers were investigated and their suitability for microrheological measure-
ments of protein solutions evaluated. Our work reveals that tracer surface hydrophobicity
is the crucial surface property that needs to be considered for the selection of a suitable
tracer particle to achieve high measurement accuracy. In addition, with the help of the
systematic screening, specific recommendations for the selection of the tracers can be
given. In order to promote the establishment of this promising methodology, future stud-
ies should focus on the optimization of further measurement-relevant parameters, such
as tracer size, tracer protein ratio and measurement time.
In conclusion, the doctoral thesis has shown that the viscoelastic response of a protein
solution contains important information on the strength of protein-protein interactions
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and protein network formation. In addition, it could be demonstrated that the rheological
characterization has the potential to precisely predict the long-term stability of highly
concentrated protein solutions. For this reason, we are working on the establishment of
the introduced rheological technique as a standard analysis in biopharmaceutical lab-
oratories. Furthermore, the aim of current research is to identify the link between the
measurable rheological properties and the forces acting in highly concentrated protein
solutions. With the resulting database the investigations of rheological properties of one
molecule class could be transferred to further molecule classes. It would thus be possible
to determine the solution stability of highly concentrated protein solutions with only one
rheological measurement.
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Abbreviations
2D two-dimensional
3D three-dimensional
ACF autocorrelation function
CEX cation exchange chromatography
Cherry-GST Glutathione-S-Transferase fused with the Cherry-Tag technology™
CytC Cytochrome C
DNA Deoxyribonucleic acid
DLVO theory named after Derjaguin, Landau, Verwey and Overbeek
DWP deep well plate
DWS diffusive wave spectroscopy
G-CSF Granulocyte colony-stimulating factor
GST Glutathion-S-Transferase
HTE high throughput experimentation
ICH International Council for Harmonisation
IgG1 subclass of Immunoglobulin G
LHS liquid handling station
mAb monoclonal antibody
MC Monte Carlo
MD molecular dynamics
µF microfluidic
MSD mean square displacement
MTP microtiter plate
OD optical density
PAV Piezo Axial Vibrator
PEG polyethylene glycol
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pH potential of hydrogen
pI pH value where the protein surface net charge is 0
PMMA Poly(methyl methacrylate)
QSAR quantitative structure activity relationship
RNA Ribonucleic acid
SEC size exclusion chromatography
UV ultraviolet
Parameter
B22 second virial coefficient
η solution viscosity
G′ storage modulus
G′′ loss modulus
Tagg aggregation temperature
Tm melting temperature
ωCO crossover point frequency of G′ and G′′
ζ-potential zeta-potential
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